var title_f35_49_36624="Transureteroureterostomy";
var content_f35_49_36624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51520&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 486px\">",
"   <div class=\"ttl\">",
"    Transureteroureterostomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 466px; height: 581px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure represents an end to side transureteroureterostomy. The injury occured in the middle portion of the ureter and the ureter is brought across the midline for an anastomosis into an uninterrupted ureter.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36624=[""].join("\n");
var outline_f35_49_36624=null;
var title_f35_49_36625="Access needles and guidewire";
var content_f35_49_36625=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F82032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F82032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Access needles and guidewire",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 394px; height: 554px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Top panel) Seldinger needle (left) with its sharp solid obturator in place, Potts-Cournand needle (center), with a hollow obturator that allows the operator to see blood flashback , and an 18-gauge thin-wall needle (right). The needles are surrounded by an 0.038-inch, 145-cm J-guidewire.",
"    <br>",
"     (Bottom panel) A Doppler-guided SmartNeedle.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Baim DS. Grossman's Cardiac Catheterization, Angiography, and Intervention, Seventh Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36625=[""].join("\n");
var outline_f35_49_36625=null;
var title_f35_49_36626="Patient information: Lupus and kidney disease (The Basics)";
var content_f35_49_36626=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"8\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86553\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/5/93\">",
"          Hemodialysis",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/22/25952\">",
"           Peritoneal dialysis",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/59/37809\">",
"            Kidney transplant",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/35/28212\">",
"         Patient information: Chronic kidney disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/31/37363\">",
"         Patient information: Glomerular disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/42/22178\">",
"         Patient information: Lupus (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/30/7651\">",
"         Patient information: Lupus and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/35/37426\">",
"         Patient information: Glomerular disease overview (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?28/35/29238\">",
"         Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/42/36518\">",
"         Patient information: Systemic lupus erythematosus and pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?35/2/35875\">",
"         Patient information: The nephrotic syndrome (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Lupus and kidney disease (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H715373382\">",
"      <span class=\"h1\">",
"       What does kidney disease have to do with lupus?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with lupus are much more likely to have kidney disease than people who don&rsquo;t have lupus. The kidneys are organs in the urinary tract that filter the blood and make urine (",
"      <a class=\"graphic graphic_figure graphicRef79864 \" href=\"mobipreview.htm?26/28/27072\">",
"       figure 1",
"      </a>",
"      ). Kidney disease can cause swelling, high blood pressure, and other symptoms.",
"     </p>",
"     <p>",
"      &ldquo;Lupus nephritis&rdquo; is the medical name for a type of kidney disease that happens in people with lupus. But people who have lupus can also get kidney disease caused by other problems. For example, if someone with lupus also has diabetes, the diabetes might be the cause of kidney problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373416\">",
"      <span class=\"h1\">",
"       What are the symptoms of lupus nephritis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people with lupus nephritis don&rsquo;t have symptoms. But about half of all people with lupus do. Symptoms can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Swelling &ndash; This can be in the hands, face, feet, belly, or around the eyes.",
"       </li>",
"       <li>",
"        Weight changes &ndash; Many people gain weight, but some people lose weight without trying to.",
"       </li>",
"       <li>",
"        Tiredness",
"       </li>",
"       <li>",
"        Urine that looks brown or foamy",
"       </li>",
"       <li>",
"        Urinating less often than normal",
"       </li>",
"       <li>",
"        High blood pressure (higher than",
"        <span class=\"nowrap\">",
"         140/90)",
"        </span>",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373431\">",
"      <span class=\"h1\">",
"       Is there a test for lupus nephritis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. If you have lupus, your doctor or nurse will do regular blood and urine tests to check for signs of lupus nephritis. You might also have a test called a &ldquo;biopsy.&rdquo; In this test, a doctor takes a small sample of kidney tissue. Another doctor looks at the sample under a microscope to check for kidney disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373446\">",
"      <span class=\"h1\">",
"       How is lupus nephritis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Medicines are usually the first treatment for lupus nephritis. These include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines to partly &ldquo;turn off&rdquo; the immune system &ndash; In lupus, the body&rsquo;s immune system attacks healthy cells. Medicines that partly turn it off can slow down the damage lupus causes in the kidneys. There are many different medicines doctors use to treat the immune system. The doctor might:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Try 1 or 2 medicines to find the 1 that works best",
"       </li>",
"       <li>",
"        Give you more than 1 medicine at a time",
"       </li>",
"       <li>",
"        Have you switch to a different medicine when the lupus nephritis is under control",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medicines called &ldquo;ACE inhibitors&rdquo; or &ldquo;angiotensin receptor blockers&rdquo; &ndash; These medicines can help with kidney damage from lupus nephritis.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Severe lupus nephritis can make the kidneys stop working. If this happens, treatment options include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Hemodialysis, often called &ldquo;dialysis&rdquo; &ndash; A machine filters your blood every few days (",
"        <a class=\"graphic graphic_figure graphicRef56992 \" href=\"mobipreview.htm?0/5/93\">",
"         figure 2",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Peritoneal dialysis &ndash; A fluid is piped in and out of your belly every day (",
"        <a class=\"graphic graphic_figure graphicRef71539 \" href=\"mobipreview.htm?25/22/25952\">",
"         figure 3",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Kidney transplant &ndash; Doctors replace your kidneys with a healthy kidney from a donor (",
"        <a class=\"graphic graphic_figure graphicRef59957 \" href=\"mobipreview.htm?36/59/37809\">",
"         figure 4",
"        </a>",
"        ). (People only need 1 working kidney to live.)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373530\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Getting pregnant when you have lupus nephritis can be risky. It can increase the chance that the unborn baby will die before birth. Being pregnant can also make lupus nephritis worse.",
"     </p>",
"     <p>",
"      If you want to get pregnant, talk to your doctor or nurse before you start trying to get pregnant. There are ways to reduce the chances of having problems. For example, it is important to wait until you have not had lupus nephritis symptoms for at least 6 months. Your doctor can work with you to try to make this happen.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373545\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with lupus must take medicine to control the symptoms and slow down the disease. This is true for people with lupus nephritis, too. Lupus nephritis sometimes goes away on its own. Other times, symptoms come back after treatment. Your doctor or nurse will work with you to treat them if this happens to you.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H715373560\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/35/28212?source=see_link\">",
"       Patient information: Chronic kidney disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/31/37363?source=see_link\">",
"       Patient information: Glomerular disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/42/22178?source=see_link\">",
"       Patient information: Lupus (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/30/7651?source=see_link\">",
"       Patient information: Lupus and pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/35/37426?source=see_link\">",
"       Patient information: Glomerular disease overview (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/2/35875?source=see_link\">",
"       Patient information: The nephrotic syndrome (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/35/29238?source=see_link\">",
"       Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/42/36518?source=see_link\">",
"       Patient information: Systemic lupus erythematosus and pregnancy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?35/49/36626?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86553 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-655B890CD5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36626=[""].join("\n");
var outline_f35_49_36626=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373382\">",
"      What does kidney disease have to do with lupus?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373416\">",
"      What are the symptoms of lupus nephritis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373431\">",
"      Is there a test for lupus nephritis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373446\">",
"      How is lupus nephritis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373530\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373545\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H715373560\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86553\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/5/93\">",
"       Hemodialysis",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/22/25952\">",
"        Peritoneal dialysis",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/59/37809\">",
"         Kidney transplant",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/35/28212?source=related_link\">",
"      Patient information: Chronic kidney disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/31/37363?source=related_link\">",
"      Patient information: Glomerular disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/35/37426?source=related_link\">",
"      Patient information: Glomerular disease overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/42/22178?source=related_link\">",
"      Patient information: Lupus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/30/7651?source=related_link\">",
"      Patient information: Lupus and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/35/29238?source=related_link\">",
"      Patient information: Systemic lupus erythematosus (SLE) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/42/36518?source=related_link\">",
"      Patient information: Systemic lupus erythematosus and pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/2/35875?source=related_link\">",
"      Patient information: The nephrotic syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_49_36627="Pediatric Galeazzi fracture and dislocation";
var content_f35_49_36627=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54885&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Pediatric Galeazzi fracture and dislocation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 440px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAG4AkgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD3r4n+P9L+HOg2+ra3b31xbz3S2ipZojOHKOwJDMoxhD39K8yP7U3goddJ8Sf+A8H/AMepP20f+SX6T/2GYv8A0RPXxnmgD7M/4an8Ff8AQJ8Sf+A8H/x6j/hqfwV/0CfEn/gPB/8AHq+M8nkUelAH2aP2pvBR6aT4k/8AAeD/AOPUf8NT+Cv+gT4k/wDAeD/49XxlQCOOaAPsz/hqfwV/0CfEv/gPB/8AHqP+Gp/BX/QJ8Sf+A8H/AMer4y7c0vrQB9mf8NT+Cv8AoE+JP/AeD/49R/w1P4K/6BPiT/wHg/8Aj1fGWentRQB9m/8ADU/gr/oE+Jf/AAHg/wDj1H/DU/gr/oE+JP8AwHg/+PV8ZjrSUAfZ3/DU/gr/AKBPiX/wHg/+PUn/AA1P4K/6BPiX/wAB4P8A49XxkDRQB9m/8NT+Cv8AoE+JP/AeD/49R/w1P4K/6BPiT/wHg/8Aj1fGfekoA+zf+Gp/BX/QJ8Sf+A8H/wAeo/4an8Ff9AnxJ/4Dwf8Ax6vjKigD7N/4an8Ff9AnxJ/4Dwf/AB6j/hqfwV/0CfEn/gPB/wDHq+MwOaTtQB9m/wDDU/gn/oE+JP8AwHg/+PUf8NT+Cv8AoE+JP/AeD/49XxlRQB9m/wDDU/gr/oE+JOP+neD/AOPUf8NT+Cv+gT4k/wDAeD/49XxmeppPTmgD7N/4an8Ff9AnxJ/4Dwf/AB6j/hqfwV/0CfEn/gPB/wDHq+MuxoNAH2b/AMNT+Cv+gT4k/wDAeD/49R/w1P4K/wCgT4k/8B4P/j1fGRpe/wCFAH2Z/wANT+Cv+gT4k/8AAeD/AOPUv/DU/gr/AKBPiT/wHg/+PV8Y9KO9AH2b/wANT+Cv+gT4k/8AAeD/AOPUf8NT+Cv+gT4k/wDAeD/49Xxl3o70AfZv/DU/gr/oE+JP/AeD/wCPUf8ADU/gr/oE+JP/AAHg/wDj1fGZ4zSHp7UAfZv/AA1P4K/6BPiT/wAB4P8A49R/w1P4K/6BPiT/AMB4P/j1fGNKelAH2b/w1P4K/wCgT4k/8B4P/j1H/DU/gr/oE+JP/AeD/wCPV8ZUe9AH2b/w1P4K/wCgT4k/8B4P/j1L/wANT+Cv+gT4l/8AAeD/AOPV8ZelJnmgD7N/4an8Ff8AQJ8Sf+A8H/x6j/hqfwV1/snxL/4Dwf8Ax6vjIHpTwr7yoBz6UAfZf/DU3grGf7J8S4/694P/AI9QP2pfBZPGk+Jf/AeD/wCPV8iWekXFyyggqDXX6R4RLbcpuY9KAPq/wN8dvDnjLxPYaHpuma7Bc3pcRyXUMKxgpG0hyVlY9EPbritH4jfF7RPAWvxaRqmnavdXMlql3us44mQIzuoBLyKc5jbt6V4z8JtBOmfEnwfPt2hrudOn/Tlcn+laf7RVit78TSCuWTRbXafQme6oA6o/tKeFQMnRPEuP+uNv/wDH6jb9pvwiv3tF8Sj/ALYW/wD8er5zmsvKLKQSQfxxWfJZ7zuQZ56GgD6aP7T/AIPAydH8S/8Afi3/APj1N/4ah8G/9AfxL/34t/8A49Xy7PYqpIkj6cHFZ81lGpOHYD0agD6y/wCGovBv/QI8Sf8Afi3/APj1H/DUPg3/AKBHiT/vxb//AB6vkGSLYcZ4PembT0WgD7A/4ai8G/8AQI8Sf9+Lf/49S/8ADUXg3/oEeJP+/Fv/APHq+PxG2M4JApmGB+lAH2F/w1F4N/6BHiT/AL8W/wD8eo/4ai8Gn/mEeJP+/Fv/APHq+PCOO9Jnke9AH2J/w1F4N/6BHiT/AL8W/wD8epf+GovBv/QI8Sf9+Lf/AOPV8d5z9etJnj60AfYn/DUXg3/oEeJf+/Fv/wDHqX/hqHwb/wBAfxJ/34t//j1fHYPNAI/DFAH2J/w1D4N/6A/iX/vxb/8Ax6lH7UHg4/8AMH8Sf9+Lf/49Xx2DwOgqRPm7UAfX/wDw1D4N/wCgP4l/78W//wAepf8AhqDwd/0B/Ev/AH4t/wD49XyB/vHgUqqT7GgD69/4ah8G5/5A/iT/AL8W/wD8epf+GoPB3/QH8Sf9+Lf/AOPV8htGQvTmmkdM8dqAPr7/AIag8Hf9AfxJ/wB+Lf8A+PUn/DUPg3/oEeJP+/Fv/wDHq+QO+OPrScA4xQB9gf8ADUHg7OP7I8Sf9+Lf/wCPUv8Aw1B4O/6A/iX/AL8W/wD8er5AVckgdaVhtPTigD6//wCGn/B/X+x/En/fi3/+PUn/AA1B4O/6A/iT/vxb/wDx6vkFjjgn3ppHHbBoA/Qr4ZePtM+ImhXGq6Lb31vbwXTWjJeIivvCI+RtZhjDjv60V5p+xr/yTTV/+wzJ/wCk8FFADP20P+SYaT/2Gov/AERPXxj2/Svs79tD/kmGk/8AYai/9ET18YjmgAz1o74pKUdRQAvakJ4oo7UAFBPWjHeigAo7UUrHLZA47CgBM/yooNHegBMUoo7UvpQAnajvRRQAdjQf6UUUAHpQaKKADpRQaOPfmgApe4pB1ooAKO1FHWgA9qO5oo7UAGKPWlNHTNAB6U00ppMUAL60UgHPHWl6mgA7UUtIen40AKeCaT/CjqaXGTgdaAEzShSSABmr9jpk1zn5T2xjvXXaL4VJ2swHOM5oA5Kx0ua5cfIQD04612ej+Fi20tGePSvQvCfgS6v5FSys5ZyOpC8fiegr2Pw98KjHGr6pMkA4zHCdzfielAHjmjeEwqKCmOeO5FekeHvBss0cZitnfPP3cfiTXrWmeGtI01V+zWaM448yX5jW1khcYGMcAdKAPMv+EdbRvE3geVwis2rSqVU5/wCYfdn+lch8aoDP8UJ8EgjRbPp/13u69V8WjHiTwJ/2GZf/AE33ledfFOMyfFK8wu4jRbIgf9t7ugDyDVNLDJJ90EDdycfr3rmxannGRt7Hg16LewRuJWMZ3dAQelcbdLHFOTIpdSfu7s/n6UAZN3Z4AbaenzHtWde2DKBkqN3r0rrobaF4iFWYgckADkGom0zKsgQhG+6JByaAOEm03gEg7TT7LSi7Zxx7iuobTSj8Kr/Nt56LWnHYGHblAHOOTwKAObGhKYGYZJK9PQ1z2o2HkOQAV716XKASwf733cL04rkPEiATAdiM0Acn5eO3Apk1uyDdg7T3rQt4DLcxoSMFqskDcyMAQMg/SgDn9uKU/wD6quXVv5bnAOD0qqe9ACNgDI5pMYbvSkY45z0oHsKAAg8E55FOjODSYwM0mKAJy6+nNOWYAgkVW/lQSc+1AGiZUkUrjrVb5QTn86gViOckHrQSCBigCYlMdPqTSEqfXNQ8/wD1jSnJHTmgCRWCnIHepX+ZQRzVbBGOcU4SHAHP40APHPTge9LsOc4pqsST6etP3HH+NAH15+xwMfDbWB/1GpP/AEnt6KX9jg5+G2sH/qNSf+k9vRQBD+2j/wAkv0n/ALDMX/oievjKvs79tD/kl+k/9hmL/wBET18ZkDNADaKWkoAKKKO1ABRzxS+lJnmgBemaQUHkml96AE+tA60uaSgA7UelKeppueaAF7UhpaKAAUUClOPXigBKUccUHrR6GgA4B9fag/rR0NJnjHagA/Giil6mgBDS9xR2NIf5UAL37UnbHvRnpRQAGiiigAFFApe1AAeR1+tBHpSdaXp0oAOgop8UbSnaq5J710Gk6IZSpcHGMk+lAGNa2Mtw+FXA+ldXovhV32u6cg85/SvRfA3w91HWjH9gsyYhjM8g2qPx7/hXvXhH4WabpXlzak32u5GDjGEB+lAHi/g34b3+psv2S1IjwMyOMKPx717V4V+FWmabsl1U/bZl52YxGPw716HBCkEYSFAkY4CgYAqXGDQBHbW8VrEIreNIY1/hQYFTfjSH6U4D86AA896dt/Kmj1FOOe/GaAOX8Xf8jH4E/wCwzJ/6bryvPvicM/E+9xuz/Y1kPl7fv7zmvQPFxz4k8CDPP9sy/wDpuvK4r4gH/i5eqKAS50Ww24/673tAHAX0CoAwEigc4APze9ctfGKGdwqli/zfU12c9wFJVo3OflJZqx3aCOVwIgSDg8ZzQBRhiaG2iSKDAKjzcYBJ+tQPazTyljhAGB5bG32rfa32RxpGis2c4brk1BJayRbj5eM85YdaAKVtYW9vM0m1CvUqxzk+tU9QEbSAjcy+3YVoSDaDuYEn0FZ91LkMNyqMdzyR0xQBRRWOwZXntnmuV8RwGSeQqp+QYx3zXaoqQr5oCeWnJYnBwK5a9zLcyTbTgsevcUAc1ols02pxgoxVAXb8KUxHzJMIPMzkjNdPaacdL0ufUpY2SS5/dwr3APU1kLGSd0i8fXn60AYt1EWjJC856VlyKQwrqJLSR1LJHlT/ABdjWfcaPcKNwUEdcGgDDx6etGME56dK1/7IlWMM6cE9qqXVi0QyOn06UAUT1oxTtuOc4wKTHFACCj6cYoP86cRkUANHvSDk56U5ulIOnvQAoPPJprDj0IpQCTig9KAEI9+Pagt2/L3o/n6UhweooAcM0/qPeox/nFSgZHT6UAfX/wCxv/yTbWM8H+2pP/SeCij9jjj4baxn/oMyf+k9vRQBH+2h/wAkw0n/ALDMX/oievjI8+ua+zP20f8Akl+k/wDYZi/9ET18ZHp06UALxSUDtSigBKXpmkHSg80AGaTvS4o70AFFFA6UAFHb6UGlPBoASjHSiigAooooAO/NHejGKKAAdaB0FH86KADrRR0zRQAelKO1JRQAHvRRRQAUUUUAA70Gl6E/Sk7UAKDyDSUU+OJ5XCqKAGdxV+y0+S4YFhgCuj8H+DdS8Q3SwaXZyXEhOC4GFX6mvo7wB8CrOyWO58Ryi6kHzeRHwgPue9AHh/gjwDqniCdY9JspJADzKwIRfqa+jfAnwa07Slin1wi9uRz5ZGI1PsO/416lpumW2n26QWcMcMSgBUjXAFaCLxgCgCC2tY7eJY4IljjUYCqMACpwuPrT1Bo4GfSgBDkjpRjIyevajgde9IWHQfrQA7HTmkz+fSkz3/SjIOc0ARXBmAyhyvXAqmbnPUitJTx0rN1S2JRpoRlwMlf71AHO6/MZPFPgZT1Gryn/AMp95XN+PZvI+JerPvC40Sx74z+/vK0b66E/jPwOoOSNUlz7f6Bd1xXxtvzZ/Eu6RMebLotntycDie7/AMaAOZ1G4XzyuTnJIJ5HNQ6dGlxeRLvZs8kjOMCsOS6mAIIXp69DUen386SzSLIVdYjsA4GaAN7V9ftLK5kjgxnpuzn8KwbvxRKQyxYcf3zz+lc3cBnYsSGLEmozG3LN6Dp2oA1E1KaZ2/eYVjkjPQ+1WI7i3j5cl29q5eXev3DweKIGllkwGwO5Pb3oA6ma9iuMJkeXnOFPX61t6R4a+2bbq5bybJOfm4Lf/Wrl9OWCEqxXzWzxn1q/Pqd9dttkmKQKMAL0/CgB3iuT+0b6OCHiGAEJGOMD1qKx0GERA3DAzZGI89BTozIYyV3BTg7l68elaUWD/pWArKMMCef940AQzWXmhUg2RAc+Xj+dVprBEsmkdFDZwykY49atRXDO6MSksm7CEfdkHqaq6pehyTC+6RG+U9dp7g+tAGW0aTXCrFExVxgDvmqWt6b9hsmknxvb5FQ/zrtvCOkNctcX0j7YI13B2+6G71wni6/GoamY4HMsScbum896AOJmTknAAqLB/wAa6QaVIUEjRt83I47VXn0ssCqgK/Y5oAwyOcjpShfU1LLE0UjRyrtccEU1SBx+NADTzy3JpuODng1PuXg4FPR1PJFAFYDHpSEe3WrxVXHA5qEwsCTtJoAqgHFJ16fSpmjK9ep/SmEdP5UACjA4p4bA7U3v3BpR6kDigD7A/Y5OfhvrB/6jMn/pPb0Un7G5z8NdYP8A1GZP/SeCigCL9tH/AJJfpP8A2Gov/RE9fGZHPHT3r7M/bQGfhhpP/YZi/wDRE9fGeD0oAO9IO1ObkCkoASlHFB/zmigApKX05oHWgApKO/HSgCgA7fjRS0YoAT0oo+tFABS9CfpQaQ9aADtRQO9LQAg6iil9KT8aAAUCgUUAFFHel9aACjHt9KTsKUfhxQAUhPBpSOBSZwRjrnigAPejvWxo/hrWNauEi0+xlkZzgfLXufgH9n0N5V34quGI6/ZoTjP1NAHhegeH9R1y+S2020muZmIAWNScfU9q+ivh78AcLFc+KZNuCCLSI9PZjXufhbwxpmgWQttIsYbOEdo1wT9T1NdHFGAOnNAGXoWgafo1qkGnWkMESjGEXFbKqF7cUowOKU4HJwAKAFAp44+lZ8+oxLkRfvG9e1VXu3lOWbA9B0oA1nnRejbj6A0xp9w4OBWWJu+aPO5AoA0t+frS7hjOfpWcJs9zz3p4lHrzmgC8X+tAkB6nrWebjB44qM3arn5utAGmZQBjOKY9wFXrWNLqKIp3PgCqF3rEa5AbBPPWgDC1aD7P8U/BRjP7me/nkA7KRY3QI/WvOP2jyV+KCNnAGjWv/o+6r0BtTjvfiB4JjXG5NSnP/kjdVwH7R/HxPU9xo1r16f6+6oA8dvr6SF/kkcH60ul6i7XGJJCwIxyeKz9WGZCOv0qpbMYpA2eKAOpuGXByOT2WoLiQk7R8oGOtV4ZcqpYnaDng1BNJy7Bzyc4FADriT5mxkN6f1oUi3HmOyoCMDnk1XWVEVpZcHHIHrWXczvcSmR8kdh2HtQBrLrYjJEaFx6muk06Zb6GGB5NuRk8YrgF5wQcV12lwCaJRz0yfQelAHRy/6LGI4pARndhecD2NVlu1VzuYyKCGVf8AH1qGKzuh8jK+zJTDDGPxqT7IsUiDcCu7DYHzD2NACzXMpBaJUCN12jke9dR4H8KS65dyTTP5VkV3F+gJ9ven+FPDD3N8FliPkthwR/B9a7vX5ToWj3FtbxRwyOAIowcfVjQBx3xT1+xs9NTw7oyhY+NwQc/pXEeHvC5nCy3Kt5fbiui0vRPNuxPKpuLhxks3au4sdPEJGYwUPygkYHSgDz+40l0lwOEPG30H+FVm8OJI3zAICSQBz+Xr/SvT5LS18z5yCzLw2OvsaxLyJI5W2DEZBH40AebeMvDSz6WLyBCJYflbHOR6mvM5o2RyMYxX0fG6OXhmCGKVCrA9OeM14h4v0qTS9RnjbdhG+U+ooA5zack459KTlTnOaUEjnH1pp56c0APWUqce9SfaTjHX0qock8dKU9OaAJWlJOe9Mpo+nNKrEdvzoAkXGDnk0hK8fLTS3NNPT60AfYX7G5z8NtYP/Uak/wDSeCik/Y1/5Jpq/wD2GZP/AEngooAj/bQx/wAKv0nP/QZi/wDRE9fGg5IHQ19l/to/8kv0n/sNRf8AoievjIHjrigBwzjmkz2pKB6dqAFA9qM8UmeKKAAfqO1L/KkJ6ip7K1uL+6jtrKCS4uJOFjiUszfhQBBzTkVpG2xqzN6KM16x4Y+Dl7cBZ/EdwLRSMi3iILf8CboPwrv9P8IaJpcAt7Cz3FerkZZj9aAPnJNNvH+5bytnrhDxUMdtNLK0caMzjqAOlfT8Xh4SS5htQrY+7t4Irn7rwWum+IJLyO3AhuB8/fa3/wBegDxW38NX80YcxtEhOAZFK1IfDFyEOGLuBnCpx+dfTEmhQ3OlhmiBUr93HTHTFZVnoEWH/cguh5HX86APnQeHdUMgQW7A4zntigaHcR3CQzAq5IUivp5fD1tDbMwiHmDk8cCsHV/CsWp31qFiAkBUlgOgBz+VAHz3qekSWSB0JkjJwSVwRWZnrivo1fCEWomZp4gkDOeB3Gf5VQufhlou4xwWgyqtI7Fj8qjknPtQB4CaK9Et/htc6irS2YeKFmbyiRksM8Ej/CuZ8U+E9W8M3Qi1K3+R/wDVzJyj/SgDBB5o7UcYFJn86AFPWjvVi3srm4/1ULkepGBWta+G7mb5pSEB7KKAME1Pb2dxcECGJm+o4rv9G8GieRFht5J5f7oG41634X+FTMscmrsLePHMSD5m/HtQB4RpHgu+1CRY0SSSQ/8ALOJcmvafBPwUSMRXOtbIEI5jAy5H17V7N4d8PWmnwrFpFnHGveUjJ/PrXVWemJGweUl39+goA53wz4XstJgEem2aQp08wj5mrrbazjjAJ5NTLtTjAH0qUZJyBQAKAOMUqsPm7bepPArJ1HXrKyVh5glkHGxT39zXK33iOa+BDPsh6bF4B+tAHYXus29udsJEsnTjoPxrGutUlnbMsnGfujgVykmoDsQAKifVEUEs3HTrQB1S3aIMZ6nil+3DGQw/GuPfWAoO0g54HtVeXXCFIGSM8CgDuG1BQcliOOlM/tNBjc5wfeuCk1jLYBwBngnmo5NX/dgqCPxoA7/+2EyQueMcetRvq45BO3Feeya4d3GMdMjtVC78RKCd0i/QUAejS61jucY9elZt7r6xg7pR+B5xXmN54nduA249sNzUFu2talxaWUuGPDEbVI+poA7fUfE6KpZTu9OeDXOX/ikueZDu6YB4qCPwhfyDfqGoQ2/+ynzNiobvwvpEA/f39zI3c5C496AL3w81b7d8W/CMPmCQLd3DAg/9Odx/jU37RxUfE75j/wAwW1wM9f391VH4a6bpdn8X/CL6fLM8xuLhWDvkY+x3H9cVb/aR/wCSoJhcn+xrX8P391QB41qyg7W/DiseTAYYx+FaupucdSCewrHmPP8ASgCeC4CZBJwe1TS3Eew5fOew61nBhjnuPSmM2ABQBZmmEvy4wvvURHHXjvTAQcDHNIzgA5z+FAHR+BPBup+OdZm0zRfkljt5LiSZlyqBRwPqzbVH1J7Grmh6gZNJR7ZAqMCs3dgR0+lfVnwA8B/8IT4LR72LZrWpbbi8yPmj4+SL/gIJz/tFq+W/iLo8/hb4neI9PtkKQreNLGo+75cuJFHuAHA/CgDQ06aSdo4zukk/5ZsWzgehrs9G8K3l1fb3QgMPkJXhh3ya890rxFeWLHy4IODwWUE10B8ca5JatFaXBi35BbBz+FAHqt9dweHbGKESKGC5lLkflXF3FxceIrs3MokK4CKMnBXtWJ4Y8Haz4nvVlvJp3hzlpGyA3517f4V8HQ6dbN5zh2I24A4UelAHO6Do/wBmhBuEKlsAEdhVnU7mFY2jhwqDg46/XHpXXahb28cew5AxjA6j/wCtXLXdhbAl5cqPr196AOXup5HOGYDHcVQlZmQLIxLZ3gjjFdG9nbkYwMk5XHT2FRfY4X8uMRbsHPsaAOTnL7jJgZyCccEmsfx3o7ajYrexoSduG4z+Nd/LbQxOY9gI69Og/wAa0tJSC7ilt3RCrDP/AOqgD5LuIWilZWBBHGMVEYn6bTnvXrnxM8N/YLz7THGMOxBwOlcGqKMAqAe/vQBzxidh8qkY657/AEo8l+yNnFb5jAU4UD+lMeMAgY69aAMLyX/umgQPgkA+9bLRhueB9KQQntmgDIEDnjFHkNnJArZ8kdR+GelAh9uM0AfUv7HK7fhvrAP/AEGZP/Se3oqb9kVdvw/1semtSf8ApPb0UAU/20f+SX6T/wBhmL/0RPXxn19M19mftof8kv0nP/QZi/8ARE9fGZyfrQAAc0nalH3gCeD1pDgHvjtQAUsaNI6pGrM7HCqoJLH0AFdt4O+HGt+J3jlaM2Fgx/4+J0+Zh/sr1P14Fe8+Cfh7o/hcK1pCJr0j5rucBpP+A9lH0oA8f8GfB/VtXaO41xm0yzYBhGRmZx9Oi/U/lXvHhHwZpPh61EWlWsVuT9+Zvmkf6sefwrQbUbOGTZEj3MmcEjpn+tXrV7+4UMbSKCI/89W5/KgCR7C1Y/vrhAe5xmrtpo1lIoaFg+09QMCnRyR24AaBJn7dgKvw3Ek6gR24VRweQFFABBp1tbHqC+eoFZHiC2ha4SNVwSN/SprnWrO3cpJMZ3GQUhXPI9+lQR6pDOn2iC2fzcYxIw6UAPS1QWj4CqwG7pXPXGoW1nbTzDDkYCxrxk1Nrepz/ZJEDsHfIAA4Fedanqz2d9i5YG3I+6Bjr3oAta5rGoXQDmQRR5O1QAAPeo9H17yGa3vNQKXVxwA3Up7fWsHWtTiC+YWVogB36+wrg21V0vjqUxLGN/MIJ6gfwg9uOKAPdjN8nlxkyDjlTwDXSRaM0eheVKQtzqBCu2OVj7qK4fwd4u07U47e4+zXMsbqGS3SPac/3S3f61654Ztb27kOpayscbvxBax8iJO2T60AVv7LtbG3SKOBQVXAAHasHxF4Ut/EmnS2GoQfuWztc8FD6iu+uEXJ2gbqryKpXBHGKAPkzXvhI/h3U2i1GaSa3YkwvGNqsPc+tJa+FLOADyoEA/vN1/M19ZXOmW+r2klneQiSFh1I5X3FcO3w1h0+5ke9ne5tgcoiDHHoxoA8d03w5NcyLFZ2sk0rHoq9Pr2r0HQ/hwgTzdZn2d/Ii5P4mu/0+2KhbfTbVUUcbUGP1roNP8P/AMd65bvsXp+JoA5/Q9Jt7NBBo9iqDHLY5/E11Njo23D3r+Y390Hgf41pIsNrHtjVEUegpDM0pxEufc0ATII4gAgAApwLtgKMD1rO1XUtP0e3M2pXKqeoXqzfQd6898QfEC4ud0OlL9mh/wCeh5c/4UAehavrenaOP9KnBlPSNTlz+FcHrvjW6vgUth9mgPYH5iPc1wEl/vuGeR98jcli2Sagl1JOTk/zNAHRNqJUfezznLd6qzakWVstsOcnHT2rmJNSkbIAGPfrVObUiud7KBjGKAOok1D5cs/GfmOarnUVGV8wDvnNcdLrEZYJEC79Nq85NOSDWb1l+z2TqGP35flBoA6dtTQEnexyenTHvVebW4kUM7jHtWbH4Zvn5vr+OFe6p8xqZdE0e1AN1cSXDDs7YB/AUARy+JVxhXUt6DnNNW71PUD/AKLbTvu/i27VFZni3xTpfh+0EWlWkKXcwwjbQSo7t9a5Kw+JeswukWRcxsdu2T7350AemwaDqk+PtNzb2gPq+5qdqenaFoenS3Wq3stwYxnGdqlu3HvXGX3jhiOG2gDjnFc5qPjBL2ExzBJY26q4yDQBraf8Qxo9y8lnZ20quxKxyKGx7A1348dzSWMLTosExXcYw2QvtXgLXNos6SwwbGU5C9qfPrNzLxuPXuaAPXNR8aErjzSB6A4rldT8WM+cyE9+vWuAkuZpD8ztz1xUOSeSSfSgD2r9n/V21H43eF42OcPct/5KTf413X7SgP8AwtGPAJH9jW2f+/8Ac15b+zLgfHPwuMgk/aT/AOSs1ep/tKOV+KCYJGdGtvx/f3NAHi1/DLJMWXAGe5xVZbJgMu6+vFalw28sehFU3dh3x2oAh+yxgAMSc9qFtIeNykgd807ccdzzS7vlz09KAG/Z4QAAAa674WN4ds/GEWpeK5fK0/TQtykCxNI1xPn92uAMYUjcckDIUdCa5IdSQ3tilyxPHTvzQB9m6V8WtCvvBuqeKXt7+20iwvUsWaWMGR2YxDeFUn5cyjvng8dq8U/aNfTNS1zRPE+iXUF7Y6latbvJC2QJIWyA3o22TGDz8lVNTb+zP2YNDXpJq2tu7L3IR5SD7jEKfmK8oYhgoLHAYNjOBnBGcd+CfzoA3NCtBeyqq8uepPpXqPh/RbOAKWjR26g46V5j4cuFt5G2thsYFd7oWrSptVzkDoR0oA9e0eZY7aNY1VAPTvWub0KoIOxB3PU1w9hrAKDcVzjqBitMXwkGFIYe9AFq9vGkk8tGJ3dWPf2rOuHj8hTOCYl6FupNTy/vIyd20dlHesy53F9zOWQDAU8Z/CgCjNIVkKlRuI+Yg8Y9RTw/kgMWLKykY9Cf6VJcW+FVlQxuBySeBVWbKFUbjK8e9AErLubcPmbH8JyMVBYKYZN6NtfOQR6ULIsCkqMSOfwqQfOwLthuowcA0AXvEOlx6zocu9AW25P5dR7V89a3pkmmXskEqnC9D0zX0XoN3832eXhc4Rc8nJrkfiz4Z8+B7y2j5HJ4oA8QVumOtSNGG5ycj8hQV2Pg9sg09cEgckEUAQCMbicDHv296RUyCB+dXIbSeVh5UTuvspNaNv4dv5MYt2Az/FxQBhBRtAGM+tORNwwATz+Ndba+C72Vl81o4wevetez8BDefPuXOOQFTFAHrv7Ji7fAmug9f7af/wBJreitT9nKxj03QPE1pDnZHrJxk5PNpan+tFAHN/to/wDJL9J/7DMX/oievjM/rX21+1tpV7rfgPQtO0uAz3k+tRiOMEDOLe4J5PoAT+FeE+G/hlaabPv8R51C5Xkww/6lD7nq36CgDzzwl4P1nxTPjTLbFuDh7mX5Yl/HufYV7h4P+GWh+GkW51MpfaiDxJOBtB/6Zp/U5roLS+WzhjggtQEXGFVdqqB2wOlUNSna/vEndwxQ8D+6PagDp0usybUAiiHc9SalupWvCsFkGKsP3jjjd7Cq2j6TdXEaM5IWQcBj29cV1mmaattIEkQCQcGgCroukrDEJNn7w8HI5H0rWa2duMZx69q1IUCEZXHpSyttyUG5h/AOuaAM821vZxh7oksR8sY6n/CqEzXN+fLAEdsOirwo+p71pmxyxnvGJkP8Oeagup0RPl2qg6AUAZ66ZAyhRnOck+tUbsfY3wp+XuKsfbdsmVbofzqrqpa8icwx7icbiTgKfegDD1S8jcBo87SuASc15l45YSlTFuaUHbtUZP5V1MCS2/nC8lEqliVRTjb+NYmtanDt2wxJGM9up+poA4SPQb2XBvHFtEecdT+XarV1pOnx6bcwBGYyRn94Wy2cdR6U681Xy3bBJB685FZU2qH5lbowx+dAGz8N9c/sjSrGZGLBAQVLd89q9p0L4n27BI7tmjJ6nbkV8rG5j066LWpIgY4kizn8R713fhRn1TTppLYb1jG7/aFAH1bpGqRapEjwyJLEwyCprajhQ5Ljdnn3rxDQdSRdLtvKk8siJSVHfius0TX76Pjzy6DnEnP4UAelA7F4GMdhUuUniKToNmOcniuNk8e6PbXK2dzcRpeEY4OUU+57Vga3q8rXonvtQMkA5jigbCNQB6VFd2MCeXa7cDj5PX6003k0x/dJgetcjpd8slnHdahKllCwzhmA496yvEPxNsdPDW2goLqYDHntxGPp60AegXE9tp9u1zqdykUa/wB9sf5+lcHr/wASWYvBoMYjj6G4lHJ/3V/xryvW/El3qUzS6lcyTMf7zcL9B2rJ+2XF4xW3ilkOOqDIoA6e91Z7iZp7m4eWVjlnckmsu81LILZHtVZNG1BoS928VrGBnLtkgd81nWl74f8AMZL67lL5OAxwj+h9qAJJtRDSgBsjuq8/yqzb2+o3x/0WzkI/vSfKv61dh13SbJQbWK3QjptA/nUGo+NoxE5idA+MrluCfSgBW0txcrDqmr29tK4yIlOWx9elX/7C0O3G64eS6YDkyScfkK8I13WNQu7+aW7b967ZJByPw9qsaV4juLKzdJLiVy/3QTnaPagD3L+1NMsBts7e3iAH8KgfrXmfxB8c3N3dCxtDIkMJyWBI3t9fQVx13r11Pn5j9WNZtxdS3H+tbd6UAdHp3i/V1k2T3ZktxywkOT9AaluvFlw5wXP0PauSJ5BJ5pevfn35oA0rzVWuxieMSem7qKpRSbMsgxJng4zx6VDnHXqeKUnnGDn0oAkkleQkyuzMTnLetM4z0rofDHg3W/EcoFlZyLBnDTyKVUfTPU11Oq/Dl9Ctw91d6csnd7y5CIo/3Rkk+1AHme4DrirulaZfaveR2ulWk13O5wqxIT+Z7V6XpPifwZoVqBdWo1q6XgR21sI4Qf8Aefk/lWT4i+KmsX0ZttCt7bw/YHjZZKBIw/2nxn8sUAdHoXwM1GWBZ/EGo2+nRAAsCw+X8TVe/wDDHwu8OTH+1PE2oazMp/49bBQQfYuOP1ryu7v729/4/by6uM/89Zmf+ZqvnOPYYH0oA+hvgv4o8O6l8XPCmleF/C0Wk26XFxObuWTzLiXFncKFY9h82cZ6gVr/ALTrMvxTgCnDHRbf/wBH3NeZ/sx/8lz8MfW5/wDSWavRf2p3Vfina56/2Nb45x/y3uaAPJndhkHjrxVdyeKje4LOeTtFRiQHnkDrxQBOzBcdzTVbJGcGoWfpxkHnNNDnt09qALZfAIHfrRuVRlugFUvNKkF8kdBTpJQylGHDcH6UAex/F3OnfC34VaTwC1g99KoP3WMcR/nK/wCVeSByWyTmr0d5e+J9Z0Sx13XLn7MskdmlxckzC1idwMgEjIHB69BWj8SfCsvgXxpeaFLO9xDEkc1vcOoUyxsvXA9GDr/wGgDKgdlIYNjnj6Vt6frclsw3c4rBjmUwhW4I79qRCXJA5oA9a0LXLa7QKG2yema6a3umjI2OGrwqCZ7eTKFlb2rqfDviK6E6RSAyIx59hQB63b6gzELJjHTJHSruTIxUL5q8gNj7tc/p12l2FEJG0dRiups45fs4zG4GeCo/WgCry8bII2JIOP8AaquLGUgrIko2rlCFzk+hrqYLd8HEYXPQmrkULjasjfd7AUAcEbWcYYxupAxtYdPwqxDpN3KiExbWByMnFdhPYoJjIxAB6KPSpFYb9o4Rf4z3IoA5+y0O6MgeXarA8Ybke9dd/YSajprQztvOPTrVOO5+fcnHfG3p9DW1pcu9hgkeoJoA8F8X/Dm10vUfMKnyZCW5PFULfQLC2I2Rrx3Ir3rxzZpLp7OybhkAHGcZrx3xDZpaXCokhXGfloAqJHaQKPKB3HsF/PFWVuUU4Majjqep/CsojLhs4GMcGnbZHkzt5xwVbNAGmt4c7owoA4Jpj3RdmDysWJwNtVYbaRuFR2fPAC55rVtPDGqXg3R2zAg8Fht/nQB6J+z6c6R4oJ6/2z/7Z2tFWfgdYzabaeK7S5x5sesjdj3srQ/1ooAi+Pep22jaZ4Xv73/j3h1gluM5zZXQH6kV88658RLvU7mQaZFHZwbvmkYZY/h0r1/9sWQRfDjRnJwBrUWT/wBu89fNWg6SNSUymdLeyT787ngfQfxH2oA6m18QT3MwthNNPM/3UBJLn6CvQdFsf7KRLnV491y2DFag5I93/wAK53w9BaaXGp8P2zicja17cL+9f/dB+6Kvaj410TQwF1a5T7WOSkQ8x2P9KAPWPCzSPHvuwA5O4AjpXQ3ZiCCTOHHTHWvniP4xT6nE0GgWJhZTgyTH5sdsCli8bavaanbNrF421zkFujD29aAPoSGbcnmTkBB3PFJLq9rGCElUEDqBXmH9u3l+mWkfb2LnaKqG75AnuW2Z5VTyaAPSrvV4ShU3A3HoO5qksc1yQyKUXrvbj8q40eINP0uHzZdiEDhmbJP41gav8RJ7lisJ22+cAKcFqAO+1K807TZAFLXE4GGx0/wrktc8UvNldoiUA4VD1+tcvJ4kinXAOPY9q5nWtVU7iJcE+lAG9f6wGRhuHPXmuL1nUEbcDLkAHisu+1M7jtYlfX0rmr++MzlR64zQBLc6g/mMVY5+vWqU15LKOSR+NQE55z160lABkk8810Pg3xFLoF9IwOYJV2sueK57uKMcUAew6T4x023vyqyObd0DDzQAYj3HHVfSote+IotxNDplwX3E7Gxgj3NeSAcc8+1GOOMY9KAOti8S7/8AWSNnPPPJPr71ox+KJViRRPJtQ7lUtwD61wGPxrQ0iazhmZ76MybcbQScGgD0N/FWra5IEQS3eOirnaPf0qt4gu77TrSNrm4jhkmPyJDiRsevpWHqfisT6VNY2i+Qjrt/drt4rnprsvBHCSCsa7VYZHFAHpXhjxHobKn261lN2DtLyncCfp2rc1X4gWFhAFtQJWY7AsGOPqe1eJLK6A4OCRjI7CoqAPSfE3ixtSsmgjnaEk5JznPsa8/nnmkkIeTcDxwetVyTgZNIcflQBefUZ9qxoxVFGABVd7iZ+GkbH1qEcnaOSTwKtJYXT4xE+T0GKAKrMWPzEn8aSt208KaxeD9xZsx9MgE1cuvA+r2CLLrAttOtz/y0nmXP4KOTQBy2cKQenWnIjuQEUsfQDNd7DYeCtPsw82tfa7jGCEhZiT9OlY1v4htNPunays2uY88efhB+S/40AYEVndSsFhtLiRvRYyTXYeHPh9e36+bqk9vp8WMhJpVRz9QTxVXUPiBrlzD5NtJDYRYxi2Ta2P8Ae61ykjNLIXmd3Y8lnJJJoA7u8s/D2gX6K2oWd0ifeSBDO5P1+6K13+Jum6fbbNB8NWxnIx9ovSGI/wCAAf1rywdBgAfypRzntQBua74s13W5zLf6lORn5YoW8tF+irxWE7NI+6Ql2/vMST+tFAOB2oAP0o685pCSaO1AC/jRSUUAepfsxf8AJc/DH1uf/SWavQP2r/8AkqVp/wBgWD/0fcV59+zD/wAlz8MfW5/9JZq739rVtvxSs+M/8SWD/wBH3FAHi0z5OPwqIv6EjmmSyZb09ai3fLjNAFrzumT8o9KPNH4VSZ/TOaZu+vFAFxp88sc4ppn4qmSfzoJPrQBalk3xlW6EYNe5/GBz40+EXgvx7H+8v7df7N1Jh1LZxuPt5iHH/XWvFNB0q/1/VYNL0mJZ724ysUTzJHvIGdoLkDPoM5PQV9IfBz4f+Jx4F8ZeCPFmkT2NlqUP2iymlKskc+AM/KTyGWJgP9k0AfOgukcHBwM459au2m4/NxjvXsPxS+GGm/Db4PWbSPHda/eajDHc3m3jGyRvLjz0Ubc54LY57AeYaRAkkBYjPGRjmgCrdSEhGwBnjjvXXeGrcRaWl0R87k89TiuY1m3ME4iYAMuCcdOa6jS5jFZwQnrt4z0FAG9BdtZjEBIbPJWus0TxpPbBI7/JQ9Oa4NQZGJLlT6Mw5x7Uszx7l2bpGBJbHb6UAe8aZqkWoW+6CRST/Bnn/wCtWi8pIAUYLEDr0+teEaRq8+nSK0MjHjJwTzXqvhXxVb6kiRXO1JunJ60AdC7MVbphuuOc01Yy8RUgAfw9t3/16vC2IO+N8r1PoaSS0KqxQM3G7PpQBkSzMhUBCpz0xV2wu0DZz84ALAZqGa2nFxkKWQnIz2pBp8iSAxbhvP3vSgDt0WHULAIRlXGea8+8S+B31KffDIIpk4DY+Uiuu0yWWOIwsybwMqSelaEN8gXE5XeKAPNLP4bLj/SJpHJxkAYWt/T/AAFptsoAt9xAwd3Ndi9/bqQpdcmop9RiUHa4yOuKAKdroVpCg2QIAOnyitD7HEnOFyeuBVKXV4lB+cDHfNVJtZjx80w6+tADfAYA1vxwFGB/bMf/AKb7OioPhpMtxqPjWVCGVtaTBH/XhZiigDzr9tDn4YaT/wBhmL/0RPXydoXiO40hNiRpNGDuVX6CvrH9tD/kmGk/9hqL/wBET18i6Xo9xqMbyKyRwqcFn/iPoBQBsX/j7XLoSIkyW6uNuYlw2Pr2rmFSSWQkHe7nkk8k/U1YubeK0faSJW9PSqhJJJ6fSgDR06V9NvI5DOYz0IT+teiXPiC1u9D2rDF5icq55Ib1yfWvKw3zAsN/qDSiZ1BEbsqntmgDr/8AhO9SVgrOzBeBk1JeePLq4AZY281VxuzgfWuJzRQBqXevahdyeZcTlj6dhTItXvAR+9PTHNZ3fpxSk85xgelAG9DrE5GGfP0qtfapI4xzk+9ZQJBHP5UEk0AP8+Tn52qPNFB6fT9aAA4oIIIzxnmjAoFACH2yaAORRnp1oPWgBR060ZOKB3PajpQAADFKePfHcU0HsacmZH2xgs54CqMmgA/WkPP/ANati38NapMoKWkpz/CFJNatl4OmibzddurbTrcc/vZBvP0WgDkiRVi3sLm4IEMTsT04rsp7zwjpI/0C3/tC5AxvYEL+tVh4/voBiwsbCDsD5eSKAKVt4PvpCv2mWK2U84frj6Vs2vguzg8x9S1GKKNBnLkDIrldU8Q6pqkvmXl45OeBH8gH5VmSFpG3OxdvVjk0Adkmq6BpdyUs7UXCDrMq9fpntRqfjC2mtvJs7BxnqXfaPyXn9a4w+lLmgDobTxprtjCYtPu1tF9YowG/76OTWLfXl1f3JnvrmW5nbq8rlj+tVxS57jigBO1HajPNFABRQc0ZoAPekpRRQAUUdqKACiikoAXHFFJS0Aeo/sxf8lz8MfW5/wDSWau1/a+bb8U7A/8AUFh/9H3FcX+zF/yXPwx9bn/0lmrsf2xD/wAXT0//ALA0P/o+4oA8PZyTzTMngUgJxxSigBCaOc8daCRQenegBf60EUZoPSgBVYoysjFWBBDKcEEdCD2r7I/Z4+MA8X2qeH/EcyjxHAh8qUjAvYwOv/XQDqO/Ud8fGtTWtxPZ3UN1ZzSQXMLCSKWNirIwOQwI6EUAfXH7Y023wRoMB24fVRJjPPywyj/2avnnwxcpFZ7m5KyAEe1bvxS+Kp+IPgrw3Z6hCI9csJ5TdMgISVdihZB2GcnK9iOOCK4PT7jZCVUncTnANAHRa4PK1Te+Spwc+3rV2BySrhiR1yKx7+4+22AJbMkYyff2p2hXwZPLkBJ/hOaAOpWU/M2D83HpmrcJ43cZJ5zyTWCJwh+bnHTJqyl75YBBy2OPUUAdFaSIzbOrcnB4AHtWhayfvy0bKjD7pU8Vx324nIVsHPP/ANapzrkNmoM7s79kXvQB7x4J8WRYWyv2zIOA7dGHvXf3dzAlu0qugXGcZ6V8cXXiu8kJFuRBD27t+db/AIT8d3Nq6QajPJLD0EjMSQPf2oA9yv8Ax/YWjMmxmkUkNgdB61xmr/FRnLR2luQQTy3H0NZGqC31MedAVRiMjb0NcybCOWTF5IImHTHf2oA6nT/iBq87lXmCHsVWtabU9VuQJ3vpo5OhG7AYfSuVso7OBDGmxSOhz1qxFfjfsuZACPuj2oA62zvLpGUGZmd8EkknitI3zZYtI5JGDtJrlLa8AYsvLD7vPStywhmuU3LFsGeuf5UAWJ7l5CqRK7bh0ao97tl3PzLxjNbdjokkgQnLt1znHFbFv4aO4tIqID375oAf8ECzWvi0vncdaHX/AK8rWitD4XW62l54zgVt4TWU+b1/0CzNFAHH/tWRrL4L8Po4BX+24yQfa2uDXy74gsW0HT/OjP7qc4THqe9fTH7X9y1n8PNEnTGU1qLr729wP618oeI9aa7sYrNgzKDuUt/D7UAc47b3JY4zyT1pvToeKQDg0lAC0lFFABR3oooAOaXvSGigBaSlNIRQAtHekoyc0AFHaj1qSKGSZgsMbOx4AAzmgBlJW3a+FtYueTZPFGOskpCKPzqaW10fSDidxqV0OSitiMH0460AZ9hompX6brS0eRfUcD86tSeG9QjO2VUD9cBxgfU1Ne+LtWuLdbeGZLO2UbVit124HpnrWHJNLL/rJXbPqaAOj0qy0XTXMuvXqTtj5ba2G8g+56VauvGkVtlPD2k2tkvQyyIHdv8ACuNGBwMUUAbt14s126B338qKw5Efy5/KsWZ3nffM7yP6ucmmZ460elAC4x1/KkPXFB69aX+dACUfXpQKMH0oAO9GMUDpRmgBRyccfjR3NITzwBijucUALxnmkPU+lHTvmjNAB9aOMdKXPFHagBKKO9FABij6UUUAFFFFABRXvPwJ+EPhjxz4C1XxD4m1LVbL7DeSwsbWWNY1iSKOQsQ0bHPzt36AcVv/AAu+EHwv+JOmXl5oOp+MIRaTCGWG7ltkkGVBVsLGw2nnHP8ACeKAPOv2YgB8cfDHrm5/9JZq6/8AbF/5Knp3/YGh/wDR9xXHfswEn44+F/8At5/9JZq7H9sT/kqenf8AYGh/9H3FAHhvakB9OtLnjpmk7UAHXmiij86AFpPeiigAooooAUDkc1PCWVsdxUGf0pR14oA0VudmMH60kE/lzkoTgGqG85xQrHtx2oA6r7YHjDE0hvD1yAfrXOpOVGMnA7UfaGcjcxxQBvNfuSViOPVvT6VCrgtuyWb3rNicnr930q1vVU4OAf1oAmllzkelCS8A5IzVUyAdOvrQGOM56UAdPomtzWhWOR2MOe5+7WlqOr71+UrkvncPSuMVsE44qTdnoxx2oA6q3vJXuFZQWzzWq0txJIqrjlwScVhaNqkdrCQVViOnHNXf+EiRXJSPPpmgD1fwfYRXGDcEHAyRXp9odLt7eMhVyBjFfMMPjG+hX/RgiEeveqGueLdbm065J1CVAsTMoj4xgGgD6g1XxlpWnRkNPBFtHTdgn8K4rVvi/YxbltN87H+6OPzrH8ZfD3wf4d8RjRJrvx7qd8dPfVG+yy2G1YEJDEmVU5G08DPtXP8AxB8E+H9G+H/hzxZ4Y1PW7qDVrtIhHqHkj920Mr9EjUhgYx3I69etAHtn7PusHX9I8U6myFDPrR+U9sWdqv8ASisj9lA58Ea8f+oy/wD6TW9FAGd+2hz8L9J/7DMX/oievjVndiCzMcDAye1fdP7TfhDXfGngTTtP8MWH268h1OO4ePzo48RiKVScuwHV14znmvmX/hQfxNxgeGG+v2+1/wDjtAHlp65FJXqX/Cgvib/0LB/8D7X/AOO0f8KB+Jv/AELB/wDA+1/+O0AeW0V6l/woH4m/9Cwf/A+1/wDjtH/Cgvib/wBCwf8AwPtf/jtAHltL1Feoj4A/E3/oWD/4H2v/AMdo/wCFBfE3/oWDj/r/ALX/AOO0AeXdKDXqP/Cgvib/ANCwf/A+1/8AjtH/AAoL4m/9Cwf/AAPtf/jtAHl3WjH0Feo/8KC+Jv8A0LB/8D7X/wCO0n/Cgfib/wBCwf8AwPtf/jtAHl/HrSYyQB1JwAK9e0v4B+PlnL6l4YuGQfdSK9tDn6kzCuu034Q+I9FgafTvAV1c6oOY3ur2zCIfwmJoA8k0fwVevbLfap5Vpabd375tuPc+lINbs9G8xNNCXcw6TMu2Mf7o6n613HiD4SfGDX5/M1LQGdAcrCt/aiNPoPN/Wsn/AIUD8Tef+KYP/gfa/wDx2gDz7VdZ1HVCTe3cjp2QHao/AVnYA7V6l/woH4m/9Cwf/A+1/wDjtJ/woH4m/wDQsH/wPtf/AI7QB5fnik4zXqP/AAoH4m/9Cwf/AAPtf/jtH/Cgfib/ANCwf/A+1/8AjtAHl1HavUf+FA/E3/oWD/4H2v8A8dpf+FA/Ez/oWD/4H2v/AMdoA8tIweTR2r1L/hQPxNz/AMiwf/A+1/8AjtH/AAoL4m4P/FMn/wAD7X/47QB5bSdq9T/4UD8Tf+hYP/gfa/8Ax2j/AIUF8Tf+hYP/AIH2v/x2gDy0Ud8mvUR8Afib/wBCwf8AwPtf/jtH/Cgfib/0LB/8D7X/AOO0AeW57UtepH4BfE0n/kWCP+3+1/8AjtH/AAoH4mdvDB/8D7X/AOO0AeW0DmvUf+FA/Ez/AKFg/wDgfa//AB2j/hQPxN/6Fg/+B9r/APHaAPLqK9R/4UD8Tf8AoWD/AOB9r/8AHaP+FA/E3j/imD/4H2v/AMdoA8u+pozXqP8AwoH4m/8AQsH/AMD7X/47R/woH4m/9Cwf/A+1/wDjtAHl1Feo/wDCgfib/wBCwf8AwPtf/jtH/Cgfib/0LB/8D7X/AOO0AeXUV6l/woH4m9vDB/8AA+1/+O0n/Cgfib/0LB/8D7X/AOO0AeXe1HavUf8AhQPxN/6Fg/8Agfa//HaP+FA/E3/oWD/4H2v/AMdoA9M+BOg6z4o/Zz8UaH4dubS1u7/WHgkmuWZVWEw2/mY2qSSVyMe55r1jwJ8MtQ8D/EKXUtK1Rbvw/d6ZFZ3UV1sScSwgLEyrFGqFQgC888knNfLR/Z/+Jh/5lf8A8n7X/wCO0f8ADP8A8S/+hX/8n7X/AOO0AH7L/wDyXHwv/wBvP/pLNXZ/tif8lT0//sCw/wDo+4q58CPhB468L/FbQtY13Qvsmm2vn+bN9rgfbugkRflRyT8zAcDvXSftK/DTxf4x8fWWpeGtGN/ZR6ZHbvILmGPEglmYjDup6OvOMc0AfLfSivTP+FE/ErP/ACK7/wDgfa//AB2j/hRPxL/6Fd//AAPtf/jtAHmdFemf8KJ+JX/Qrv8A+B9r/wDHaP8AhRPxK/6Fd/8AwPtf/jtAHmnaivS/+FE/Ev8A6Fd//A+1/wDjtH/CifiV28Lv/wCB9r/8doA8z70V6Z/won4lf9Cu/wD4H2v/AMdo/wCFE/Er/oV3/wDA+1/+O0AeZ0o616X/AMKJ+JWP+RXf/wAD7X/47R/won4lf9Cu3/gfa/8Ax2gDzQdaXPHHFelD4E/Ev/oWH/8AA+1/+O0f8KJ+JX/Qrv8A+B9r/wDHaAPNelGcknNelf8ACifiX/0K7/8Agfa//HaP+FE/Ev8A6Fh//A+1/wDjtAHnKOQM5qQS+vWvQv8AhRPxK5/4pd//AAPtf/jtH/CiviWP+ZYf/wAD7X/47QB575gJ4p4bIyeRXoB+BXxL/wChYf8A8D7X/wCO09fgb8SwP+RXfP8A1/2v/wAdoA4FH9Dg+9PWQ+uBXe/8KO+JXfwu/wD4H2v/AMdpy/BD4kj/AJleT/wOtf8A47QBwscvy9cetSfaCucniu4HwS+JA/5laT/wPtf/AI7Tz8E/iOSP+KXl/wDA20/+O0AcUtwucHtUeoTA2F1joYn/AJV3g+CfxD7+GLj8Ly0/+PU8/BPx8y4fwvcnIwR9ss8Y/wC/1AH0H8R/h3qPiH4i2fiCHS/DusWEOkvYGz1eV0AlLswkGIZBwD7HryK4H4z+Hr3wh8CPBmi6rqJ1G8s9WVZLg5IOYblgozzhQQoz2A6dK8vn+BHj1mxH4RZU/wCvuzyf/ItWdN+B/jm3lDTeD5SB0KXlnuH/AJGoA9w/ZKIbwHrhHQ6y/wD6TW9Fbv7PXhbVfCfhTVrTW9Pk0+WfU2uIopJY5GMZghTJMbMPvI3Gc8UUAeo0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAcZ8YfFF94M+HWq69pMdtLe2pgEaXKs0Z3zRxnIVlPRz3HOK+b/8Ahpjxxj/kH+Gv/AWf/wCPV7n+01/yRLxD/v2n/pVDXxBgg5HFAHth/aY8bg4+weGv/AWf/wCP00/tNeNxn/QPDX/gLP8A/Hq8UPU8VExw3SgD3i0/aS8cXGf9B8Nrj/p0nP8A7Xq9H+0F45dci18N+3+hT8/+R68J0n5W5xg10lrFvIHc0AetJ8ePHTkbbfw2cnH/AB4z/wDx+rX/AAu7x0pXzIvDaqep+wTnH/kxXAaRamRDtTnPOa6WDRhPbyRSLjcMKc9DQB1P/C3vHG1Tnw383T/iXT9P/AimT/GHxvFJEufDZDgnP9nTjH/kxXCWcbLF5Eww8ZKGhwZtRC8bIV5PvQB6PB8VPHUyqUbw5yMkf2bPx/5M1DJ8WvHKjKnw23/cOn/+SK41VZXK8qT6Ul8TC6xgngZI6UAdjb/FzxxKjNnw2NpwQNNnJz/4EVftfiX48uEZhJ4aXHQHTZ+f/JmuB0R4JJdrNtlLcBuM11EzxwxJuxgDntigC8fip47WVkdvDQI/6h0//wAk1Vm+L/jmPJ/4por2P9nT8/8AkxWH9tt3Nyso+WRCEI6g44NctaX5hSSzvMP82UY9QfrQB6P/AMLg8amNWWTw0WIztOnTj/25rFufj342gLZi8NlV6n7DP/8AJFcVqFwqwtyBnkHuK43UrguWLHjnigD3/wCFXxw8U+K/iNo2gara6ItletMJHtreVJBshkkGC0rDqg7dM1qfHr4w+I/AHjS10jQ7XSJbaTT47tmvIZHfe0kqkArIoxiMdvWvFv2d23fG/wAL/wC/c/8ApJNXR/teIZPipYADP/Emg/8AR9xQAn/DTHjjbn+z/DeP+vWf/wCP0o/aX8cEjGn+Gz/26T//AB+qfwY+FGj+OfDl/qOr32qW88F81sqWjxKu0RRuCd0bHOXPf0rz/VdHi0zxDq1hA0kkNnfXFtG8pG5ljlZAWwAM4UZwBXnYbNMPicTUwtNvnhvoW4NJSfU9Rj/aQ8dvjGn+G+f+nSf/AOP1ftvj/wCO5iB9k8NL/wBuc5/9r15LbWwzggYHYVqJAI8YwOK9Eg9VHxw8dEAmHw0PrYz/APyRSf8AC8fHPaLw17f6BP8A/JFeZBvl54PrTQScDJyeBz0oA9Of45+OFBxF4bOP+nCf/wCSKg/4X1453lRB4a465sp//j9eblWPAbgdPelEDNnHB96APSh8d/HOcGDw2D/14z//ACRQPjt45LAeT4b/APAGf/5IrzdYCBycL1IzT0t8noOaAPSU+OXjdukfhrH/AF4z/wDyRT/+F3+OO8fhof8AbhP/APJFecfZ+gA47mpBGcgLncOhNAHoS/HHxuxx5fhsH0+wT/8AyRQfjh457Q+HD/24T/8AyRXF2uj3d1F5kMRdTxmphoF8pIWBunOTQB1w+OPjgn/V+GunX7BP/wDJFL/wvHxvtz5fhv8A8AJ//kiuTHhu8Iz5XOKX/hHr9ANtq38waAOsX43eOWP+q8N4/wCvCf8A+SKP+F3+OOcR+G+P+nCf/wCSK5NtFvExutpMA9hSf2Xd7iFt2Az6UAdc3xt8cIPmTw0P+3Cf/wCSKP8AhdvjjYSU8NZ/68J//kiuT/sW7AJa2YjGc1WbTJ0zmJgcdMZoA7ZfjZ44OPk8Nc/9OE//AMkU/wD4XT444O3w1/4AT8f+TFefiznByY5BjrxUogmYBvKbJGeB0oA70fGbxyc/L4bGP+ofP/8AJFO/4XJ44448Nc/9Q+f/AOSK4VLeUnPlvyOm004QsByjDPYCgDuT8ZPHG4gf8I0cf9Q+f/5IpD8ZPHQH3fDY+unzj/24ridjBjlXyfamkZByMgd6APoz4MeL9V8ZaDql1riWK3NpqBtFNnE8aMnkxSAkM7HOZCOvYUVg/s1DHhrxIPTWT/6SW1FAHr1FFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHl/7TP/JE/EH+/af+lcNfEZHX+dfbv7TH/JFPEH+/af8ApXDXxIx+bPWgCIjA6c44qNuCeKmbqc9O1MC7pFHrQBesRhVIGPeum0twXUcDiudthtPH5elbumEoRuHB70AeneFEtxandtLNnPtitoXcCunlgbV4ZK83a/8AsllNNIzhIUMjYPJAGfzrVWS8igWe8hlgsSwRrtWSWFSegaWNmRT7MRmgCzq8okvZDBgSMTkLzUmn2jxwhghLE7m9zWvpttZQ3qQuY3ldDIEzlmUEAn6ZI/Ot+60OSMG60p0ltz9+LuDQByb7t+5/vZ64xSyQPNJv2b89xzzT9SuHe98iSFklA24ro9AgEAW6vAAgGI4/X3NAGBqOgstsk5R4psZDYxWTLeSyJ5dxJho+MGvTL69/tKNhJj5RwOwryfxAyJfTqhGAeCD+tAEc92kXIYZ7j+lYVw5lkLt1PNJczmRy55PfNVJ59qZ6GgCK7l2Lt3ZNYN9NuL881cu5/VsnvWFdTb2wM7R70Aeifs4Nn44+GB/tXP8A6SzV3P7VEfmfFO1x20a3/wDR9xXC/s3f8lv8Lnj71z/6SzV6D+1Barc/FCAMI2ZNHtXQSIHXcLi5Iyp4I45B6jik/IDpv2ZF2+DtaH/UWb/0ngrxbxJCH8X+Iz3Or3v/AKUSV9M/Cm+0fU/B1teaFpllpayMftVpaQrEsdwAFcEKB6DBPJXbXjHxebRdR8bSW+kaVpsH9nuz3d3BbIslxdNywZwMttB555Zjnla/OuH8ZOpnmI/dtOV7/wB23f56HXVilSWpxEMW09hipwjH2qytvyCDx6VN5JHVeBX6MchTSMngjiniDPPTtmrYidhgKamisriUjbE5J6YFAFIxgKAOSP1pfKLoVGfoa110e7xk27Y7D0qQ6PeYAEJP4dKAMXyOx79fanrAynvkenpWsdIuwT+4bJPc9aemk3jHAhOAaAMtVYEckp3NPVcYYg8Vsf2Lec/u8dwKd/Yt4c/u/Y80AdR4Z16xjtlt548ELjI7n6V06ajprbfkAyAeorytNEv0Y7VK7ePvVtaVomrXEoSPHPAoA79biw4OzJ9qnWSwY8sQ3UnGAazdO8HauUBm2rntnNaieEb/AIyRjHrQAvkac5PzKPqKa1tpwPyyJ6U8eE9Qyclfbmnr4Uv8gEqFoArtDYE4DpzSf2dYOODH7n1p83hXURIAuMA8EUg8MangqCpBHvQAi6NZuuAItxpqaHY8H919eBU48MapyCRjbS/8IzqQGSAT+WaAIRolqpBDR4FKug2jDgR8dhipF8OasFIJH1qRfD+p43Kw4+vNAEaeHrQglQhxz0qJvDNo4ICIRnngVqQaFqCRn95jj9KcNE1HaCJenIFAFn4PWqWR8YW8YAVNZXp72Nof60VN8KIJLW48ZQztukXWVyfrY2hooA72iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzD9pj/kiniD/ftP/SuGviQsM+9fbf7TH/JFPEH+/af+lcNfEbHkZzigBrccYFOtlBkz6U1/bpVyxi+RWz96gC5FH93jJNdLo8SPEFde+N3pWFCuHHTA5rsvD9lA5QyhjnBJBoAuweHb12j2xZhbpIehph0+TRtVtbhZJbBcmOW9s4lkkVD1XyyQJFPQoxwRnhuldlbQS2CB7EtdWxHzwSNnH0rL1W9s50dE3x8YMcg5U0AdvrmheG7TwjoOp+ELmCa1e/eKWdWO1fMib5ApJMYEiRgRn7u7FRpavHbmQXQTAyCrYNcj4Q8Lpq0rYu54iXiklWKTYkvluHUSdmGQO2RzgjNemR+DrZSrvd8DqOuaAOHtYUutaM8zmU8hXfjcfpXQnTkuJM5KOBjJPArdufC9lsIimcSjlWjTgj3rn7lobHeHSdpc8EjA/GgDD1u1ngLpbzEgA/P6V55q8EkMjLK24nv613l/qfmFsfdPGCOK4zxDOrYIIPPpQBzEgzyfTmsq7lyfb2rSvWwpzgZ6Vi3DYySeKAM6/mOcZzWePvelTStvkbI70wjOKAPR/wBm0f8AF7/C/puuf/SWavT/ANouF5fiohTkjRrXj/tvc15l+zeP+L3eFzn+K5/9JZq9d+OiqfiwC/QaNaf+j7qgDg/Cuu674TnvzoluZ/7Ti8nYfuwz4wk+D2UZDDuNvpTrbQ3s4Y4pN7yd2Ylmdiclie5JJJPqa2bBEMylWDHPeuiWyBuYl2sSORz0HauenhKNKrOtCNpTtd97bDcm1Y5YaOsbgkZUDPNXfsSJtVYlz3465rpZ9Od1BjUnYcHI5zTJdOmA3GLJ7HFdAjAiUIQFhTHUHH51bjVtwZByeemKt/YJSd2w5z6cVKbafczCNic+maAKRZ1Dc89j0/8A1043MoUDPUc1el0e7uWCpbyDI6gYq1D4X1ErgKMdAzEZxQBkfanwSOMHrUgu5emB9B1Fb8Xg+7cESTRoPrWnb+DYI9v2i8U464oA5P7VJjkKB6d6Bcyk7UHXr8teh2/h3SI8birnuTzWhFa6TAPljTA6cUAeaWsN7LgLbs2fUYrqdCtr6LBaMIB3IrqPtFlGAU2/pSf2jAeVZF+lAF61lbygZWOR+FZ2qeIIrG68so2APTOaSW8iYFQ/05rKuollOZF3Dt60AW38XQBSSrflUZ8YW4Hr6kA8VS+wxMm0pkZ6+lZuow21twUAB96AN5fF9uSGYEDHcVYHiu34wy1w2Ld3XLfKO2aljudORipZSR1+tAHbjxbaBuWUe39ad/wldsf4l49TXFI9hNypXJ75/SjyLEfxgH60Ad0via3YA7l/Oj/hI4AG5Ujtz1riRHYDd8wOOODVhfsAUYIwPfNAHZW/iOGQsMDiria1DjotcEI0LZhdFP8AOrSvDDgysD9DQB0nw8mFxq/jeReh1pP00+zFFUvhJIksvjF4vuHWVx/4A2lFAHoFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHmH7TP8AyRPxB/v2n/pXDXxG3JwK+3P2mf8AkifiD/ftP/SuGviJj0z+lADSASMd617dQoA4471lwYMw7gGtqFQRyM/0oAu2UXmzxqCTzgV3mmweUg4+bpwa57wpaCa73BRtQZNd9YWq+SWABPOBQA61vzarwxOOBXPeINTS5uNrBQy8sR29qta1P9ktwduHzhc9frXKqN5LEksT3oA9V8BeR/Z7lGIUgkkHnNdTDdGI4WdlB/SvPvA0+LeWLoVPauinmIlOCcdPqKAOplkMijbqDhhwCPWq99Fey2jCWRLmID+7hh75rmzdPySeAeMdac+ryRRFVZiAPWgDmNaC2kjM8cnP8OMVxWo3HnTliQMdvSux8T6q9xbvvAXjAHvXn88nBPGaAKN629iO/fmsS/fbGRnk+taVw5bPTJ61i6gSXAAAAoAq44oP1pQuccdeeOtB4GM59jQB6P8As4f8lu8Mcfx3I/8AJWavYfjcoPxUcntotpx6/v7qvH/2cc/8Lt8L5/v3P/pLNXt/xctDc/FG5ZCA6aNZYz0OZ7ugDhbBWa6hC4BLAdK9NistpJUMHGM+/Fcd4dtFOpp56kFDnB/iNenRRrKyuF/dONpI7GgCLT4oyOVO/jJqzdQKijgfX1qi8psbsxMoOwgNj+dWdRvVaDKkMxGAAOM0AUpWjiG+QqoBwCagOrWkLZVWkYHpjisu6Z5m/eklh69KqKhDZx/9agDSuNWu5ZSwk2oD0Fc/q3iyeJ5IrOZW8qQRSTSswjWQjIjUKrPJJjnYikgcsVHNVdRvZmS4t7NXjuROlotxLH+6RnCneW6YRSXIJBIRqp+FvsVwq3dsysRHttYmcM9vbsSV3DP+skwXdjyzk9lAAB0Gi6vql5pdvLfq1tdMv7xP6jk4B64JyM1f+2zY5lYj2NUs9nJ59PSnJGzYKjgD6UAWjdTdTM4J4x6Ux7mUMcSPgHqafBbO59M9eOtXYbINgFefegDOJuCc+Y2DU0UV0eFYnNbaWkMKAzEJjkGq95r+m2Qb5kBHtnNABZaZeSHMkhAxxuNaMdnHESZrklhjjtXG3/jaVmK2yE+jHiufvde1C4yTLtJ/u9qAPSdS1WC1QiJgB0z1rzTxBq8rzMqTMzfXgVQmmlfPmyyMPcmqbjKHuCec0AQtd3czMGlkC4xw1SRmQIvztjtk0LGRgHr2qRYs9fqfrQBUS8mE3Esg7YzxVtZ7kZzcOc8AbulRm3wysMbQe9SgHGcEY6kigBRNcgAec+3v81OWe6VuJZOOcZpSgOAWPGKlWNhjIA6Z70AOj1a+iPyysB2JNMl1O9nJEkpA9jSNGGkyT39OlNEJEjYH1Pp70Aevfs7Mz6H4nZyWY6yck9f+PO1opP2deNC8TY/6DJ/9JLWigD1iiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDy/9pn/kifiD/ftP/SuGviEnkGvt79pn/kifiH/ftP8A0rhr4fbrxQBatB++JI5rXgHBJ79Ky7JDs+vvWtCuNp5oA77wfbhNJec5BkfHtgV1tq/l2bSbgVRSxJH6Vj6dCtvotjEBhiu41e1mQW/h9yvBmIXr2oA4rUZ5Lud5JpGkZm6n0oQAAZximbcn1qyFCpuP5UAdJ4IG43o9AD9K6GUjzFcDj61jeA1322ovjjCj61rTjkZznOSB6UARGT94wIbB+biqN5L1G7jPpVmUk7ye3Q56Vz2uXbW1mzDBkbKL7GgDB1m78+ZhncqHGRWFduOeeKtO2Y89CevvWdcn5SM4oAozcnOfesWdt0xPetW4YhD6jmsfOXbPQmgAGQeuDQcY4pcZPXrRn5ugGPegD0b9nH/kt3hf03XP/pLNX0D8RAD8Ur7PX+xbHB/7b3lfP37OI/4vd4X/AN+5/wDSWavorxyit8TtTZhnbo1hj/v/AHtAHPwxAzDLYfOQa67R3aRDFuwGGSfQ1y7QujFl6Ht7+taukzvHLhjgA+vJoA2dZtwLiJpT8zrsY/yqjLbvBmORQR1DZzmuj1uJJrVT94PF5irj+IVn2X+l2YDHBTg8c/WgDmLmNtxwvQ8mqSxldwZs5HfpXUXtqu3ayYIOeO9ZUtp8xIC4x3P6UAVfDHiW28KatrbXq+ct3YRvBbAjdPNHIU2L7t58YJ7AZPANZ8MdxJLdXuouJb+8fzZ5F4BbgBV7hVACqPQDvmrr6XBLeQXE0avNAGMUhGSm4YOD7gYqw6oGGQNwoApw2564AJ7CtGKAZ44H581GZY4ULXDBUz+NYt3r7MGSxwqE4DMOaAOoea2s1Lzuo9z/AErB1HxYsYZbGMFj/FXM3Ej3LFpZWYnnJP8ASqzEFsdAO2OpoAtX+rXt2T50rD1CnrVAjIJPOeTzmnnJGGBzntTiw64DEjntQBBszhhnjqRT9hP8IX+VTR4UEhckj1pCWz2Uexzj60AQlVIHB47imNGMjccZqZlOe+OhB7VE4YA5GCOmeaAIihzkDHJpytknnHYZpyqQzDJyeeaHUgDGSp7igCMrwuRuYnI4/lRzyADjPGafGcNz93sMc1LlSVwAR0A9KAIUDZB79jUyg8Akj2NKAWJ7kCpAMY38cZ5oAjVmzjlQTkd6cDgucDn9acV64Py9jSDHIJzt/WgD1X9nnnRfE/8A2Gf/AGztaKX9noY0bxQD/wBBr/2ztaKAPVaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPL/2mePgn4h/37T/0rhr4gbnIxzjivt/9pr/kiXiH/ftP/SqGvh/qwBHf1oA1LNMIvP1rY02NpbqKMDO5wP1rKtsADk103gyA3Wv2iYyN4JoA9QuLYK8ECALsUJWV40fatpbKRhRlvrXTCIS6r0ACnn0rifFk/n65Kqt8q/KMUAZCnkD9KdK/OM1ej0mb5XVvkYfex0qUaQAHLuS+OKAOl8EJs0K5fu0grT2bgzknngZPeofDsDW/h2NX4Jb061bUbhgdMd6AM+RN0TKcZ4H1rgPFFwJL4RIcLH1HYmvQ9TKwWUkrj7gNeU3Dma4eRvmLNk+1AFW4yF6cVm3BPOcY7Vo3RBbuD6etZcxxxjPrQBn3rYjJ7His1OTwPerl8/G0dM1VHSgBAMMRjrQeTjrQCCep20pA5wcigD0X9nH/AJLb4X/37n/0lmr6S8Wrv+J+rLnH/ElsDn/tve183fs5jHxu8L/79z/6SzV9K+JVDfFbVM540Ww/9H3tAGSke1yWHG7inXKGHUAck7xyPTirckaRo8jngetU5JPO8t3UZzn6CgDs5iW0Oyk6OFIFZNlL5GoLsTHmgbhjv61cnlK6LZID26VhXU6pfl92WUjAzQBu3yL5oYH5T39Kyb5FAJBBBPrUVzqauyBRxjnPrWZqOpDB54xgjpxQAryKu4ck+h9KyL/UlhLbB5jr0APArP1DUtwKxNj+82eTWJNMoJw3oOvNAF26uXnUvMxOeg9KpSTEZ8vjnr61XacuCTn2PTihGVsnt6etADjM5IOOvtRulBPB/H0pwxztGMZ60mSRngHv70AKC7AYIwePpUyrgLn72cYBqHdk5bGccj0p275gQSCBjdQBOkgBJK4Y+vepd2D93gdD2/Kq4DeWu/O0+nWk8zI4wAT1HOaAH7wB8uBg5NQ7gFJ6qSfxpxYonBIX6dRVdm9Op9aAJg+W+YZ9ulPJ4wQOemD0qssmcjknPSlDlW9Bz370AS/KGy3UDr/WnEjGS2DggECocjH3etKZDgMQBn0oAljPRs4AHr+lSMXCDd0PPrVdXIYnpkY4qYSAKuPlK8EelAAFYZyACeozxS7iznIIOefeo9+RlsAAYI6Zpcgdjx0oA9Z/Z6/5A3ij/sNH/wBI7Wik/Z5O7RfE5z11n/2ztaKAPVqKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPL/2mv+SJeIf9+0/9K4a+IIhulXnvX2/+0z/yRPxDn+/af+lUNfEVqoaXtgetAGtbjHtmu9+Fdv5viAuQCI0JrgoxgAZr0/4SQHfezdgmKAO9sQyTTS8YUFjmvMdVm83VrhsdXOBXqcn7rS7qT1TAz2NeSzEieVm+9uNAHoOhQLd6bExHyjGB71pPo0csgyR5h49jWd8NphLZPA/zFScA+tdMF23Hy8jNAGl4k0Q6ZpdiEIww6+hrn449q4/Mius+IlzMfC1s8TAbNpzXA6ZdXU93AjsChODgUAUPiDc/ZtLih43S/wAq8zI54P412/xInDa0sC/ciTGK4srlC3OOtAFK4JZsDHPrWdPtboRkVfuuQSOtZtwQDkHA74oAx73mfA9M1CM5HXPenTNumY88UbT6YOO9ACHg0poApenPagD0X9nT/kt3hbPXdc/+ks1fR3i6cQ/FHVcsFzolh/6Pva+cP2cgf+F2eF/Z7kf+Sk1e+fEmTy/ihfHH/MGscn0Hn3lAEF/eGdgicRjnA5zVS2vlW5xIcIOVIqlcXAjgJBO5xhfb3qhE4XPQE+/WgDvG1SFrNFklUADqDzjtXOapqQlkzEp2g9ehrGaQLz1/HJqCWYEAox29z6UAXZtTcqS4x9DWTe3skpyzfN2FRtOSxA5OcgYqCQksRx16igCB3fPy4HvmkWNn4BGcZ+lSk4OAAR06UocKVwccYz3oAQRBBlsHgnFTxIqrwmVPFRmXaww2cdKQSnOOgHOaALDkbSGHPY1A7ICRxjscdaYz8ZJ5YdaaZC7cdB7UASAqcehPXpTsjnIDD3701EypJwPegDJwAf8AGgB+Q2OTnqaUBsgZyO2KaFYYzw3IpwHJ69PzoAQgkZAI7CocZORzjPTrTp5DjI4+lUnnIydw4FAFwBSOM59+TQD2LZ5qj55zz0/lThMD1JOOevWgC4WPU4bHA5pGbHAGfxqos46HHsSaUzk5Gc0AWsnO5hiob+9FnZXV3IGMcEbSttGSQoyce/FQ+eC2cnHes7xLKP8AhG9VAx/x6zfqhoA7v/hD/G+Mf8IfqH/gZZf/AB+s/WtM17QDZya5oF7p8F1MbeKaWe2dTJsd8ERysR8qNzjHFdR8Rf8AhFv+Gjo/+E5/sv8Asj/hFD/yENu3f9ofGzPO/G7G35uuKwtQ/tlPgl4LOv8A2vzBr0n2T7ZnzhbfZrryt+efu9M9sUAekfs7Z/sPxNnr/bJ/9JLWim/s4nPh/wASknJ/tk/+kltRQB61RRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5f+01/yRLxD/v2n/pVDXxNZqckgAV9s/tNf8kS8Q/79p/6VQ18UWZwOfWgDSjH0A7mvYfhJBt0O8lOMMSK8gjHvXt/wviVPCDuejNx+dAHQan8vh6bBBPPNeQvlncnHU8V61qxb/hH5exOeleTy/ebnn1oA6z4bTGK8dWIPI4716LJEBOcHnOeleU+Bn2a3tAwWx/OvYrmPEqMoABGeO9AFfx1OZfBrLHyyrzxXlOha6LW/jNwCVGACOxr1vVrbzvC92p5IU4/KvBpE2hjk5BxxQBNrV2b7WLq4zlWfANZcw9OCanPAJHA9KrO25j7UAUbjO0gAH+lZN2epNa1wSdw6YrF1BisbnHagDI/iJx15zTgD6U0AZHpUnGfpQAAUEcU7H5009cGgD0T9nQf8Xs8MHsZLn/0kmr3P4pkD4o3YPfRrLj1/f3leG/s6/wDJa/C+P79z/wCks1fZet+E/DmvXSXWuaBpGpXKII1lvLOOZ1QEkKCyk4ySce5oA+a7y5MlzIyklBwBnpiqrXpVMhjjocV9Hf8ACuPA/wD0Jvhv/wAFcH/xNH/CuPA//Qm+G/8AwVwf/E0AfNz3pI+U9eaglvCuCTwPevpj/hXHgf8A6E3w3/4K4P8A4mj/AIVx4H/6E3w3/wCCuD/4mgD5k+35x8xz0HtS/bQcYIYnI64r6a/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA+YzdqwIDccZNMW5RhtzgdOa+n/+FceB/wDoTfDf/grg/wDiaP8AhXHgf/oTfDf/AIK4P/iaAPmMTqQNx/OnLMB1PGa+mv8AhXHgf/oTfDf/AIK4P/iaP+FceB/+hN8N/wDgrg/+JoA+ZXkAJOenSozKN/B5HNfT3/CuPA//AEJvhv8A8FcH/wATR/wrjwP/ANCb4b/8FcH/AMTQB8zpdYTb6GrFvOGkyMEn1r6Q/wCFceB/+hN8N/8Agrg/+Jo/4Vx4H/6E3w3/AOCuD/4mgD55kYBgDjHPOc1BJMAMk/hX0b/wrjwP/wBCb4b/APBXB/8AE0f8K48D/wDQm+G//BXB/wDE0AfMF1cZ7mq+5ueAfwr6n/4Vx4H/AOhN8N/+CuD/AOJo/wCFceB/+hN8N/8Agrg/+JoA+V94xnHHXFCycZzjPP1r6o/4Vx4H/wChN8N/+CuD/wCJo/4Vx4H/AOhN8N/+CuD/AOJoA+Vy4LY7njPpSEnG7O4Cvqn/AIVx4H/6E3w3/wCCuD/4mj/hXHgf/oTfDf8A4K4P/iaAPlfceB3PaoNSgN7p9zbK23z4mi37c7dykZxX1f8A8K48D/8AQm+G/wDwVwf/ABNH/CuPA/8A0Jvhv/wVwf8AxNAHig+Mvjgk5Hhsf9w6f/5IrB8YeN/Efi+3sLfW30hLazufta/Y7OSN2fy5I8EtK4xiQnp2FfRP/CuPBH/Qm+G//BXB/wDE0f8ACuPBH/Qm+G//AAVwf/E0AcX+zSc+GvEZznOsnn/t0tqK9O0TRNK0G1e10PTLHTbZ3MjRWcCQozkAFiqgDOABn2FFAGhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5d+03/yRHxD/AL1p/wClUNfFFp0r7Y/aa/5Il4h/37T/ANKoa+KLQfKCc4z60AacZJI717z4AjI8ER+7dK8FjweufWvofwJEB4Jt2AJPHGKAJ9VjP9gy9xz/ACryiYZYnJ6mvXda40JwuSST+HFeTSDLMMc56UAX/CbGLWYCehOPrXuc0e62gbHG0d68J0Rtmq27cZ3jNe92Z36TAw6gYoAUQiXRrqPjG0449q+eL+Py5Zl6YcjH419I6cm+0uFJxlTjNfPfiOLydUvExyJTyPrQBhTvth+UDOaqFh5Z9ye9S3B4GT37VE68AnoaAKVxyPesTU2/d4x371t3PGc5rB1PqvpQBRXn6GpB70iDj2p5oASk/nS0D1oA9D/Z2P8Axe3wt/v3P/pJNX3LXwz+zsP+L3eF/wDfuf8A0lmr7moAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8v8A2m/+SJeIf9+0/wDSqGviy0xsx3r7T/aa/wCSJeIf9+0/9Koa+LLXBQcfjQBoxAZHua+kfBMRXwLbkDng184QDO37vXPNfS3gcH/hCIFIHAFABrsfl6JHkHJBORXk1wmJH9Qea9i8QrnQQMH5SQK8ku1xI5zxnmgCKxYJdwsBzvBr3rRW83QlI7Y6V4LEFVoyOACK938IN5mg4YfwgjH0oA1NHG9ZQx4KGvB/HMfl+I71cgAvn9K960hQLtlPQg14p8T4PK8TXBxhXGf/AK9AHn9wfnXB9cmopXG3hfeppwfMXOPwqGbqTQBTuASCawtSGPSt6fgHHNYWpkcY9aAKSdKU/nSKaX2oAKQ8UtIx4NAHof7Ov/JbfC3+/c/+ks1fc1fDH7On/JbfC/8Av3P/AKSzV9z0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAeXftN/8kR8Rf71p/wClUNfF9oPkXpwK+0P2m/8AkiPiL/etP/SqGvi+0xtGRjHSgDRiHC8Ywa+nPBC7fBUPHJCj2r5ngGSua+m/BKn/AIRC3wOijNAEviGPOgSMueGryK8X941ez63GH8PSjP8AFxXj12uJ3AwSD+dAFILgYPXrXt/gEl9FBx1SvFR1BA7V7L8On3aci46Lzn6UAdLpIxeAnucV5N8YrcLr0bklVKkcCvXdP/4+lGMHP515p8bYCLy1fkZLDNAHjlwAHXaPXmq0y85q9Ov7we9VZ19DjPXNAGdOeTnrjpWFqbfNiuguEOcn37VzupZ81cA4oAqrTjTV7U4+lABTGBJp55FIRQB6F+zpz8bvCx/2rn/0lmr7nr4a/Z2/5Lb4W/37n/0lmr7loAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8u/ab/AOSJeIf9+0/9Koa+MLYfIPT619oftNf8kS8Q/wC/af8ApVDXxjbZwM9aANO3UFkA65r6f8DqR4Pt16fKOPWvmSwG65jBPVgK+qfCtuY/DVqMcFR0oAm1NQ2hyrnqPSvGNQUfaXGOQ1e36lHjTZF7d68X1VduoSADjNAGcqfNx/OvXvhyR9hXkZ215KxIJ45716p8N2xaxDoMZoA7W1UC4THX2FcP8cYC1vZyKvR8H8q7qDi4OB0PauV+NMe7QoH9HBBoA8BuUCtweh5qrKBgY49q0L0YLcVTkA2kmgDOuVGPWud1ZNuNvrXTXCfKeeKwtVT90epxQBkDHHB5pxHrTFJwPSpMDAPegBuKG/SnGmnrQB6H+zt/yW3wtx/Hc8/9us1fctfDf7Ox/wCL1+Fv9+5/9JJq+5KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPL/2m/8AkiXiH/ftP/SqGvjO0H7sbvw96+zP2mv+SJeIf9+0/wDSqGvjW1GFA4FAGpY/Lcxk/wB6vq7wm5n8K2rZ6KK+UIOJAewPbtX1N8PSJPCNsc87e3agDXuU8yxkHNeMeIYwmpydPr617YfmtXAz0ryPxbHsv5Gx3xigDndpx6n3r074b4aCLr+NebryB3B/SvR/hvjy09jxQB3YyLtiGP8AhWL8W4hJ4TLEfdKn8fWtsqTcEg/LWf8AE2Pd4OnOeiigD51vYzlsjjHUVnoPkIwa27lCFII6+1ZO3a7g5yDQBnTLnd1zWNqEW5GHOTXQXC9TnP4VlXiEg5B9aAOT74NSdh0ouF2XDY6Hmkz680AHekoooA9F/Z3/AOS1+Fv9+5/9JJq+46+G/wBnf/ktnhb/AH7n/wBJJq+5KACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPL/wBpn/kifiH/AH7T/wBK4a+N7XGB619kftM/8kT8Q/79p/6Vw18cWvJAOMEUAadtncB3r6m+GwH/AAiEPA4UGvlu3wHwBwe1fUXwzBfwdCAedgFAHQAARP15HFeT+M1xdnkHNeubCY+enTmvI/G+Vuj2IY0Ac2ARzivRvhsAYRzjmvOVJ7d+oNeifDcgo3PegDvwf355H0qt8QVD+DroZ/5Z96n4Fweuf50eMlDeErtf+mRoA+e2UtHkD2xWVdJsuc44YfrW0FzH8pwM1naihxnoe/FAGVcRjHPesy7j+VvyFbEqkpnA4rNuBlW6k/yoA5DV0w6vjjoSBVIZ/StvVYt0bgDmsJDkc0AP60Co2uIlJVpY1YdiwFM+0wdfOiz/ALwoA9L/AGdz/wAXt8Lf79z/AOkk1fclfDP7OrBvjZ4WKkEF7k8f9ek1fc1ABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHl/7TP8AyRPxDj+/af8ApXDXxvbcBRk/U19kftNf8kS8Q/79p/6VQ18cWvO30xmgDYswfMGOtfUPwm/e+DYeei847V8v2QJnC9scGvp/4NkHweh9AcYoA6kRkK2e/SvKviDHslU579K9ZlwIm69K8w+Iq4II5yQeRQBwgXHJr0D4aMCsi4yQ1cEwPFdz8MCBcTg5JyM0Aehg4umHXmrXiGMy+GbpeuYm/lVY4W6ds8npWhqnz+H5/Uoc/lQB86qhCEdx0qK5hzGwNaONxf5cfMfxqpIuB82c96AOdkXAKehrOuF+8AK3b2PEuQMbu9ZlwgycfyoA53UIsjPr0rl5VCysMd+K7K+UHcMH8K5bUkCy7h9KAPefhB4lvPCH7OHjfXNNRWvbXU28nK7grPFaoGI77d2fwr3/AMIafrMEdte6l4luNVhuLVGeCa2gVUlODuieJEOzkjDbj054OfmH4NfFHw14Q8D6x4e8T6PqeoxaheyTOkEMMkTxNDEhVt8inOUbt6c12Hhz40/Dfw5OJdK8PeLUdYvIj8+ZbgQx5B2RiS5YRrkDhcDgegoA8p/Zq/5LH4Q4/wCfj/0kmr7rr4W/ZuUp8ZfCSPwym4BH/bpNX3TQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBgeO/C1l408K3ugapNcw2l2Yy8lsyrIuyRZBgsrDqg6g8V5cn7NnhZMbdc8SjH/Ta2/+MUUUATx/s7+HIyCmv+JAR/00tv8A4xXTaL8Mf7FtPs2meMPEsMHPy7bFv1a2JoooAunwJeFSP+E28S4P/TKw/wDkWsvUvhPDqX/H74t8SS/hZD+VtRRQBR/4Uhpf/QzeJPztP/kerumfCWDTHZrHxZ4liZupxZN/O2NFFAGk3gC5Ztx8aeJSf+udh/8AItSP4GvXt2gbxt4kMRGCvlWH/wAi0UUAYC/BbT1JI8UeJOTk82f/AMj01vgnprH5vE/iU/jZ/wDyPRRQBFL8DNJlxv8AEviQ4/2rT/5HqFvgHojdfEXiQ/8AA7X/AOMUUUARN+z54fc5bxB4kP8A20tf/jFVZf2bPC0v+s1zxIf+2tsP/aFFFAEf/DMvhH/oNeJP+/1v/wDGaP8AhmXwl/0GvEn/AH+t/wD4zRRQBt+CPgT4b8H+KrDX9P1PW57uzMhjjuZYTGS8bRnIWJT0c9+uK9ZoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) View of the entire forearm of an 11-year-old boy with a Galeazzi fracture-dislocation.",
"    <br>",
"     (B) Close-up of the distal forearm shows that there has been disruption of the distal radioulnar joint (arrows). The distal radial fragment is dorsally displaced (apex volar), making this a supination type of mechanism. Note that the distal ulna is volar to the distal radius.",
"     <br>",
"      (C) In this second patient, the AP view shows some shortening of the distal radius (arrow) in relation to the distal ulna, which has a small greenstick component.",
"      <br>",
"       (D) The pronation component (white arrow) is better appreciated on this lateral view. The distal ulna lies dorsal to the distal radius (yellow arrow).",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Waters PM, Bae DS. Fractures of the distal radius and ulna. In: Rockwood and Wilkin's Fractures in Children, 7th Edition, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"       </div>",
"       <div class=\"contractual\">",
"        <br/>",
"        <a href=\"file://www.lww.com\">",
"         file://www.lww.com",
"        </a>",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36627=[""].join("\n");
var outline_f35_49_36627=null;
var title_f35_49_36628="LBBB and AVRT rate";
var content_f35_49_36628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51093&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effect of LBBB on the tachycardia cycle length in AVRT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 446px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With the development of a left bundle branch block (LBBB), the impulse during an atroventricular reentrant tachycardia (AVRT) in Wolff-Parkinson-White syndrome must cross the interventricular septum from the right bundle to reach the accessory pathway; because of the additional time to reach the accessory pathway, the cycle length of the tachycardia increases. The slowing of the tachycardia rate with the development of a LBBB proves the accessory pathway participation in the tachycardia and localizes the pathway to the left side. Arrows indicate the direction of impulse conduction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36628=[""].join("\n");
var outline_f35_49_36628=null;
var title_f35_49_36629="Adnexa at hysterectomy";
var content_f35_49_36629=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63463&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Removal or conservation of adnexa at hysterectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A and B) Placement of stapling device for ligation of utero-ovarian or infudibulopelvic ligaments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36629=[""].join("\n");
var outline_f35_49_36629=null;
var title_f35_49_36630="Chapter 4A: Cell model for loop of Henle transport";
var content_f35_49_36630=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 4A: Cell model for loop of Henle transport",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36630/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/49/36630/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 9, 2003.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 40 to 45 percent of the filtrate that is not reabsorbed in the proximal tubule enters the loop of Henle, which has a characteristic hairpin configuration in the medulla. The loop of Henle consists of four different segments: the descending limb; the thin ascending limb; the medullary thick ascending limb; and the cortical thick ascending limb, which ends at the macula densa adjacent to the parent glomerulus (",
"    <a class=\"graphic graphic_figure graphicRef55088 \" href=\"mobipreview.htm?22/60/23503\">",
"     figure 1",
"    </a>",
"    ). These segments perform two major functions: (1) they reabsorb approximately 25 to 35 percent of the filtered NaCl, primarily in the thick ascending limb; and (2) they reabsorb NaCl in",
"    <strong>",
"     excess",
"    </strong>",
"    of water, an effect that is essential for the excretion of urine with an osmolality different from that of the plasma. As will be seen, this latter characteristic of loop function is dependent upon the varying transport and permeability properties of the different loop segments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CELL MODEL FOR SODIUM CHLORIDE TRANSPORT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Active NaCl transport in the thick ascending limb is driven by the basolateral Na+-K+-ATPase pump. The activity of this transporter is higher in the thick ascending limb than in other nephron segments, indicating the importance of active Na+ reabsorption at this site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. The Na+-K+-ATPase pump has two major effects on Na+ handling: it actively transports reabsorbed Na+ out of the cell and back into the systemic circulation via the peritubular capillaries; and it maintains a low cell Na+ concentration that allows luminal Na+ to continue to enter the cell down a concentration gradient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Mechanism of NaCl entry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sodium chloride entry into the medullary and cortical aspects of the thick ascending limb (including the macula densa) primarily occurs via an electroneutral Na+-K+-2Cl- carrier in the luminal membrane (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]. Net transport into the cell is seen only when all four sites on the carrier are occupied. Confirmation of the 1:1:2 stoichiometry for this transporter in the thick ascending limb has come from the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Na+ is required, since removal of Na+ from the lumen abolishes the reabsorption of Cl-.",
"     </li>",
"     <li>",
"      Cl- is required, since removal of Cl- abolishes the reabsorption of Na+.",
"     </li>",
"     <li>",
"      K+ is required, since removal of K+ prevents the reabsorption of both Na+ and Cl-.",
"     </li>",
"     <li>",
"      The process is electroneutral, since changing the transepithelial electrical potential is without effect on NaCl reabsorption.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of Na+-K+-2Cl- cotransporters have been cloned and characterized, with alternative splicing resulting in a diversity of renal transporters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/10\">",
"     10",
"    </a>",
"    ]. The cotransporter termed, NKCC2, is principally responsible for Na+-K+-2Cl- transport in the apical membrane of the thick ascending limb [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/11\">",
"     11",
"    </a>",
"    ]. Mutations in this transporter cause classic Bartter syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/12\">",
"     12",
"    </a>",
"    ]; this disorder has clinical features (hypokalemia, metabolic alkalosis, and hypercalciuria) similar to those seen in patients given a loop diuretic, which inhibits the Na+-K+-2Cl- cotransporter of the thick ascending limb.",
"   </p>",
"   <p>",
"    Sodium that enters the cells via Na+-K+-2Cl- cotransport is returned to the systemic circulation by the active Na+-K+-ATPase pump in the basolateral membrane; chloride, on the other hand, exits through selective Cl- channels (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/13\">",
"     13",
"    </a>",
"    ]. Mutations in the gene for these channels result in the same manifestations as classic Bartter syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/14\">",
"     14",
"    </a>",
"    ]. In comparison, solute transport in the descending and thin ascending limbs is passive, occurring down favorable concentration and osmotic gradients (see below).",
"   </p>",
"   <p>",
"    Loop transport is very different from that in the proximal tubule. Filtered glucose, amino acids, and phosphate are almost entirely removed in the proximal tubule by coupled transport with Na+. Thus, loop Na+ reabsorption is not linked to organic solutes and must occur by coupled transport with Cl- or by Na+-H+ exchange, leading to HCO3- reabsorption.",
"   </p>",
"   <p>",
"    Several important characteristics of the loop NaCl reabsorption deserve emphasis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The affinity of the carrier for Na+ and K+ is very high, reaching near maximum activity at concentrations under 5 to 10",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      (",
"      <a class=\"graphic graphic_figure graphicRef54349 \" href=\"mobipreview.htm?0/56/909\">",
"       figure 3",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/8\">",
"       8",
"      </a>",
"      ]. In comparison, it is Cl- delivery that is rate-limiting, as net NaCl transport increases directly with the tubular fluid Cl- concentration. The loop diuretics, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"       furosemide",
"      </a>",
"      , appear to inhibit loop NaCl reabsorption by competing for the Cl- site on the carrier (see Chap. 15).",
"     </li>",
"     <li>",
"      It might appear that K+ should also be limiting, since its concentration is so much lower than that of Na+ or Cl-. This problem is overcome, however, by recycling of K+ across the luminal membrane via specific K+ channels [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/3,6,15\">",
"       3,6,15",
"      </a>",
"      ]. Thus, reabsorbed K+ is returned to the lumen for continued activation of the Na+-K+-2Cl- carrier. The activity of the K+ channels is inhibited by ATP which allows it to be appropriately linked to the level of Na+ reabsorption. As more Na+ enters the cell, for example, transport of this Na+ out of the cell by the Na+-K+-ATPase pump lowers cell ATP levels. The latter change increases the activity of the luminal membrane K+ channels, permitting the return of reabsorbed K+ into the lumen and further Na+ reabsorption. Mutations in this channel cause another variant of Bartter syndrome [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/16\">",
"       16",
"      </a>",
"      ], illustrating the requirement for the integrated function of multiple channels for normal loop transport.",
"     </li>",
"     <li>",
"      The backleak of cationic K+ plus the movement of reabsorbed anionic Cl- (via a Cl- channel) into the peritubular capillary generates a net positive current from capillary to lumen, thereby creating a lumen-positive potential difference (",
"      <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"       figure 2",
"      </a>",
"      ). This potential is important because it can drive the passive paracellular reabsorption of cations, such as Na+, Ca2+, and Mg2+ [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/6,17,18\">",
"       6,17,18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Role in acid-base balance",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the reabsorption of NaCl, the medullary thick limb also contributes to the regulation of acid-base balance. It reabsorbs most of the HCO3- that is delivered out of the proximal tubule [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/19\">",
"     19",
"    </a>",
"    ]. This process is primarily mediated by a Na+-H+ exchanger in the luminal membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Loop HCO3- reabsorption is appropriately stimulated by acidemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/20,21\">",
"     20,21",
"    </a>",
"    ] and inhibited by alkalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/21\">",
"     21",
"    </a>",
"    ], thereby promoting the desired changes in HCO3- excretion.",
"   </p>",
"   <p>",
"    The medullary thick limb also reabsorbs luminal NH4+, as NH4+ substitutes for K+ on the Na+-K+-2Cl- cotransporter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. The net effect is recycling of ammonia within the medulla, thereby maximizing urinary NH4+ excretion in the presence of an acid load [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=see_link&amp;anchor=H10#H10\">",
"     \"Chapter 11A: Renal hydrogen excretion\", section on 'Ammonium excretion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Role in urine calcium excretion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although calcium is passively reabsorbed in the thick ascending limb, following the lumen-positive gradient created by sodium reabsorption, the loop of Henle may still participate in the regulation of calcium excretion with changes in calcium intake. Calcium-sensing receptors expressed on the basolateral membrane on the cells of the thick ascending limb appear to mediate this process [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When calcium intake is increased, some of the excess calcium is absorbed, enters the systemic circulation, and slightly raises the plasma calcium concentration. Binding of calcium to the calcium-sensing receptor leads to the generation of an arachidonic acid metabolite (which may be 20-HETE [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/24\">",
"     24",
"    </a>",
"    ]) that inhibits the potassium channel in the luminal membrane [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/27\">",
"     27",
"    </a>",
"    ]. Inhibition of potassium recycling via the potassium channel reduces sodium chloride reabsorption via the Na+-K+-2Cl- cotransporter, thereby diminishing the generation of the lumen-positive electrical gradient and the subsequent passive reabsorption of calcium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Passive Na+ reabsorption and medullary hypoxia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Almost one-half of oxygen utilization by the thick ascending limb is involved in active NaCl transport [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/28\">",
"     28",
"    </a>",
"    ]. It is important to note in this regard that the 2Cl--to-1Na+ stoichiometry of the luminal Na+-K+-2Cl- carrier reduces the energy requirement for net Na+ transport by 50 percent: for every 2 Cl- ions that are reabsorbed, one 1 Na+ ion is actively transported out of the cell by the Na+-K+-ATPase pump and 1 Na+ ion is passively reabsorbed between the cells down the lumen-positive electrical gradient (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This increase in efficiency is physiologically important because the renal medulla is relatively poorly oxygenated. The medulla usually receives less than 10 percent of the renal blood flow. Furthermore, the hairpin configuration of the vasa recta capillaries results in the exchange of oxygen between the oxygen-rich blood leaving the cortex and entering the descending capillary limb and the oxygen-poor blood draining the inner medulla in the ascending capillary limb (",
"    <a class=\"graphic graphic_figure graphicRef77591 \" href=\"mobipreview.htm?16/45/17118\">",
"     figure 4",
"    </a>",
"    ). The net effect is that the PO2 bathing the thick limb cells in the outer medulla is as low as 10 to 20 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/29\">",
"     29",
"    </a>",
"    ]. Thus, the ability of the Na+-K+-2Cl- carrier to lower the energy requirement for Na+ reabsorption may help to preserve the functional integrity of the tubular cells. A similar adaptation is present in the thin ascending limb where Na+ reabsorption appears to be entirely passive, occurring down a concentration gradient between the tubular fluid and the medullary interstitium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Clinical implications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoperfusion-induced acute tubular necrosis is one of the most common causes of acute renal failure developing in the hospital. This finding is somewhat surprising, since the kidney is more highly perfused than most other organs yet cellular injury is usually limited to the kidney. Experimental evidence suggests that this apparent paradox can be explained in part by preferential injury to the thick ascending limb and the S3 segment of the proximal tubule, which ends in the outer medulla (",
"    <a class=\"graphic graphic_figure graphicRef55088 \" href=\"mobipreview.htm?22/60/23503\">",
"     figure 1",
"    </a>",
"    ). These cells normally function in a borderline ischemic environment and are therefore particularly susceptible to injury when renal perfusion is impaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is of potential interest in this regard that, in response to renal ischemia, the thick ascending limb cells produce nonprostaglandin, cytochrome P450 arachidonic acid metabolites that diminish NaCl transport [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]; this response is mediated at least in part by reduced activity of the luminal Na+-K+-2Cl- transporter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/31\">",
"     31",
"    </a>",
"    ]. The inhibitory effect of ischemia could represent an appropriate protective response, since reducing cellular transport and therefore energy requirement may preserve cell viability when there is inadequate energy delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Adenosine, a breakdown product of ATP, also may contribute to this local adaptation. The release of adenosine from the thick limb is increased when renal perfusion is reduced; as with the arachidonic acid metabolites, adenosine also reduces active NaCl reabsorption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CONCENTRATION AND FLOW DEPENDENCE OF LOOP REABSORPTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The loop of Henle, like the proximal tubule, tends to reabsorb a relatively constant fraction of the load delivered to it (this is the phenomenon of glomerulotubular balance) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24617?source=see_link&amp;anchor=H11#H11\">",
"     \"Chapter 3A: Cell model for proximal transport\", section on 'Glomerulotubular balance'",
"    </a>",
"    .) In the proximal tubule, total reabsorption is ultimately limited by the availability of luminal solutes (such as bicarbonate, glucose, and amino acids) to be cotransported with Na+ and by the balance of hemodynamic forces in the peritubular capillary that promotes or retards fluid uptake.",
"   </p>",
"   <p>",
"    In comparison, solute concentration is the limiting factor in the thick ascending limb [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/8,33,34\">",
"     8,33,34",
"    </a>",
"    ]. The ascending limb is essentially impermeable to water. As a result, NaCl reabsorption leads to a reduction in the luminal concentration of these ions. In this setting, two factors combine to restrict the level of net reabsorption:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fall in the tubular fluid Cl- concentration progressively decreases the activity of the Na+-K+-2Cl- carrier, thereby diminishing NaCl entry into the cell (",
"      <a class=\"graphic graphic_figure graphicRef54349 \" href=\"mobipreview.htm?0/56/909\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The reduction in NaCl concentration below that in the plasma promotes the backleak of NaCl into the lumen across the tight junction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Eventually, the reduced reabsorptive flux will be balanced by a backflux of equal magnitude. This steady state appears to occur at a minimum Cl- concentration of 50 to 75",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    in the cortical aspect of the thick ascending limb [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/8,34\">",
"     8,34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The limiting concentration gradient can explain the flow dependence of loop reabsorption. Suppose, for example, that more fluid is delivered to the ascending limb because of an increase in glomerular filtration rate. If NaCl reabsorption remains constant in the early part of the medullary thick ascending limb, there will be less of a reduction in the tubular fluid Cl- concentration. Thus, the fluid in the more distal parts of the ascending limb will have a higher Cl- concentration, which will promote increased entry into the cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Flow-dependence also influences the distribution of NaCl reabsorption between the medullary and cortical aspects of the thick limb. As will be described below, antidiuretic hormone stimulates NaCl reabsorption in medullary thick limb by increasing entry via the Na+-K+-2Cl- carrier; this effect is mediated at least in part by enhanced generation of cyclic AMP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/6\">",
"     6",
"    </a>",
"    ]. The increase in reabsorption will reduce the Cl- concentration, thereby limiting reabsorption in the cortical thick limb, which can only reabsorb Cl- until the limiting gradient of 50 to 75",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    is reached. The net effect is that NaCl reabsorption is increased in the medullary portion but not in the thick limb as a whole; this response permits increased efficiency of the countercurrent system and subsequent urinary concentration without affecting overall loop NaCl transport [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other peptide hormones also act to increase cyclic AMP generation and NaCl transport in the thick ascending limb [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/35\">",
"     35",
"    </a>",
"    ]. These include glucagon in the medullary segment and glucagon, calcitonin, parathyroid hormone, and beta-adrenergic agonists in the cortical segment. The function of these responses is not clear. They are not likely to be important regulators of NaCl balance, but parathyroid hormone and perhaps calcitonin do contribute to the local regulation of Ca2+ and Mg2+ reabsorption, particularly in the cortical thick ascending limb (see Chap. 3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TRANSPORT IN CORTICAL THICK ASCENDING LIMB",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cortical aspect of the thick ascending limb makes a variable contribution to nephronal NaCl reabsorption. The juxtamedullary nephrons have long medullary loops (which are essential for concentrating ability; see below) but short cortical segments. In comparison, the cortical aspect is more prominent in the outer cortical nephrons, which are relatively far from the corticomedullary junction (",
"    <a class=\"graphic graphic_figure graphicRef55088 \" href=\"mobipreview.htm?22/60/23503\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The Na+-K+-2Cl- carrier appears to mediate most of NaCl reabsorption in the cortex, as it does in the medullary thick limb [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/8,36\">",
"     8,36",
"    </a>",
"    ]. In addition, the cortical thick ascending limb also plays a major role in Ca2+ and Mg2+ reabsorption. This segment is the site at which more than 50 percent of the filtered Mg2+ is reabsorbed, a level that changes appropriately with alterations in Mg2+ balance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/17\">",
"     17",
"    </a>",
"    ]. As an example, the urine can be rendered almost Mg2+-free in states of magnesium depletion due primarily to increased reabsorption in the thick ascending limb and distal convoluted tubule. Some of this Mg2+ transport is passive, occurring between the cells down the lumen positive gradient created by the Na+-K+-2Cl- carrier (",
"    <a class=\"graphic graphic_figure graphicRef75301 \" href=\"mobipreview.htm?30/62/31725\">",
"     figure 2",
"    </a>",
"    ) and being regulated in part by the calcium-sensing receptor as described above for calcium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/25\">",
"     25",
"    </a>",
"    ]. In addition, specific changes in Mg2+ handling are mediated by an active transcellular process in the distal convoluted tubule that may be activated by changes in the plasma Mg2+ concentration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/17,37\">",
"     17,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cortical thick ascending limb is also one of the sites (with the distal tubule and connecting segment) at which Ca2+ reabsorption is actively regulated according to physiologic needs. Parathyroid hormone plays an important role in this process, increasing Ca2+ reabsorption by activating a hormone-specific adenylate cyclase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36630/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/59/32694?source=see_link\">",
"     \"Chapter 5A: Distal tubule and connecting segment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/44/29384?source=see_link\">",
"     \"Chapter 4B: Countercurrent mechanism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW, Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/1\">",
"      Katz AI. Distribution and function of classes of ATPases along the nephron. Kidney Int 1986; 29:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/2\">",
"      Farman N, Corthesy-Theulaz I, Bonvalet JP, Rossier BC. Localization of alpha-isoforms of Na(+)-K(+)-ATPase in rat kidney by in situ hybridization. Am J Physiol 1991; 260:C468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/3\">",
"      Gamba G. Molecular biology of distal nephron sodium transport mechanisms. Kidney Int 1999; 56:1606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/4\">",
"      Xu JC, Lytle C, Zhu TT, et al. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter. Proc Natl Acad Sci U S A 1994; 91:2201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/5\">",
"      Haas M. The Na-K-Cl cotransporters. Am J Physiol 1994; 267:C869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/6\">",
"      Molony DA, Reeves WB, Andreoli TE. Na+:K+:2Cl- cotransport and the thick ascending limb. Kidney Int 1989; 36:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/7\">",
"      Lapointe JY, Bell PD, Cardinal J. Direct evidence for apical Na+:2Cl-:K+ cotransport in macula densa cells. Am J Physiol 1990; 258:F1466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/8\">",
"      Greger R, Vel&aacute;zquez H. The cortical thick ascending limb and early distal convoluted tubule in the urinary concentrating mechanism. Kidney Int 1987; 31:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/9\">",
"      Oberm&uuml;ller N, Kunchaparty S, Ellison DH, Bachmann S. Expression of the Na-K-2Cl cotransporter by macula densa and thick ascending limb cells of rat and rabbit nephron. J Clin Invest 1996; 98:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/10\">",
"      Gamba G. Alternative splicing and diversity of renal transporters. Am J Physiol Renal Physiol 2001; 281:F781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/11\">",
"      Gamba G, Miyanoshita A, Lombardi M, et al. Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. J Biol Chem 1994; 269:17713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/12\">",
"      Simon DB, Karet FE, Hamdan JM, et al. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 1996; 13:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/13\">",
"      Winters CJ, Reeves WB, Andreoli TE. Cl- channels in basolateral renal medullary vesicles. VIII. Partial purification and functional reconstitution of basolateral mTAL Cl- channels. Kidney Int 1994; 45:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/14\">",
"      Simon DB, Bindra RS, Mansfield TA, et al. Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 1997; 17:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/15\">",
"      Wang WH, White S, Geibel J, Giebisch G. A potassium channel in the apical membrane of rabbit thick ascending limb of Henle's loop. Am J Physiol 1990; 258:F244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/16\">",
"      Simon DB, Karet FE, Rodriguez-Soriano J, et al. Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 1996; 14:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/17\">",
"      Quamme GA. Renal magnesium handling: new insights in understanding old problems. Kidney Int 1997; 52:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/18\">",
"      Friedman PA. Basal and hormone-activated calcium absorption in mouse renal thick ascending limbs. Am J Physiol 1988; 254:F62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/19\">",
"      Capasso G, Unwin R, Agulian S, Giebisch G. Bicarbonate transport along the loop of Henle. I. Microperfusion studies of load and inhibitor sensitivity. J Clin Invest 1991; 88:430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/20\">",
"      Good DW. Adaptation of HCO-3 and NH+4 transport in rat MTAL: effects of chronic metabolic acidosis and Na+ intake. Am J Physiol 1990; 258:F1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/21\">",
"      Capasso G, Unwin R, Ciani F, et al. Bicarbonate transport along the loop of Henle. II. Effects of acid-base, dietary, and neurohumoral determinants. J Clin Invest 1994; 94:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/22\">",
"      DuBose TD Jr, Good DW, Hamm LL, Wall SM. Ammonium transport in the kidney: new physiological concepts and their clinical implications. J Am Soc Nephrol 1991; 1:1193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/23\">",
"      Garvin JL, Burg MB, Knepper MA. Active NH4+ absorption by the thick ascending limb. Am J Physiol 1988; 255:F57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/24\">",
"      Amlal H, Legoff C, Vernimmen C, et al. Na(+)-K+(NH4+)-2Cl- cotransport in medullary thick ascending limb: control by PKA, PKC, and 20-HETE. Am J Physiol 1996; 271:C455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/25\">",
"      Hebert SC. Extracellular calcium-sensing receptor: implications for calcium and magnesium handling in the kidney. Kidney Int 1996; 50:2129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/26\">",
"      Riccardi D, Lee WS, Lee K, et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996; 271:F951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/27\">",
"      Wang WH, Lu M, Hebert SC. Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271:C103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/28\">",
"      Chamberlin ME, LeFurgey A, Mandel LJ. Suspension of medullary thick ascending limb tubules from the rabbit kidney. Am J Physiol 1984; 247:F955.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/29\">",
"      Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: a new perspective. Kidney Int 1984; 26:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/30\">",
"      Carroll MA, Schwartzman M, Baba M, et al. Renal cytochrome P-450-related arachidonate metabolism in rabbit aortic coarctation. Am J Physiol 1988; 255:F151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/31\">",
"      Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 1991; 251:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/32\">",
"      Beach RE, Good DW. Effects of adenosine on ion transport in rat medullary thick ascending limb. Am J Physiol 1992; 263:F482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/33\">",
"      Wright FS. Flow-dependent transport processes: filtration, absorption, secretion. Am J Physiol 1982; 243:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/34\">",
"      Reeves WB, Dudley MA, Mehta P, Andreoli TE. Diluting power of thick limbs of Henle. II. Bumetanide-sensitive 22Na+ influx in medullary vesicles. Am J Physiol 1988; 255:F1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/35\">",
"      De Rouffignac C, Di Stefano A, Wittner M, et al. Consequences of differential effects of ADH and other peptide hormones on thick ascending limb of mammalian kidney. Am J Physiol 1991; 260:R1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/36\">",
"      Di Stefano A, Greger R, de Rouffignac C, Wittner M. Active NaCl transport in the cortical thick ascending limb of Henle's loop of the mouse does not require the presence of bicarbonate. Pflugers Arch 1992; 420:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/37\">",
"      Bapty BW, Dai LJ, Ritchie G, et al. Extracellular Mg2(+)- and Ca2(+)-sensing in mouse distal convoluted tubule cells. Kidney Int 1998; 53:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36630/abstract/38\">",
"      Gesek FA, Friedman PA. On the mechanism of parathyroid hormone stimulation of calcium uptake by mouse distal convoluted tubule cells. J Clin Invest 1992; 90:749.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7282 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36630=[""].join("\n");
var outline_f35_49_36630=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CELL MODEL FOR SODIUM CHLORIDE TRANSPORT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Mechanism of NaCl entry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Role in acid-base balance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Role in urine calcium excretion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Passive Na+ reabsorption and medullary hypoxia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Clinical implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CONCENTRATION AND FLOW DEPENDENCE OF LOOP REABSORPTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TRANSPORT IN CORTICAL THICK ASCENDING LIMB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7282\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7282|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/60/23503\" title=\"figure 1\">",
"      Loop of Henle segments",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?30/62/31725\" title=\"figure 2\">",
"      Loop of Henle transport",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/56/909\" title=\"figure 3\">",
"      Cl dependence of renin release",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?16/45/17118\" title=\"figure 4\">",
"      Hypoxia in the renal medulla",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/29/12762?source=related_link\">",
"      Chapter 11A: Renal hydrogen excretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/2/24617?source=related_link\">",
"      Chapter 3A: Cell model for proximal transport",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/44/29384?source=related_link\">",
"      Chapter 4B: Countercurrent mechanism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/59/32694?source=related_link\">",
"      Chapter 5A: Distal tubule and connecting segment",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_49_36631="Medroxyprogesterone acetate: Pediatric drug information";
var content_f35_49_36631=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Medroxyprogesterone acetate: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"    see \"Medroxyprogesterone acetate: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/25/36245?source=see_link\">",
"    see \"Medroxyprogesterone acetate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F192012\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Depo-Provera&reg;;",
"     </li>",
"     <li>",
"      Depo-Provera&reg; Contraceptive;",
"     </li>",
"     <li>",
"      depo-subQ provera 104&reg;;",
"     </li>",
"     <li>",
"      Provera&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F192013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alti-MPA;",
"     </li>",
"     <li>",
"      Apo-Medroxy&reg;;",
"     </li>",
"     <li>",
"      Depo-Prevera&reg;;",
"     </li>",
"     <li>",
"      Depo-Provera&reg;;",
"     </li>",
"     <li>",
"      Dom-Medroxyprogesterone;",
"     </li>",
"     <li>",
"      Gen-Medroxy;",
"     </li>",
"     <li>",
"      Medroxy;",
"     </li>",
"     <li>",
"      Medroxyprogesterone Acetate Injectable Suspension USP;",
"     </li>",
"     <li>",
"      Novo-Medrone;",
"     </li>",
"     <li>",
"      PMS-Medroxyprogesterone;",
"     </li>",
"     <li>",
"      Provera-Pak;",
"     </li>",
"     <li>",
"      Provera&reg;;",
"     </li>",
"     <li>",
"      Teva-Medroxyprogesterone",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060100\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Contraceptive, Progestin Only",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Progestin",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060093\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"      see \"Medroxyprogesterone acetate: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adolescents and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Abnormal uterine bleeding:",
"     </b>",
"     Oral: 5-10 mg for 5-10 days starting on day 16 or day 21 of menstrual cycle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Amenorrhea:",
"     </b>",
"     Oral: 5-10 mg/day for 5-10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Contraception:",
"     </b>",
"     First dose to be given only during first 5 days of normal menstrual period; only within 5 days postpartum if not breast-feeding, or only at sixth postpartum week if exclusively breast-feeding. When switching from other contraceptive methods, depo-subQ provera 104&trade; should be administered within 7 days after the last day of using the last method (pill, ring, patch).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     I.M. (Depo-Provera&reg;): 150 mg every 3 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     SubQ (depo-subQ provera 104&reg;): 104 mg every 3 months (every 12-14 weeks)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Endometriosis-associated pain:",
"     </b>",
"     SubQ (depo-subQ provera 104&trade;): 104 mg every 3 months; treatment longer than 2 years is not recommended due to impact of long-term use on bone mineral density",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Accompanying cyclic estrogen therapy (postmenopausal):",
"     </b>",
"     Oral: 5-10 mg for 12-14 consecutive days each month, starting on day 1 or day 16 of cycle; lower doses may be used if given with estrogen continuously throughout the cycle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Endometrial carcinoma, recurrent or metastatic:",
"     </b>",
"     I.M. (Depo-Provera&reg;): 400-1000 mg/week",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosing adjustment in hepatic impairment:",
"     </b>",
"     Use is contraindicated with severe impairment. Discontinue with jaundice or if liver function disturbances occur. Consider lower dose or less frequent administration with mild to moderate impairment. Use of the contraceptive injection has not been studied in patients with hepatic impairment; consideration should be given to not readminister if jaundice develops.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F191989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension, as acetate: 150 mg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Depo-Provera&reg;: 400 mg/mL (2.5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Depo-Provera&reg; Contraceptive: 150 mg/mL (1 mL) [contains polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     depo-subQ provera 104&reg;: 104 mg/0.65 mL (0.65 mL) [contains polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as acetate: 2.5 mg, 5 mg, 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Provera&reg;: 2.5 mg, 5 mg, 10 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F191974\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060103\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer with food",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: (Depo-Provera&reg; Contraceptive): Shake suspension vigorously; administer by deep I.M. injection in the gluteal or deltoid muscle",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ (depo-subQ provera 104&reg;): Shake vigorously; administer by subQ injection over 5-7 seconds in the anterior thigh or abdomen; avoid boney areas and the umbilicus. Do not rub the injection area; not for I.M. or I.V. use.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F14237053\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F); protect oral formulation from light",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060102\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Secondary amenorrhea or abnormal uterine bleeding due to hormonal imbalance; prevention of pregnancy; reduction of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens; endometrial carcinoma; management of endometriosis-associated pain (FDA approved in adults)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F192043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Depo-Provera&reg; may be confused with depo-subQ provera 104&trade;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       MedroxyPROGESTERone may be confused with hydroxyprogesterone caproate, methylPREDNISolone, methylTESTOSTERone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Provera&reg; may be confused with Covera&reg;, Femara&reg;, Parlodel&reg;, Premarin&reg;, Proscar&reg;, PROzac&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The injectable dosage form is available in different formulations. Carefully review prescriptions to assure the correct formulation and route of administration.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F192040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects as reported with any dosage form",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Depression, dizziness, fatigue, headache, insomnia, nervousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast pain, hot flashes, libido decreased, menstrual irregularities (includes bleeding, amenorrhea, or both)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain/discomfort, bloating, nausea, weight gain (&gt;10 lbs at 24 months)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Cervical smear abnormal, leukorrhea, menometrorrhagia, menorrhagia, pelvic pain, urinary tract infection, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Dysmenorrhea, leukorrhea, vaginitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction (SubQ administration): Atrophy, induration, pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic reaction, anaphylaxis, anaphylactoid reactions, angioedema, asthma, blood dyscrasia, bone mineral density decreased, breast cancer, breast changes, cervical cancer, chest pain, chloasma, cholestatic jaundice, deep vein thrombosis, diaphoresis, dyspnea, facial palsy, galactorrhea, glucose tolerance decreased, hirsutism, hoarseness, injection site reactions, jaundice, lack of return to fertility, lactation decreased, melasma, nipple bleeding, optic neuritis, osteoporosis, osteoporotic fractures, paralysis, paresthesia, pulmonary embolus, rectal bleeding, retinal thrombosis, scleroderma, seizure, syncope, tachycardia, thrombophlebitis, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to medroxyprogesterone or any component; history of or current thrombophlebitis or thromboembolic disorders (DVT, PE, MI), cerebral vascular disease, undiagnosed vaginal bleeding, liver dysfunction, breast cancer or other estrogen- or progesterone-dependent neoplasia, pregnancy (known or suspected), missed abortion, diagnostic test for pregnancy",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060092\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Unscheduled bleeding/spotting may occur; presentation of irregular, unresolving vaginal bleeding following previously regular cycles warrants further evaluation, including endometrial sampling, if indicated, to rule out malignancy. May cause weight gain; contraceptive therapy with medroxyprogesterone commonly results in an average weight gain of ~2.5 kg after 1 year and ~3.7 kg after 2 years of treatment. Use with caution in patients with diseases which may be exacerbated by fluid retention, including epilepsy, asthma, migraines, or renal or cardiac dysfunction. Use caution in diabetes mellitus; may adversely affect glucose tolerance. Use with caution in patients with a history of depression; discontinue therapy if depression recurrs. Estrogen plus progestin therapy may exacerbate hepatic hemangiomas, porphyria, and SLE; use caution in women with these conditions. Elevations in plasma triglycerides may occur with estrogen and progestin therapy; use caution in patients with pre-existing hypertriglyceridemia as this may lead to pancreatitis and other complications. Medroxyprogesterone is extensively metabolized in the liver; discontinue if jaundice develops or if acute or chronic hepatic disturbances occur.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060091\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Discontinue if there is a sudden partial or complete loss of vision, proptosis, diplopia, migraine, if papilledema or retinal vascular lesions are present, or any other symptom of a thromboembolic event.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Prolonged use of medroxyprogesterone as a contraceptive reduces estrogen levels and has been associated with increased bone mineral density (BMD) loss",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Loss is related to the duration of use and not significantly different between the SubQ and I.M. dosage forms. Bone loss may not be completely reversible on discontinuation of the drug; in adolescents following 2 years of medroxyprogesterone treatment, femoral neck and hip BMD values did not fully recover to baseline at 60 months after discontinuation of therapy; age-matched cohorts' BMD increased throughout evaluation. It is not known if use during adolescence or early adulthood will decrease peak bone mass accretion or increase the risk for osteoporitic fractures later in life. The impact on peak bone mass in adolescents should be weighed against the potential for unintended pregnancies in treatment decisions. Consider alternative contraceptive methods in patients at risk for osteoporosis (eg, metabolic bone disease, family history of osteoporosis, chronic use of medications associated with osteoporosis such as corticosteroids). Use as a long-term contraceptive agent (&ge;2 years) should be reserved for situations when other contraceptives are not effective or contraindicated",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Monitor BMD if prolonged use is necessary. Inform patients that injectable contraceptives do not protect against HIV infection or other sexually transmitted diseases",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . When used for contraception, the possibility of ectopic pregnancy should be considered in patients with abdominal pain.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Based on data from the Women&rsquo;s Health Initiative (WHI) studies, an increased risk of invasive breast cancer was observed in postmenopausal women using conjugated estrogens (CE) in combination with medroxyprogesterone acetate (MPA)",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . This risk may be associated with duration of use and declines once combined therapy is discontinued (Chlebowski, 2009). The risk of invasive breast cancer was decreased in postmenopausal women with a hysterectomy using CE only, regardless of weight. However, the risk was not significantly decreased in women at high risk for breast cancer (family history of breast cancer, personal history of benign breast disease) (Anderson, 2012). An increase in abnormal mammogram findings has also been reported with estrogen alone or in combination with progestin therapy. Use is contraindicated in patients with known or suspected breast cancer.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     MPA is used to reduce the risk of endometrial hyperplasia in nonhysterectomized postmenopausal women receiving conjugated estrogens. The use of unopposed estrogen in women with an intact uterus is associated with an increased risk of endometrial cancer. The addition of a progestin to estrogen therapy may decrease the risk of endometrial hyperplasia, a precursor to endometrial cancer. Adequate diagnostic measures, including endometrial sampling if indicated, should be performed to rule out malignancy in postmenopausal women with undiagnosed abnormal vaginal bleeding. Estrogens may exacerbate endometriosis. Malignant transformation of residual endometrial implants has been reported posthysterectomy with unopposed estrogen therapy. Consider adding a progestin in women with residual endometriosis posthysterectomy. Postmenopausal estrogen therapy and combined estrogen/progesterone therapy may increase the risk of ovarian cancer; however, the absolute risk to an individual woman is small. Although results from various studies are not consistent, risk does not appear to be significantly associated with the duration, route, or dose of therapy. In one study, the risk decreased after 2 years following discontinuation of therapy (M&oslash;rch, 2009). Although the risk of ovarian cancer is rare, women who are at an increased risk (eg, family history) should be counseled about the association (NAMS, 2012).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Estrogens with or without progestin should not be used to prevent dementia",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . In the Women&rsquo;s Health Initiative Memory Study (WHIMS), an increased incidence of dementia was observed in women &ge;65 years of age taking CE alone or in combination with MPA. Estrogens with or without progestin should not be used to prevent cardiovascular disease",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Using data from the WHI studies, an increased risk of DVT and stroke has been reported with CE and an increased risk of DVT, stroke, pulmonary emboli, and MI has been reported with CE with MPA in postmenopausal women. Additional risk factors include diabetes mellitus, hypercholesterolemia, hypertension, SLE, obesity, tobacco use, and/or history of venous thromboembolism. Risk factors should be managed appropriately; discontinue use if adverse cardiovascular events occur or are suspected. If thrombosis develops with contraceptive treatment, discontinue treatment (unless no other acceptable contraceptive alternative).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Estrogens with or without progestin should be used for the shortest duration possible at the lowest effective dose consistent with treatment goals",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     . Available data related to treatment risks are from WHI studies, which evaluated oral CE 0.625 mg with or without MPA 2.5 mg relative to placebo in postmenopausal women. Other combinations and dosage forms of estrogens and progestins were not studied. Outcomes reported from clinical trials using CE with or without MPA should be assumed to be similar for other doses and other dosage forms of estrogens and progestins until comparable data becomes available.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Anaphylaxis or anaphylactoid reactions have been reported with use of the injection; medication for the treatment of hypersensitivity reactions should be available for immediate use. Injection may contain polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F192030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F191983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acitretin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Given the potential for progestin-only preparations to fail to prevent pregnancy during acitretin therapy, such products should not be relied upon. Alternative, nonhormonal forms of contraception must be employed during acitretin therapy.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglutethimide: May increase the metabolism of Progestins. Management: Progestin-containing contraceptives are not recommended; consider the use of alternative, nonhormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aprepitant: May decrease the serum concentration of Contraceptives (Progestins). Management: Alternative or additional methods of contraception should be used both during treatment with aprepitant or fosaprepitant and for at least one month following the last aprepitant/fosaprepitant dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inducers may decrease the serum concentration of ARIPiprazole.  Management: Double the oral aripiprazole dose and closely monitor clinical response.  Reduce the oral aripiprazole dose to 10-15 mg/day if the inducer is discontinued. Avoid use of CYP3A4 inducers for more than 14 days with extended-release injectable aripiprazole.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Artemether: May decrease the serum concentration of Contraceptives (Progestins). Management: Consider the use of an alternative (i.e., non-hormonal) means of contraception in all women of childbearing potential who are using artemether.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atazanavir: May increase the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Barbiturates: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines (metabolized by oxidation): Contraceptives (Progestins) may increase the serum concentration of Benzodiazepines (metabolized by oxidation).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bexarotene (Systemic): May decrease the serum concentration of Contraceptives (Progestins). Management: Women of childbearing potential receiving bexarotene should use two reliable forms of contraception (including at least one nonhormonal form).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the serum concentration of Contraceptives (Progestins). Management: Administer oral progestin-containing contraceptives at least 1-4 hours prior to or 4-6 hours after administration of a bile acid sequestrant.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Boceprevir: May increase the serum concentration of Contraceptives (Progestins). This has been seen specifically with drospirenone. Boceprevir may increase the serum concentration of Contraceptives (Progestins). This has been seen specifically with norethindrone. Management: Patients receiving boceprevir, ribavirin, and peginterferon alfa should use two reliable forms of contraception.  Norethindrone/ethinyl estradiol may be used for one of these when norethindrone dose is at least 1 mg/day. Avoid drospirenone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bosentan: May decrease the serum concentration of Contraceptives (Progestins). Management: Use an alternative (i.e., non-hormonal) means of contraception for all women of childbearing potential who are using bosentan, and do not rely on hormonal contraceptives alone.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Use of alternative, nonhormonal contraceptives is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloBAZam: May decrease the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cobicistat: May increase the serum concentration of Contraceptives (Progestins). Management: Consider the use of an alternative, non-hormone-based contraceptive, in patients who are being treated with the elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate combination product.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May increase the metabolism of CYP3A4 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Felbamate: May decrease the serum concentration of Contraceptives (Progestins). Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal method of contraception is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosaprepitant: May decrease the serum concentration of Contraceptives (Progestins). The active metabolite aprepitant is likely responsible for this effect. Management: Alternative or additional methods of contraception should be used both during treatment with aprepitant or fosaprepitant and for at least one month following the last aprepitant/fosaprepitant dose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Griseofulvin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Progestogenic Properties) (eg, Bloodroot, Yucca): May enhance the adverse/toxic effect of Progestins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     LamoTRIgine: May decrease the serum concentration of Contraceptives (Progestins). Management: Women using progestin-only &ldquo;minipill&rdquo; products may be at risk for contraceptive failure; it is unclear if other progestin-containing products would be significantly impacted.  Alternative, non-hormonal, means of contraception are recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May diminish the therapeutic effect of Contraceptives (Progestins). Mifepristone may increase the serum concentration of Contraceptives (Progestins). Management: Women of childbearing potential should use an effective, nonhormonal means of contraception during and 4 weeks following mifepristone treatment.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: May decrease the serum concentration of Contraceptives (Progestins). Management: Use of an additional or alternative (nonhormonal) method of contraception should be considered.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nevirapine: May decrease the serum concentration of Contraceptives (Progestins). Management: Instruct patients receiving nevirapine to use an alternative or additional nonhormonal contraceptive. Nevirapine product labeling however suggests that depo-medroxyprogesterone acetate may be used as a sole method of contraception.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OXcarbazepine: May decrease the serum concentration of Contraceptives (Progestins). Management: Contraceptive failure is possible.  Use of an additional or alternative, nonhormonal method of contraception is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May decrease the serum concentration of Contraceptives (Progestins). Management: Patients should use an alternative, non-hormonal based form of contraception for the duration of concurrent perampanel.  Both oral and non-oral progestin-based contraceptives are likely to be impacted by this interaction.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prucalopride: May decrease the serum concentration of Contraceptives (Progestins).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Retinoic Acid Derivatives: May diminish the therapeutic effect of Contraceptives (Progestins). Retinoic Acid Derivatives may decrease the serum concentration of Contraceptives (Progestins). Management: Two forms of effective contraception should be used in patients receiving retinoic acid derivatives.  Particularly, microdosed progesterone-only preparations may be inadequately effective.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifamycin Derivatives: May decrease the serum concentration of Contraceptives (Progestins). Contraceptive failure is possible. Management: Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selegiline: Contraceptives (Progestins) may increase the serum concentration of Selegiline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     St Johns Wort: May diminish the therapeutic effect of Contraceptives (Progestins). Contraceptive failure is possible. Management: Consider using a product other than St John's wort.  Contraceptive failure is possible.  Use of an alternative, nonhormonal contraceptive is recommended.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telaprevir: May decrease the serum concentration of Contraceptives (Progestins). Management: Two different nonhormonal forms of contraception are required for women of childbearing potential taking telaprevir.  Hormonal contraceptives may be less effective during concurrent telaprevir and for up to 2 weeks after telaprevir discontinuation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: May decrease the serum concentration of Contraceptives (Progestins). Management: Caution patients that this combination may be associated with reduced contraceptive effectiveness.  Consider adding an additional (non-hormonal) contraceptive method.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tranexamic Acid: Contraceptives (Progestins) may enhance the thrombogenic effect of Tranexamic Acid.  Management: Ensure that the potential benefits of concurrent therapy outweigh the increased risk of potential thrombosis that accompanies use of tranexamic acid with hormonal contraceptives.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Contraceptives (Progestins) may diminish the anticoagulant effect of Vitamin K Antagonists. In contrast, enhanced anticoagulant effects have also been noted with some products.  Management: When possible, concomitant hormonal contraceptives and coumarin derivatives should be avoided in order to eliminate the risk of thromboembolic disorders.  Consider using an alternative, nonhormonal contraceptive.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Voriconazole: May increase the serum concentration of Contraceptives (Progestins). Contraceptives (Progestins) may increase the serum concentration of Voriconazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F191985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     X (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F191997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In general, there is not an increased risk of birth defects following inadvertent use of the injectable medroxyprogesterone contraceptives early in pregnancy. There is an increased risk of minor birth defects in children whose mothers take progesterones during the first 4 months of pregnancy. Hypospadias has been reported in male babies and mild masculinization of the external genitalia has been reported in female babies exposed during the first trimester. High doses are used to impair fertility. Ectopic pregnancies have been reported with use of the MPA contraceptive injection. Median time to conception/return to ovulation following discontinuation of MPA contraceptive injection is 10 months following the last injection.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1060099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Before starting therapy, a physical exam with reference to the breasts and pelvis are recommended, including a Papanicolaou smear. Exam may be deferred if appropriate prior to administration of MPA contraceptive injection; pregnancy should be ruled out prior to use. Monitor patient closely for loss of vision; sudden onset of proptosis, diplopia, or migraine; signs and symptoms of thromboembolic disorders; signs and symptoms of depression; glucose in patients with diabetes; or blood pressure. BMD with long-term use.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Adequate diagnostic measures, including endometrial sampling, if indicated, should be performed to rule out malignancy in all cases of undiagnosed abnormal vaginal bleeding.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits secretion of pituitary gonadotropins, which prevents follicular maturation and ovulation, transforms a proliferative endometrium into a secretory one",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1060105\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Time to ovulation (after last injection): 10 months (range: 6-12 months)",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Slow",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 86% to 90% primarily to albumin; does not bind to sex hormone-binding globulin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic via hydroxylation and conjugation; forms metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 0.6% to 10%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 12-17 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M. (Depo-Provera&reg; Contraceptive): ~50 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ: ~40 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M. (Depo-Provera&reg; Contraceptive): ~3 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ (depo-subQ provera 104&reg;): 1 week",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060098\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/25/36245?source=see_link\">",
"      see \"Medroxyprogesterone acetate: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Notify physician if sudden loss of vision, severe headache, sharp chest pain, coughing up blood, weakness or numbness in an arm or leg, severe pain or swelling in calf, unusual heavy vaginal bleeding or severe pain or tenderness in lower abdominal area",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists Committee on Gynecologic Practice, \"ACOG Committee Opinion No. 415: Depot Medroxyprogesterone Acetate and Bone Effects,\"",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2008, 112(3):727-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?35/49/36631/abstract-text/18757687/pubmed\" id=\"18757687\" target=\"_blank\">",
"        18757687",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anderson GL, Chlebowski RT, Aragaki AK, et al, \"Conjugated Equine Oestrogen and Breast Cancer Incidence and Mortality in Postmenopausal Women With Hysterectomy: Extended Follow-Up of the Women's Health Initiative Randomised Placebo-Controlled Trial,\"",
"      <i>",
"       Lancet Oncol",
"      </i>",
"      , 2012.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?35/49/36631/abstract-text/22401913/pubmed\" id=\"22401913\" target=\"_blank\">",
"        22401913",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chlebowski RT, Kuller LH, Prentice RL, et al, \"Breast Cancer After Use of Estrogen Plus Progestin in Postmenopausal Women,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2009, 360(6):573-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?35/49/36631/abstract-text/19196674/pubmed\" id=\"19196674\" target=\"_blank\">",
"        19196674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      M&oslash;rch LS, L&oslash;kkegaard E, Andreasen AH, et al, \"Hormone Therapy and Ovarian Cancer,\"",
"      <i>",
"       JAMA",
"      </i>",
"      , 2009, 302(3):298-305.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?35/49/36631/abstract-text/19602689/pubmed\" id=\"19602689\" target=\"_blank\">",
"        19602689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      North American Menopause Society, \"The 2012 Hormone Therapy Position Statement of: The North American Menopause Society,\"",
"      <i>",
"       Menopause",
"      </i>",
"      , 2012, 19(3):257-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?35/49/36631/abstract-text/22367731/pubmed\" id=\"22367731\" target=\"_blank\">",
"        22367731",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12577 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36631=[""].join("\n");
var outline_f35_49_36631=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709035\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192012\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192013\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060100\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060093\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191989\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191974\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060103\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14237053\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060102\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192043\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192040\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060107\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060092\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060091\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F192030\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191983\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191985\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191997\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060099\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060090\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060105\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060106\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060098\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12577\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12577|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=related_link\">",
"      Medroxyprogesterone acetate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/25/36245?source=related_link\">",
"      Medroxyprogesterone acetate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_49_36632="Computed tomographic colonography";
var content_f35_49_36632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Computed tomographic colonography",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Jonathan B Kruskal, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36632/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/49/36632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomographic (CT) colonography (also virtual colonoscopy or CT colography), first described by Vining in 1994 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/1\">",
"     1",
"    </a>",
"    ], provides a computer-simulated endoluminal perspective of the air-filled distended colon. The technique uses conventional spiral or helical CT scan or magnetic resonance images acquired as an uninterrupted volume of data, and employs sophisticated postprocessing software to generate images which allow the operator to fly-through and navigate a cleansed colon in any chosen direction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATIENT PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;With current technology, the colon should be as clean as possible since stool can simulate polyps (",
"    <a class=\"graphic graphic_picture graphicRef75282 \" href=\"mobipreview.htm?13/61/14302\">",
"     picture 1",
"    </a>",
"    ). The presence of fat density within a polypoid mass suggests stool, but technical improvements are required before stool and polyps are easily distinguished. Researchers are using intravenous contrast material (stool will not enhance), densitometric analysis, and even oral fecal tagging agents to facilitate this distinction.",
"   </p>",
"   <p>",
"    The standard",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema preparation (Fleet Prep; Fleet Pharmaceutical, Lynchburg, VA) produces adequate cleansing of the colon and a drier mucosal surface than is seen after preparation with the standard endoscopy agent GoLYTELY&reg; (GoLYTELY&reg;; Braintree Laboratories, Braintree, MA). Retained fluid in the lumen may obscure small polyps.",
"   </p>",
"   <p>",
"    The cleansed colon must be distended with air throughout its length during virtual colonoscopy. This may be facilitated by use of smooth muscle relaxants, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/32/25093?source=see_link\">",
"     glucagon",
"    </a>",
"    hydrochloride, which also reduce peristalsis. However, these agents also enhance reflux of air into the small bowel which complicates interpretation of the study and automated computerized tracking along the air-filled lumen. Some centers are using carbon dioxide which may be better tolerated by patients. Colonic distension is evaluated on the CT table immediately prior to image acquisition by reviewing the planar CT scout image.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SCANNING TECHNIQUE AND DATA ACQUISITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;With CT colonography, the patient lies supine on the CT table, and an uninterrupted volume of data is acquired through the abdomen during a single 32-second breath-hold. In large patients or those unable to hold their breath, two scans are acquired but this may lead to image misregistration when images are subsequently reformatted. Scanning parameters are designed to cover a large volume of data with thin (5 mm) slices to optimize subsequent image reformation.",
"   </p>",
"   <p>",
"    The radiation dose is similar to or less than that of a conventional",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema, and considerably less than a standard abdominal or pelvic CT scan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/2\">",
"     2",
"    </a>",
"    ]. The technique is similar with magnetic resonance colonography, although it does not involve any radiation exposure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the presence of stool, fluid, or bowel spasm, many radiologists are acquiring data in both the supine and prone projections, such that fluid and colonic gas are redistributed to facilitate polyp detection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Image processing and reconstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once image data are acquired, postprocessing is performed on a computer using a variety of commercially available software packages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/7\">",
"     7",
"    </a>",
"    ]. The hardware and software requirements are significant and several CT scan manufacturers now include virtual reality software into off-line workstations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/3\">",
"     3",
"    </a>",
"    ]. The data are then used to render multiplanar reformatted images (in coronal, sagittal and axial planes), mucosal relief profiles, or hybrid, surface-shaded or volume-rendered endoluminal perspectives (",
"    <a class=\"graphic graphic_picture graphicRef71187 \" href=\"mobipreview.htm?3/18/3374\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Each technique provides different information and studies should be tailored to answer the specific clinical question. For the virtual endoluminal study, interactive viewing of the study is performed at near real-time speeds, with the operator capable of simultaneously viewing other anatomic projections at the same site, while being able to control the speed and direction of flight. Shutter widths, bowel wall transparency, lesion and bowel wall measurements, and image recording can all be performed.",
"   </p>",
"   <p>",
"    Three rendering techniques are currently in clinical use:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surface rendering relies on selection of a specific range of CT attenuation values whereby only pixels within a preselected range are included in the 3D reconstruction [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/4\">",
"       4",
"      </a>",
"      ]. A simulated light source provides a sense of depth.",
"     </li>",
"     <li>",
"      With volume rendering, voxels are assigned different degrees of opacity; and the entire CT data set is used, producing a final image that more faithfully represents the true anatomic structures being imaged [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Perspective rendering, an adjunct to volume rendering, provides a sense of motion, depth, and the ability to navigate or fly-through the bowel lumen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Software designed to enhance polyp detection automatically (computer-aided detection) is under development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TEST CHARACTERISTICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A growing number of studies have evaluated test characteristics of CT colonography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/4,9-18\">",
"     4,9-18",
"    </a>",
"    ]. Estimates of test performance have varied among studies due in part to the specific techniques used, the patient population studied, the reference standards used, and the experience of the radiologists performing and evaluating the examinations. The following examples illustrate the findings in the largest and most methodologically rigorous reports. Taken together, they support a primary role for CT colonography as an option for screening average risk persons for colorectal cancer, provided that the center is using contemporary imaging methods and has well-trained radiologists.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An enhanced method of virtual colonoscopy uses three-dimensional image display and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      tagging of stool and retained fluids to allow for electronic \"cleansing\" of the colon. This reduces the misidentification of these materials as polyps and so reduces false positives. A study compared the use of this technique for screening in 1233 asymptomatic adults (97 percent considered at average risk for colorectal cancer) found the test to perform comparably with optical colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/15\">",
"       15",
"      </a>",
"      ]. The sensitivity and specificity of virtual colonoscopy for adenomatous polyps &ge;10 mm were 94 and 96 percent, respectively, while the sensitivity of optical colonoscopy was 88 percent. Two adenocarcinomas were found by virtual colonoscopy, one of which was missed by optical colonoscopy.",
"      <br/>",
"      <br/>",
"      In a follow-up report, the authors described characteristics of the lesions that had been missed by optical colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/19\">",
"       19",
"      </a>",
"      ]. Fourteen of 15 non rectal neoplasms were located on a fold, most of which (71 percent) were on the backside of the fold, making it difficult to visualize. Five of six rectal lesions were located within 10 cm of the anal verge. The authors estimated that when state-of-the-art 3-dimensional virtual colonoscopy was used as a reference standard, the miss rate of optical colonoscopy for large adenomas (&ge;10 mm) was 12 percent. This miss rate is much higher than previous estimates (0 to 6 percent) that were based upon optical colonoscopy as its own reference standard (typically the results of two optical colonoscopies performed shortly after one another).",
"      <br/>",
"      <br/>",
"      A later study from the same group compared optical and CT colography in 3120 consecutive adults undergoing screening colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/20\">",
"       20",
"      </a>",
"      ]. Detection rates for advanced neoplasia were similar but the number of polypectomies and complications were smaller in the CT group.",
"     </li>",
"     <li>",
"      A prospective blinded study included 703 asymptomatic patients considered to be at variable risk for colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/21\">",
"       21",
"      </a>",
"      ]. Patients underwent CT colonography followed by same-day colonoscopy. Three experienced radiologists reviewed the studies.",
"      <br/>",
"      <br/>",
"      The overall prevalence of adenomas &ge;1 cm was 5 percent. Compared with colonoscopy as the gold standard, the sensitivity of CT colonography for adenomas &ge;1 cm ranged from 34 to 73 percent between the different interpreters. Specificity ranged from 95 to 98 percent. For adenomas 5 to 9 mm, the sensitivities ranged from 35 to 57 percent while specificity ranged from 86 to 95 percent.",
"     </li>",
"     <li>",
"      Another study included 205 patients at variable risk for colorectal cancer who were studied with virtual colonoscopy and conventional colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/22\">",
"       22",
"      </a>",
"      ]. The overall sensitivity and specificity was 62 and 71 percent, respectively. Sensitivity was greater with lesions &ge;6 mm (sensitivity 84, specificity 83 percent) and in lesions &ge;1 cm (sensitivity 90 specificity 95 percent). The authors estimated that using a 1 cm cutoff size, virtual colonoscopy precluded the need for conventional colonoscopy in 86 percent of patients with a 1 percent false-negative rate (68 percent with a 2 percent false-negative rate with a 6-mm cutoff).",
"     </li>",
"     <li>",
"      A study involving nine centers compared CT colonography with standard colonoscopy in 600 subjects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/23\">",
"       23",
"      </a>",
"      ]. A total of 827 lesions were detected in 308 subjects of whom 104 were &ge;6 mm. The sensitivity of CT colonography was only 39 percent (95% CI 30 to 48 percent). For lesions &gt;10 mm, the sensitivity was 55 percent (95% CI 40 to 70 percent). The values were significantly lower than for conventional colonoscopy (sensitivity 99 and 100 percent for lesions &ge;6 mm or &ge;10 mm, respectively). Specificity (defined as the proportion of patients correctly designated as not having an adenoma &ge;6 mm) was 91 percent for CT colonography and 100 percent for conventional colonoscopy. CT colonography missed 2 of 8 cancers. The accuracy of CT colonography varied considerably between centers and did not improve as the study progressed. The authors concluded that CT colonography is not yet ready for widespread clinical application.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The variable results described in the individual trials above were underscored in a meta-analysis of 33 studies (with a total of 6393 patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/24\">",
"     24",
"    </a>",
"    ]. Studies were included only if they used \"state-of-the-art\" technology. Pooled estimates of sensitivity varied according to polyp size ranging from 48 percent for polyps &lt;6 mm to 85 percent for polyps &gt;9 mm. Specificity was consistently in the range of 92 to 97 percent. The authors concluded that CT colonography using state-of-the-art technology was highly specific but was associated with marked variation in sensitivity, an issue that must be resolved before its role can be advocated. Similar conclusions were reached in a subsequent meta-analysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another meta-analysis specifically looked at the sensitivities of CT colonography and optical colonoscopy for the detection of colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/26\">",
"     26",
"    </a>",
"    ]. The analysis included 49 studies with over 11,000 patients. The prevalence of colorectal cancer was 3.6 percent. The sensitivity of CT colonography for detecting cancer was 96 percent and the sensitivity for optical colonoscopy was 95 percent. When cathartics and stool tagging agents were used, the sensitivity for CT colonography was 100 percent.",
"   </p>",
"   <p>",
"    As CT colonography has evolved, increasing evidence suggests that its accuracy and reliability have improved, supporting it role as a primary colorectal screening option [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/17\">",
"     17",
"    </a>",
"    ]. As an example, a study published after the meta-analyses compared CT colonography to optical colonoscopy in 2600 asymptomatic patients aged 50 or older (most at average risk for colorectal cancer). The study was performed in 15 centers using multidetector CT with two- and three-dimensional image processing interpreted by radiologists trained in CT colonography. The sensitivity, specificity, positive and negative predictive values of CT colonography for detecting large adenomas and cancers were 90, 86, 23, and 99 percent, respectively. Thus, CT colonography missed a potentially important lesion in 10 percent of patients. The per patient sensitivity for polyps 6 mm or more was 78 percent.",
"   </p>",
"   <p>",
"    Sensitivity increases with experience of the radiologist. A small study found that novice radiologists needed to read 164 studies to attain sensitivity for polyp detection equal to that of experienced readers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Patients at increased risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The studies described above focused mostly on patients who were at average risk for colorectal cancer, although some included patients at variable risk. The accuracy of virtual colonoscopy in patients at increased risk (eg, because of a personal or family history of colorectal polyps or cancer) has not been studied extensively.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest study included 937 participants at increased risk for colorectal cancer (because of a family history, personal history of adenomas or positive fecal occult blood) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/28\">",
"       28",
"      </a>",
"      ]. Compared to unblinded colonoscopy as the reference standard, CT colonography had sensitivity and specificity of 85 and 88 percent, respectively, for lesions 6 mm or larger. The negative predictive value was 96 percent overall, but only 85 percent in patients with a positive fecal occult blood test. The positive predictive value was 62 percent overall.",
"     </li>",
"     <li>",
"      Another study included 614 patients (with a history of hematochezia, positive occult blood, iron-deficiency anemia or a family history of colorectal cancer) who underwent a double contrast",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"       barium",
"      </a>",
"      enema, CT, and conventional colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/29\">",
"       29",
"      </a>",
"      ]. The sensitivity for lesions larger than 10 mm was 48, 59, and 98 percent for double contrast enema, CT, and conventional colonoscopy, respectively. These values were 35, 51, and 99 percent for lesions 6 to 9 mm in size. Specificity for lesions 10 mm or more was greater for standard colonoscopy (99.6 percent) versus double contrast barium enema (90 percent) or CT colonography (96 percent) and declined for double contrast barium enema and CT colonography when smaller lesions were considered.",
"     </li>",
"     <li>",
"      A third report included 249 patients who underwent CT colonography and standard colonoscopy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/30\">",
"       30",
"      </a>",
"      ]. CT colonography detected large polyps in 26 of 31 patients (84 percent). Specificity was 92 percent, positive and negative predictive values were 60 and 98 percent, respectively. When considering all large polyps, CT colonography detected 75 to 77 percent of all large polyps, missing nine flat lesions, a potentially significant limitation.",
"     </li>",
"     <li>",
"      In a prospective study of 67 frail elderly patients using a limited-preparation CT colonography, the overall image quality in the evaluation of the colon (excluding mass lesions and polyps greater than 1 cm) was rated good or excellent in 84 percent of the colonic segments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/31\">",
"       31",
"      </a>",
"      ]. The preparation consisted of a low residue diet for three days, one liter of 2 percent oral",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/0/14340?source=see_link\">",
"       diatrizoate meglumine",
"      </a>",
"      (Gastrografin&reg;) 24 hours prior to the procedure, and one liter of oral Gastrografin&reg; over the two hours immediately prior to the procedure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Correlation of polyp size to colonoscopy estimates",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT colonography permits estimation of polyp size but the correlation of such estimates to measurements obtained during colonoscopy has not been well studied. One of the largest reports to compare these estimates included 600 patients who underwent both procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/32\">",
"     32",
"    </a>",
"    ]. There was variable agreement depending upon polyp size. Overall, measurements differed in 43 percent of participants for classifying polyps as &lt;0.6 cm, between 0.6 to 0.9 cm, or &gt;0.9 cm. Whether these differences are important when guiding management decisions remains to be determined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Risk of advanced histology based on polyp size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated that an increase in the risk of advanced histology correlates with increasing polyp size. One of the largest studies (which included 13,992 asymptomatic patients, 5977 of whom had polyps with available histology) found that the risk of advanced histology was 1.7 percent for patients whose largest polyp was 1 to 5 mm, 6.6 percent for if the polyp was 6 to 9 mm, and 30.6 percent if the polyp was larger than 10 mm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/33\">",
"     33",
"    </a>",
"    ]. In a second study that included 2361 polyps in 756 patients, the per-polyp risk of advanced histologic features was 0.5 percent for polyps &le;5 mm, 1.5 percent for polyps 6 to 9 mm, and 15 percent for polyps &ge;10 mm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/34\">",
"     34",
"    </a>",
"    ]. On a per-patient basis, the risks of having advanced histologic features based on the size of the patient&rsquo;s largest polyp were 0.8, 1.6, and 23 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=see_link\">",
"     \"Approach to the patient with colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These findings are relevant for CT colonography for two reasons. First, they provide support for the recommendation to perform colonoscopy for polyps larger than 6 mm (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Guidelines'",
"    </a>",
"    below). Second, they underscore a limitation of CT colonography compared with standard colonoscopy, since CT colonography has lower sensitivity for lesions in this size range.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Acceptability and safety",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have addressed the acceptability of virtual colonoscopy to patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/35-39\">",
"     35-39",
"    </a>",
"    ]. Both virtual and standard colonoscopy require the same type of vigorous bowel cleansing. The main discomfort of virtual colonoscopy relates to air or carbon dioxide insufflation with resultant distention and cramping. Patients are not routinely sedated during virtual colonoscopy. While this may lead to increased anxiety and discomfort, it allows patients to return to their usual activities more quickly and eliminates the need for a ride home following the procedure.",
"   </p>",
"   <p>",
"    Most studies have suggested a similar degree of satisfaction with virtual or standard colonoscopy but results have not been uniform. One of the largest studies to evaluate preferences in detail involved 614 patients who underwent standard and virtual colonoscopy and air contrast",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    enema [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/40\">",
"     40",
"    </a>",
"    ]. Patients preferred standard colonoscopy to the other two procedures; they were least satisfied with barium enema (particularly those younger than 64).",
"   </p>",
"   <p>",
"    Virtual colonoscopy has been associated with at least two published cases of colonic perforation due to air insufflation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. One patient had an obstructing sigmoid lesion while the other had ulcerative colitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Radiation exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of radiation exposure to the population as CT colonography evolves to an accepted cancer screening method is incompletely understood. Repeated examination might lead to substantial cumulative radiation exposure with the associated risk of excess cancer mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=see_link\">",
"     \"Radiation-related risks of imaging studies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study estimated that CT colonography performed every five years for patients between the ages of 50 and 80 years would result in 150 radiation-related",
"    <span class=\"nowrap\">",
"     cancers/100,000",
"    </span>",
"    individuals screened, but would prevent 3580 to 5190 colorectal",
"    <span class=\"nowrap\">",
"     cancers/100,000",
"    </span>",
"    individuals screened [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/44\">",
"     44",
"    </a>",
"    ]. The benefit-risk ratio for cancers prevented:cancers induced varied from 24:1 to 35:1. However, the model did not include an estimate of the benefit-risk ratio for standard colonoscopy for comparison.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Incidental findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Virtual colonoscopy has the potential to uncover unexpected findings outside of the colon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/45\">",
"     45",
"    </a>",
"    ], potentially leading to serendipitous discovery of important diseases or unnecessary evaluation of incidental findings. A study of 459 patients found that 23 percent had at least one incidental finding for which clinical or radiological follow-up was recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/46\">",
"     46",
"    </a>",
"    ]. The most common findings were single or multiple pulmonary nodules (18 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cost-effectiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cost-effectiveness of virtual colonoscopy is uncertain. However, at least four decision-analyses helped elucidate the main features that would determine its cost-effectiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One found that if the costs of performing virtual and standard colonoscopy were equal, virtual colonoscopy would end up costing 15 percent more (because of patients who ultimately require a colonoscopy) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/47\">",
"       47",
"      </a>",
"      ]. The greater the likelihood of being referred for standard colonoscopy after virtual colonoscopy, the greater the advantage of standard colonoscopy. Even if the sensitivities of the tests were equal, standard colonoscopy would likely be preferred over virtual colonoscopy unless virtual colonoscopy costs were significantly lower than standard colonoscopy.",
"     </li>",
"     <li>",
"      Another concluded that if virtual colonoscopy was used as the primary modality for colorectal cancer screening, 1.78 million standard colonoscopies would be eliminated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/48\">",
"       48",
"      </a>",
"      ]. However, the loss would be partially offset by an increase in the number of follow-up colonoscopies required after a positive virtual colonoscopy. The number of such cases would depend heavily upon the size of a polyp found on virtual colonoscopy that would require a follow-up standard colonoscopy. If polyps ranging from 6 to 10 mm were considered to require a follow-up standard colonoscopy, for example, 1.21 million standard colonoscopies would be required, leading to a net decrease of 0.57 million colonoscopies (8 percent) overall.",
"     </li>",
"     <li>",
"      A decision analysis based on Canadian costs concluded that screening by virtual colonoscopy would cost 2.7 million dollars extra per 100,000 patients screened, compared to optical colonoscopy, and would marginally increase the death rate, with projected deaths due to missed adenomas exceeding deaths prevented due to perforation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/49\">",
"       49",
"      </a>",
"      ]. Costs in the United States are substantially different than in Canada thus the results may not be directly applicable to the United States.",
"     </li>",
"     <li>",
"      A fourth study focused on the cost-effectiveness of CT colonography in patients with a positive fecal occult blood test [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/50\">",
"       50",
"      </a>",
"      ]. Overall, CT colonography was found to be less accurate, less effective and more costly than colonoscopy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     CT colonography without bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing virtual colonoscopy in the studies described above required a similar bowel preparation to that required prior to standard colonoscopy. Several studies have described the potential to perform virtual colonoscopy without a cathartic bowel preparation, which would likely contribute to greater acceptability of virtual colonoscopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/6,51-59\">",
"     6,51-59",
"    </a>",
"    ]. This was examined in a randomized trial looking at participation rates for colorectal cancer screening [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/59\">",
"     59",
"    </a>",
"    ]. Patients were assigned to either be invited to undergo screening with CT colonography without a preparation or colonoscopy. Patients assigned to CT colonography were more likely to undergo the procedure (982 of 2920 patients, 34 percent) than patients assigned to colonoscopy (1276 of 5924 patients, 22 percent, p &lt;0.0001). However, it is not known from this study if failing to use a standard cathartic preparation influenced the diagnostic yield of CT colonography.",
"   </p>",
"   <p>",
"    For CT colonography without bowel preparation, patients are required to ingest a contrast agent (typically with several meals prior to the examination) that leads to \"fecal tagging\". The contrast-enhanced feces can then be differentiated from the surrounding colonic mucosa; imaging can be improved using digital subtraction techniques.",
"   </p>",
"   <p>",
"    Studies suggest that CT colonography without bowel preparation is sensitive for detecting polyps that are 6 mm in size or greater:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of CT colonography without a bowel preparation included 203 patients (with a variety of indications for colonoscopy) who underwent virtual colonoscopy followed by optical colonoscopy within three to seven days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/51\">",
"       51",
"      </a>",
"      ]. Patients were instructed to consume a contrast agent (Gastrografin&reg;) with each of five principal meals beginning 48 hours before the examination.",
"      <br/>",
"      <br/>",
"      Virtual colonoscopy had an average sensitivity of 96 percent (95% CI 92-99 percent) for identification of polyps &ge;8 mm. On a per-patient basis, the average sensitivity was 90 percent (95% CI 86-94 percent) and average specificity was 92 percent (95% CI 90-95 percent), while the average negative predictive value was 94 percent (95% CI 91-96 percent). The authors noted that test characteristics may have been even better had they had the ability to perform digital subtraction (a method not available with the software that they used). Interobserver agreement was generally good. Most patients preferred the virtual colonoscopy (although one-third stated that they would prefer standard colonoscopy for future examinations).",
"      <br/>",
"      <br/>",
"      Extracolonic findings were present in 28 patients (14 percent). Of these, four were considered to have high and seven were considered to have moderate clinical importance. Further diagnostic imaging was recommended in eight patients (4 percent).",
"     </li>",
"     <li>",
"      In a subsequent prospective study, 605 patients underwent CT colonography without a bowel preparation using",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?30/14/30949?source=see_link\">",
"       iohexol",
"      </a>",
"      for stool tagging [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/60\">",
"       60",
"      </a>",
"      ]. Within five weeks of the CT colonography, patients underwent a routine optical colonoscopy with segmental unblinding (ie, the endoscopist was unaware of the CT colonography findings while examining a segment of colon; after the segment was inspected, the CT colonography results were revealed to the endoscopist so that any discrepancies could be resolved). Optical colonoscopy taking into account both the first pass and any re-examination based upon possible lesions identified by CT colonography was considered the gold standard.",
"      <br/>",
"      <br/>",
"      For adenomas 10 mm in size or larger, the per-patient and per-lesion sensitivities for CT colonography were 0.91 and 0.82, respectively. The corresponding values for optical colonoscopy were and 0.95 and 0.95, respectively. The differences in sensitivities between CT colonography and optical colonoscopy did not reach statistical significance. For polyps 6 mm or larger (of any histology), CT colonography had a per-patient sensitivity of 0.47, compared with 0.56 for optical colonoscopy (p = 0.06). When analyzed on a per-lesion basis, the sensitivity of CT colonography was 0.48, compared with 0.65 for optical colonoscopy (p = 0.002).",
"      <br/>",
"      <br/>",
"      Potentially clinically significant extracolonic findings were detected in 3 percent of patients, and extracolonic findings of indeterminate significance were found in 16 percent. Overall, 465 patients (77 percent) expressed a preference for one procedure over the other. Of those with a preference, 62 percent preferred CT colonography and 38 percent preferred optical colonoscopy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two different guidelines regarding CT colonography have been issued by major medical organizations in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=see_link\">",
"     \"Screening for colorectal cancer: Strategies in patients at average risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Guidelines issued jointly by the US Multi-Society Task Force on Colorectal Cancer, the American Cancer Society, and the American College of Radiology support use of CT colonography as an option for screening asymptomatic adults aged 50 and older who are considered to be at average risk for colon cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/61\">",
"       61",
"      </a>",
"      ]. The guidelines recommend that patients undergo a conventional colonoscopy if one or more polyps &gt;6 mm are detected. In patients with a normal examination, the test should be repeated every five years. CT colonography was not recommended in patients with a history of polyps on prior colonoscopy and those with an increased risk of colorectal cancer.",
"     </li>",
"     <li>",
"      By contrast, recommendations from the US Preventive Services Task Force conclude that there is insufficient evidence to assess the benefits and harms of computed tomographic colonography [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/62\">",
"       62",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25123?source=see_link\">",
"       \"Patient information: Colon and rectal cancer screening (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/11/18611?source=see_link\">",
"       \"Patient information: Colonoscopy (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/23/7541?source=see_link\">",
"       \"Patient information: Colon and rectal cancer screening (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The exact clinical utility and role of virtual colonoscopy and associated CT colonographic techniques are still being debated. As noted above, it is considered to be an acceptable option for colon cancer screening in adults older than 50 who have an average risk of colorectal cancer but not those with a history of polyps or who are considered to be at increased risk for colorectal cancer. Insurance coverage for the procedure in the United States is variable; it is not covered by the Centers for Medicare and Medicaid Services.",
"   </p>",
"   <p>",
"    CT colonography may also be an acceptable option in certain clinical settings including those in whom a colonoscopy cannot be performed due to intolerance, technical difficulty, obstructing colorectal cancer, or other risk factors for the procedure. It may also be useful in the evaluation of patients with colonic diverticular disease (",
"    <a class=\"graphic graphic_picture graphicRef62323 \" href=\"mobipreview.htm?19/25/19871\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    However, there remain a number of issues regarding its role in colorectal cancer screening.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Local expertise in performing and interpreting virtual colonoscopy may be important. Sensitivity has been variable in different reports raising questions about the generalizability of findings from studies that reported sensitivity comparable to optical colonoscopy.",
"     </li>",
"     <li>",
"      The methods of performing and interpreting virtual colonoscopy have not been standardized.",
"     </li>",
"     <li>",
"      The size of a polyp found on virtual colonoscopy that should prompt an optical colonoscopy is unclear, although a cutoff of 6 mm was proposed in a guideline described above. Furthermore, systems to allow patients to go directly from virtual colonoscopy to optical colonoscopy (if needed) may be difficult to coordinate. Thus, a significant proportion of patients who have a positive virtual colonoscopy may have to undergo two bowel preparations and two procedures. Even worse, some patients found to have a polyp on virtual colonoscopy may not follow-up with their standard colonoscopy.",
"     </li>",
"     <li>",
"      Virtual colonoscopy has the potential to uncover unexpected findings outside of the colon, potentially leading to serendipitous discovery of important diseases or unnecessary evaluation of incidental findings. The net effect is unclear.",
"     </li>",
"     <li>",
"      Virtual colonoscopy exposes patients to radiation. Repeated examination might lead to substantial cumulative radiation exposure with associated risk of excess cancer mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36632/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Furthermore, the sensitivity and specificity of optical colonoscopy (currently considered the gold standard) is not remaining static. Newer imaging techniques (such as magnification colonoscopy and chromoendoscopy) continue to evolve suggesting that optical colonoscopy will likely remain superior for detecting neoplastic lesions. On the other hand, virtual colonoscopy offers the possibility of increasing colorectal cancer screening (and possibly reducing its costs) suggesting that it holds promise for reducing the incidence of colorectal cancer.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/1\">",
"      Vining DJ. Virtual endoscopy: is it reality? Radiology 1996; 200:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/2\">",
"      Kay CL, Evangelou HA. A review of the technical and clinical aspects of virtual endoscopy. Endoscopy 1996; 28:768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/3\">",
"      Fenlon HM, Ferrucci JT. Virtual colonoscopy: what will the issues be? AJR Am J Roentgenol 1997; 169:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/4\">",
"      Royster AP, Gupta AK, Fenlon HM, Ferrucci JT. Virtual colonoscopy: current status and future implications. Acad Radiol 1998; 5:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/5\">",
"      Hartmann D, Bassler B, Schilling D, et al. Incomplete conventional colonoscopy: magnetic resonance colonography in the evaluation of the proximal colon. Endoscopy 2005; 37:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/6\">",
"      Wong TY, Lam WW, So NM, et al. Air-inflated magnetic resonance colonography in patients with incomplete conventional colonoscopy: Comparison with intraoperative findings, pathology specimens, and follow-up conventional colonoscopy. Am J Gastroenterol 2007; 102:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/7\">",
"      Summers RM, Yao J, Pickhardt PJ, et al. Computed tomographic virtual colonoscopy computer-aided polyp detection in a screening population. Gastroenterology 2005; 129:1832.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/8\">",
"      Halligan S, Altman DG, Mallett S, et al. Computed tomographic colonography: assessment of radiologist performance with and without computer-aided detection. Gastroenterology 2006; 131:1690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/9\">",
"      Fenlon HM, Nunes DP, Schroy PC 3rd, et al. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999; 341:1496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/10\">",
"      Kay CL, Kulling D, Hawes RH, et al. Virtual endoscopy--comparison with colonoscopy in the detection of space-occupying lesions of the colon. Endoscopy 2000; 32:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/11\">",
"      Spinzi G, Belloni G, Martegani A, et al. Computed tomographic colonography and conventional colonoscopy for colon diseases: a prospective, blinded study. Am J Gastroenterol 2001; 96:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/12\">",
"      Royster AP, Fenlon HM, Clarke PD, et al. CT colonoscopy of colorectal neoplasms: two-dimensional and three-dimensional virtual-reality techniques with colonoscopic correlation. AJR Am J Roentgenol 1997; 169:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/13\">",
"      Pappalardo G, Polettini E, Frattaroli FM, et al. Magnetic resonance colonography versus conventional colonoscopy for the detection of colonic endoluminal lesions. Gastroenterology 2000; 119:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/14\">",
"      Johnson CD, Toledano AY, Herman BA, et al. Computerized tomographic colonography: performance evaluation in a retrospective multicenter setting. Gastroenterology 2003; 125:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/15\">",
"      Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349:2191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/16\">",
"      Johnson CD, MacCarty RL, Welch TJ, et al. Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clin Gastroenterol Hepatol 2004; 2:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/17\">",
"      Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/18\">",
"      Heresbach D, Djabbari M, Riou F, et al. Accuracy of computed tomographic colonography in a nationwide multicentre trial, and its relation to radiologist expertise. Gut 2011; 60:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/19\">",
"      Pickhardt PJ, Nugent PA, Mysliwiec PA, et al. Location of adenomas missed by optical colonoscopy. Ann Intern Med 2004; 141:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/20\">",
"      Kim DH, Pickhardt PJ, Taylor AJ, et al. CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 2007; 357:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/21\">",
"      Pineau BC, Paskett ED, Chen GJ, et al. Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps. Gastroenterology 2003; 125:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/22\">",
"      Johnson CD, Harmsen WS, Wilson LA, et al. Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps. Gastroenterology 2003; 125:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/23\">",
"      Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/24\">",
"      Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med 2005; 142:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/25\">",
"      Rosman AS, Korsten MA. Meta-analysis comparing CT colonography, air contrast barium enema, and colonoscopy. Am J Med 2007; 120:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/26\">",
"      Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. Radiology 2011; 259:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/27\">",
"      Liedenbaum MH, Bipat S, Bossuyt PM, et al. Evaluation of a standardized CT colonography training program for novice readers. Radiology 2011; 258:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/28\">",
"      Regge D, Laudi C, Galatola G, et al. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. JAMA 2009; 301:2453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/29\">",
"      Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005; 365:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/30\">",
"      Van Gelder RE, Nio CY, Florie J, et al. Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer. Gastroenterology 2004; 127:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/31\">",
"      Keeling AN, Slattery MM, Leong S, et al. Limited-preparation CT colonography in frail elderly patients: a feasibility study. AJR Am J Roentgenol 2010; 194:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/32\">",
"      Gupta S, Durkalski V, Cotton P, Rockey DC. Variation of agreement in polyp size measurement between computed tomographic colonography and pathology assessment: clinical implications. Clin Gastroenterol Hepatol 2008; 6:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/33\">",
"      Lieberman D, Moravec M, Holub J, et al. Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography. Gastroenterology 2008; 135:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/34\">",
"      Gupta N, Bansal A, Rao D, et al. Prevalence of advanced histological features in diminutive and small colon polyps. Gastrointest Endosc 2012; 75:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/35\">",
"      Svensson MH, Svensson E, Lasson A, Hellstr&ouml;m M. Patient acceptance of CT colonography and conventional colonoscopy: prospective comparative study in patients with or suspected of having colorectal disease. Radiology 2002; 222:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/36\">",
"      Angtuaco TL, Banaad-Omiotek GD, Howden CW. Differing attitudes toward virtual and conventional colonoscopy for colorectal cancer screening: surveys among primary care physicians and potential patients. Am J Gastroenterol 2001; 96:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/37\">",
"      Akerkar GA, Yee J, Hung R, McQuaid K. Patient experience and preferences toward colon cancer screening: a comparison of virtual colonoscopy and conventional colonoscopy. Gastrointest Endosc 2001; 54:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/38\">",
"      Thomeer M, Bielen D, Vanbeckevoort D, et al. Patient acceptance for CT colonography: what is the real issue? Eur Radiol 2002; 12:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/39\">",
"      Gluecker TM, Johnson CD, Harmsen WS, et al. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003; 227:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/40\">",
"      Bosworth HB, Rockey DC, Paulson EK, et al. Prospective comparison of patient experience with colon imaging tests. Am J Med 2006; 119:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/41\">",
"      Kamar M, Portnoy O, Bar-Dayan A, et al. Actual colonic perforation in virtual colonoscopy: report of a case. Dis Colon Rectum 2004; 47:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/42\">",
"      Coady-Fariborzian L, Angel LP, Procaccino JA. Perforated colon secondary to virtual colonoscopy: report of a case. Dis Colon Rectum 2004; 47:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/43\">",
"      Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology 2004; 231:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/44\">",
"      Berrington de Gonz&aacute;lez A, Kim KP, Knudsen AB, et al. Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. AJR Am J Roentgenol 2011; 196:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/45\">",
"      Ginnerup Pedersen B, Rosenkilde M, Christiansen TE, Laurberg S. Extracolonic findings at computed tomography colonography are a challenge. Gut 2003; 52:1744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/46\">",
"      Burt JR, Iribarren C, Fair JM, et al. Incidental findings on cardiac multidetector row computed tomography among healthy older adults: prevalence and clinical correlates. Arch Intern Med 2008; 168:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/47\">",
"      Ladabaum U, Song K, Fendrick AM. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? Clin Gastroenterol Hepatol 2004; 2:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/48\">",
"      Hur C, Gazelle GS, Zalis ME, Podolsky DK. An analysis of the potential impact of computed tomographic colonography (virtual colonoscopy) on colonoscopy demand. Gastroenterology 2004; 127:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/49\">",
"      Heitman SJ, Manns BJ, Hilsden RJ, et al. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening. CMAJ 2005; 173:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/50\">",
"      Walleser S, Griffiths A, Lord SJ, et al. What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clin Gastroenterol Hepatol 2007; 5:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/51\">",
"      Iannaccone R, Laghi A, Catalano C, et al. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology 2004; 127:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/52\">",
"      Callstrom MR, Johnson CD, Fletcher JG, et al. CT colonography without cathartic preparation: feasibility study. Radiology 2001; 219:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/53\">",
"      Zalis ME, Hahn PF. Digital subtraction bowel cleansing in CT colonography. AJR Am J Roentgenol 2001; 176:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/54\">",
"      Lefere PA, Gryspeerdt SS, Dewyspelaere J, et al. Dietary fecal tagging as a cleansing method before CT colonography: initial results polyp detection and patient acceptance. Radiology 2002; 224:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/55\">",
"      Thomeer M, Carbone I, Bosmans H, et al. Stool tagging applied in thin-slice multidetector computed tomography colonography. J Comput Assist Tomogr 2003; 27:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/56\">",
"      Zalis ME, Perumpillichira J, Del Frate C, Hahn PF. CT colonography: digital subtraction bowel cleansing with mucosal reconstruction initial observations. Radiology 2003; 226:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/57\">",
"      Bielen D, Thomeer M, Vanbeckevoort D, et al. Dry preparation for virtual CT colonography with fecal tagging using water-soluble contrast medium: initial results. Eur Radiol 2003; 13:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/58\">",
"      Chen D, Liang Z, Wax MR, et al. A novel approach to extract colon lumen from CT images for virtual colonoscopy. IEEE Trans Med Imaging 2000; 19:1220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/59\">",
"      Stoop EM, de Haan MC, de Wijkerslooth TR, et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 2012; 13:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/60\">",
"      Zalis ME, Blake MA, Cai W, et al. Diagnostic accuracy of laxative-free computed tomographic colonography for detection of adenomatous polyps in asymptomatic adults: a prospective evaluation. Ann Intern Med 2012; 156:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/61\">",
"      Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134:1570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36632/abstract/62\">",
"      U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149:627.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2526 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-2F5800EE8D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36632=[""].join("\n");
var outline_f35_49_36632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATIENT PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SCANNING TECHNIQUE AND DATA ACQUISITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Image processing and reconstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TEST CHARACTERISTICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Patients at increased risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Correlation of polyp size to colonoscopy estimates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Risk of advanced histology based on polyp size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Acceptability and safety",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Radiation exposure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Incidental findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cost-effectiveness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CT colonography without bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2526\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2526|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/61/14302\" title=\"picture 1\">",
"      Stool on virtual colonoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/18/3374\" title=\"picture 2\">",
"      Polyp on virtual colonoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/25/19871\" title=\"picture 3\">",
"      Divertics virtual colonoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=related_link\">",
"      Approach to the patient with colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?7/23/7541?source=related_link\">",
"      Patient information: Colon and rectal cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?24/34/25123?source=related_link\">",
"      Patient information: Colon and rectal cancer screening (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?18/11/18611?source=related_link\">",
"      Patient information: Colonoscopy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21785?source=related_link\">",
"      Radiation-related risks of imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/10/37034?source=related_link\">",
"      Screening for colorectal cancer: Strategies in patients at average risk",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_49_36633="Approach to women with symptoms of vaginitis";
var content_f35_49_36633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to women with symptoms of vaginitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Jack D Sobel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?35/49/36633/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?35/49/36633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginitis is the general term for disorders of the vagina caused by infection, inflammation, or changes in the normal vaginal flora. Symptoms include vaginal discharge, odor, pruritus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discomfort. These symptoms are extremely common and frequently lead to self-diagnosis and therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/1\">",
"     1",
"    </a>",
"    ]. In a telephone survey of random women in the United States, 8 percent of Caucasian women and 18 percent of African American women reported an episode of vaginal symptoms of any severity in the previous year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/2\">",
"     2",
"    </a>",
"    ]. A healthcare professional was consulted in 55 and 83 percent of cases, respectively, and most women purchased an over-the-counter antifungal preparation to treat their symptoms, whether or not they saw a physician.",
"   </p>",
"   <p>",
"    Laboratory documentation of the etiology of vaginitis is mandatory before initiating therapy, given the nonspecific nature of the symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/3\">",
"     3",
"    </a>",
"    ]. Empiric therapy should be avoided because of frequent misdiagnosis and inappropriate therapy when assessment is based on history and physical examination alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H635661\">",
"    <span class=\"h1\">",
"     CAUSES OF VAGINITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common causes of vaginal discharge, odor, pruritus,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    discomfort are bacterial vaginosis, candida vulvovaginitis, and trichomoniasis. These disorders account for over 90 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link\">",
"       \"Bacterial vaginosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link\">",
"       \"Candida vulvovaginitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link\">",
"       \"Trichomonas vaginalis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Less common causes of these symptoms include vaginal",
"    <span class=\"nowrap\">",
"     atrophy/atrophic",
"    </span>",
"    vaginitis, cervicitis, foreign body, irritants and allergens, and several rarer entities, including some systemic medical disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1860628\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nonkeratinized stratified squamous epithelium of the vagina in premenopausal women is rich in glycogen. Glycogen from sloughed cells is the substrate for D&ouml;derlein's lactobacilli, which convert glucose into lactic acid, thereby creating an acidic vaginal environment (pH 4.0 to 4.5). This acidity helps maintain the normal vaginal flora and inhibits growth of pathogenic organisms. Disruption of the normal ecosystem can lead to conditions favorable for development of vaginitis. Some of these potentially disruptive factors include phase of the menstrual cycle, sexual activity, contraceptive choice, pregnancy, foreign bodies, estrogen level, sexually transmitted diseases, and use of hygienic products or antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H635499\">",
"    <span class=\"h1\">",
"     PATIENT PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with vaginitis typically present with one or more of the following vulvovaginal symptoms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Change in the volume, color, or odor of vaginal discharge",
"     </li>",
"     <li>",
"      Pruritus",
"     </li>",
"     <li>",
"      Burning",
"     </li>",
"     <li>",
"      Irritation",
"     </li>",
"     <li>",
"      Erythema",
"     </li>",
"     <li>",
"      Dyspareunia",
"     </li>",
"     <li>",
"      Spotting",
"     </li>",
"     <li>",
"      Dysuria",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vaginal discharge is a prominent symptom of vaginitis, but may be difficult to distinguish from normal vaginal discharge. In reproductive aged women, normal vaginal discharge consists of 1 to 4 mL fluid (per 24 hours), which is white or transparent, thick or thin, and mostly odorless. This physiologic discharge is formed by mucoid endocervical secretions in combination with sloughing epithelial cells, normal vaginal flora, and vaginal transudate. The discharge may become more noticeable at times (&ldquo;physiological leukorrhea&rdquo;), such as at midmenstrual cycle close to the time of ovulation or during pregnancy or use of estrogen-progestin contraceptives. Diet, sexual activity, medication, and stress can also affect the volume and character of normal vaginal discharge. Although normal discharge may be yellowish, slightly malodorous, and accompanied by mild irritative symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5\">",
"     5",
"    </a>",
"    ], it is not accompanied by pruritus, pain, burning or significant irritation, erythema, local erosions, or cervical or vaginal friability. The absence of these signs and symptoms distinguishes it from discharge related to a pathological process, such as vaginitis or cervicitis. (See",
"    <a class=\"local\" href=\"#H186474307\">",
"     'Management of physiological leukorrhea'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H635637\">",
"    <span class=\"h1\">",
"     GENERAL PRINCIPLES OF EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The three main steps in the evaluation of women with symptoms of vaginitis are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obtain a history and perform a physical examination. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical examination'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H3894620\">",
"       'History'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Test for bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis since these disorders account for over 90 percent of vaginitis in premenopausal women and can be diagnosed by pH testing, microscopy,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      culture (or rapid antigen and nucleic acid amplification tests) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic studies'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      If this evaluation does not lead to a diagnosis, then evaluate for less common and rare causes of vaginitis. (See",
"      <a class=\"local\" href=\"#H12175230\">",
"       'Women without a diagnosis after the initial evaluation'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;None of the findings from the history allows a definitive diagnosis since there is considerable overlap in symptoms among the different etiologies of vaginitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Thus, all women with suspected vaginitis should undergo a physical examination and some diagnostic studies.",
"   </p>",
"   <p>",
"    The history often suggests a particular diagnosis (",
"    <a class=\"graphic graphic_table graphicRef81449 \" href=\"mobipreview.htm?39/6/40043\">",
"     table 1",
"    </a>",
"    ), which must be confirmed in the office by examination of vaginal secretions and, if necessary, culture (or rapid antigen and nucleic acid amplification tests). A literature review concluded that the initial office evaluation (history and physical examination; pH, wet mount microscopy, and whiff test of vaginal discharge) correctly diagnosed 60 percent of candidal vulvovaginitis, 70 percent of trichomoniasis, and 90 percent of bacterial vaginosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3894620\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The key questions on history are to determine the patient&rsquo;s symptoms. If discharge is present, what is the quantity, color, consistency, and odor? Is there burning or other discomfort? Vaginal bleeding? Dysuria or dyspareunia?",
"   </p>",
"   <p>",
"    <br/>",
"    The severity of symptoms correlates with the extent of inflammation. Candida vulvovaginitis often presents with marked inflammatory symptoms (pruritus and soreness), but scant discharge (thick, white, odorless, and curd-like). In contrast, bacterial vaginosis is associated with only minimal inflammation and minimal irritative symptoms, but the thin, gray or yellow, malodorous discharge is a prominent complaint. Trichomoniasis is characterized by purulent, malodorous, thin discharge, which may be accompanied by burning, pruritus, dysuria, frequency,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dyspareunia. The vulva is affected by candidiasis and sometimes by trichomoniasis, but not by bacterial vaginosis. Vaginal dryness and dyspareunia are common features of atrophic vaginitis. Symptoms of candidal vulvovaginitis often occur in the premenstrual period, while symptoms of trichomoniasis often occur during or immediately after the menstrual period.",
"   </p>",
"   <p>",
"    However, as discussed above, none of the findings from the history allows a definitive diagnosis since there is considerable overlap in symptoms among the different etiologies of vaginitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is focused upon the degree of vulvovaginal inflammation and the characteristics of the vaginal discharge, as well as the presence of lesions or foreign bodies. Other potentially significant findings include signs of cervical inflammation and pelvic or cervical motion tenderness.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The vulva usually appears normal in bacterial vaginosis, whereas erythema, edema, or fissures suggest candidiasis, trichomoniasis, or dermatitis. Atrophic changes are caused by hypoestrogenemia, and suggest the possibility of atrophic vaginitis. Changes in vulvovaginal architecture (eg, scarring) may be caused by a chronic inflammatory process, such as erosive lichen planus, as well as lichen sclerosis, or mucous membrane pemphigoid, rather than vaginitis.",
"     </li>",
"     <li>",
"      Speculum examination may reveal a lesion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A foreign body (eg, retained tampon) is easily detected and is often associated with vaginal discharge, intermittent bleeding or spotting,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      an unpleasant odor due to inflammation and secondary infection. Removal of the foreign body is generally adequate treatment. Antibiotics are rarely indicated.",
"     </li>",
"     <li>",
"      Vaginal warts are skin-colored or pink, and range from smooth flattened papules to a verrucous, papilliform appearance (",
"      <a class=\"graphic graphic_picture graphicRef51759 \" href=\"mobipreview.htm?19/30/19942\">",
"       picture 1",
"      </a>",
"      ). When extensive, they can be associated with vaginal discharge, pruritus, bleeding, burning, tenderness, and pain. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23144?source=see_link\">",
"       \"Condylomata acuminata (anogenital warts)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/34/27178?source=see_link\">",
"       \"Treatment of vulvar and vaginal warts\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Granulation tissue or surgical site infection can cause vaginal discharge after hysterectomy or after childbirth.",
"     </li>",
"     <li>",
"      Necrotic or inflammatory changes associated with malignancy in the lower or upper genital tract can result in vaginal discharge; spotting is more common in this setting than in infectious vaginitis.",
"     </li>",
"     <li>",
"      The presence of multifocal rounded macular erythematous lesions (like a spotted rash or bruise), purulent discharge, and tenderness suggests erosive vulvovaginitis, which can be caused by trichomoniasis or one of several noninfectious inflammatory etiologies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The characteristics of the vaginal discharge may help distinguish the type of infection, if present (",
"      <a class=\"graphic graphic_table graphicRef68759 \" href=\"mobipreview.htm?38/29/39388\">",
"       table 2",
"      </a>",
"      ). Trichomoniasis is classically associated with a greenish-yellow purulent discharge; candidiasis with a thick, white, adherent, \"cottage cheese-like\" discharge; and bacterial vaginosis with a thin, homogeneous, \"fishy smelling\" gray discharge. Inflammation",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      necrosis related to malignancy of the lower or upper genital tract can result in watery, mucoid, purulent,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bloody vaginal discharge.",
"      <br/>",
"      <br/>",
"      However, the appearance of the discharge is unreliable and should never form the basis for diagnosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cervical inflammation with a normal vagina is suggestive of cervicitis, rather than vaginitis. The cervix in women with cervicitis is usually erythematous and friable, with a mucopurulent discharge (",
"      <a class=\"graphic graphic_picture graphicRef67848 \" href=\"mobipreview.htm?35/17/36114\">",
"       picture 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=see_link\">",
"       \"Acute cervicitis\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Cervical erythema in cervicitis should be distinguished from ectropion, which represents the normal physiologic presence of endocervical glandular tissue on the exocervix. Ectropion is more common in women taking estrogen-progestin contraceptives and during pregnancy. Ectropion may increase the volume of normal vaginal discharge. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=see_link&amp;anchor=H10#H10\">",
"       \"Congenital cervical anomalies and benign cervical lesions\", section on 'Ectropion'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vesicovaginal and rectovaginal fistulas are rare, can be hard to detect, and are a source of chronic vaginal discharge. At-risk patients include those who are postpartum, posthysterectomy, post surgery for prolapse, or have a history of inflammatory bowel disease or radiation therapy to the pelvis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32951?source=see_link\">",
"       \"Rectovaginal, anovaginal, and colovesical fistulas\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44792?source=see_link\">",
"       \"Urogenital tract fistulas in women\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Bimanual examination may reveal pelvic or cervical motion tenderness suggestive of PID. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnostic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examining the vaginal discharge for pH and fishy amine odor, and by microscopy, may lead to a definitive diagnosis (",
"    <a class=\"graphic graphic_table graphicRef68759 \" href=\"mobipreview.htm?38/29/39388\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Vaginal pH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of vaginal pH is the single most important finding that drives the diagnostic process and should always be determined. A pH test stick (or pH paper if available) is applied for a few seconds to the vaginal sidewall (to avoid contamination by blood, semen, or cervical mucus which pool in the posterior fornix and distort results). Alternatively, the vaginal sidewall can be swabbed with a dry swab and then the swab rolled onto pH paper (if available). The pH of the specimen is stable for about two to five minutes at room temperature. The swab should not be pre-moistened, as the moistening liquid can affect pH.",
"   </p>",
"   <p>",
"    Narrow range pH paper (4.0 to 5.5) is easier to interpret than broad range paper (4.5 to 7.5). An elevated pH in a premenopausal woman suggests infections such as bacterial vaginosis (pH&gt;4.5) or trichomoniasis (pH 5 to 6), and helps to exclude candida vulvovaginitis (pH 4 to 4.5).",
"   </p>",
"   <p>",
"    The pH of the normal vaginal secretions in premenopausal women is 4.0 to 4.5 because these women have relatively high estrogen levels. Under the influence of estrogen, the normal vaginal epithelium cornifies and produces glycogen, which is the substrate for lactic acid production by lactobacilli. In premenarchal and postmenopausal women in whom estrogen levels are low, the pH of the normal vaginal secretions is &ge;4.7. The higher pH is due to less glycogen in epithelial cells, reduced colonization of lactobacilli, and reduced lactic acid production. Thus measurement of pH for diagnosis of bacterial vaginosis, trichomoniasis, or candidiasis is less useful at the extremes of age. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vaginal pH may be altered (usually to a higher pH) by contamination with lubricating gels, semen, douches, and intravaginal medications. In pregnant women, leakage of amniotic fluid raises vaginal pH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Microscopy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87576964\">",
"    <span class=\"h4\">",
"     Saline wet mount",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal discharge is generally sampled with a plastic or wood",
"    <span class=\"nowrap\">",
"     vaginal/cervical",
"    </span>",
"    scraper or a cotton-tipped swab. The sample of vaginal discharge is mixed with one to two drops of 0.9 percent normal saline solution at room temperature on a glass slide. Cover slips are then placed on the slides, which are examined under a microscope at low and high power. Microscopy should be performed within 10 to 20 minutes of obtaining the sample to reduce the possibility of loss of motility of any trichomonads. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link\">",
"     \"Trichomonas vaginalis\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Microscopic examination of normal vaginal discharge reveals a predominance of squamous epithelial cells, rare polymorphonuclear leukocytes (PMNs), and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    species morphotype (",
"    <a class=\"graphic graphic_table graphicRef68759 \" href=\"mobipreview.htm?38/29/39388\">",
"     table 2",
"    </a>",
"    ). The primary goal of the examination is to look for candidal buds (",
"    <a class=\"graphic graphic_picture graphicRef61326 \" href=\"mobipreview.htm?11/46/12005\">",
"     picture 3",
"    </a>",
"    ) or hyphae (",
"    <a class=\"graphic graphic_picture graphicRef59030 \" href=\"mobipreview.htm?9/37/9809\">",
"     picture 4",
"    </a>",
"    ), motile trichomonads (",
"    <a class=\"graphic graphic_picture graphicRef71667 \" href=\"mobipreview.htm?41/1/42014\">",
"     picture 5",
"    </a>",
"    ), epithelial cells studded with adherent coccobacilli (clue cells; (",
"    <a class=\"graphic graphic_picture graphicRef52425 \" href=\"mobipreview.htm?20/47/21240\">",
"     picture 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef73248 \" href=\"mobipreview.htm?36/29/37332\">",
"     picture 7",
"    </a>",
"    )), and increased numbers of PMNs.",
"   </p>",
"   <p>",
"    Excess PMNs without evidence of yeast, trichomonads, or clue cells suggest cervicitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=see_link\">",
"     \"Acute cervicitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87576971\">",
"    <span class=\"h4\">",
"     Potassium hydroxide wet mount",
"    </span>",
"    &nbsp;&mdash;&nbsp;The addition of 10 percent potassium hydroxide (KOH) to the wet mount of vaginal discharge destroys cellular elements, thus it is helpful for identifying hyphae and budding yeast for the diagnosis of candidal vaginitis (",
"    <a class=\"graphic graphic_picture graphicRef61326 \" href=\"mobipreview.htm?11/46/12005\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef59030 \" href=\"mobipreview.htm?9/37/9809\">",
"     picture 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87577006\">",
"    <span class=\"h5\">",
"     Amine test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smelling (\"whiffing\") the slide immediately after applying KOH is useful for detecting the fishy (amine) odor of bacterial vaginosis (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H5#H5\">",
"     \"Bacterial vaginosis\", section on 'Diagnosis'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2343327\">",
"    <span class=\"h3\">",
"     Options when microscopy is not available",
"    </span>",
"    &nbsp;&mdash;&nbsp;If microscopy is not available, commercial diagnostic testing methods (eg, rapid antigen and nucleic acid amplification tests) are used for confirming the clinical suspicion of bacterial vaginosis or trichomonas vaginitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H9465777#H9465777\">",
"     \"Bacterial vaginosis\", section on 'Commercial tests'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link&amp;anchor=H10#H10\">",
"     \"Trichomonas vaginalis\", section on 'Rapid antigen and nucleic acid amplification tests'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    None of these methods are sufficiently sensitive for diagnosis of Candida species; a culture for Candida species must be obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link&amp;anchor=H7#H7\">",
"     \"Candida vulvovaginitis\", section on 'Office diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Vaginal culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;If microscopy is negative, culture for Candida species or Trichomonas vaginalis (the choice is dictated by the clinical findings) is important because microscopy is not sufficiently sensitive to exclude these diagnoses in symptomatic patients. A diagnostic test card using nucleic acid amplification (NAAT), if available, is an acceptable alternative to culture if trichomoniasis is suspected. In one study, the sensitivity of microscopy for diagnosis of Candida species and Trichomonas vaginalis was only 22 and 62 percent, respectively, using Gram&rsquo;s stain as the standard [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/3\">",
"     3",
"    </a>",
"    ]. Sensitivity of microscopy is 50 percent compared to a standard of NAAT for trichomoniasis or culture for Candida species.",
"   </p>",
"   <p>",
"    Bacterial cultures are rarely indicated in women with vaginal discharge. In fact, they are frequently misleading since a large variety of bacterial species colonize the vagina and are not vaginal pathogens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/9\">",
"     9",
"    </a>",
"    ]; identification of these bacteria may lead to unnecessary antibacterial therapy. Apart from Group A streptococcus, a clear causal relationship between any bacteria and vaginitis has not been established in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Cervical culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;A diagnosis of cervicitis, typically due to Neisseria gonorrhoeae or Chlamydia trachomatis, must always be considered in women with purulent cervical discharge since women with this disorder may go on to develop PID and its potential complications. Any women with new or multiple sexual partners, a symptomatic sexual partner, or an otherwise unexplained cervical or vaginal discharge that contains a high number of PMNs should be tested for the presence of these organisms, by culture or an alternative sensitive test. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=see_link\">",
"     \"Acute cervicitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12175230\">",
"    <span class=\"h1\">",
"     WOMEN WITHOUT A DIAGNOSIS AFTER THE INITIAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3063536\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exclusion of the three common infectious causes of vaginitis, Candida vaginitis, bacterial vaginosis, and trichomoniasis, cannot be accomplished by history and physical examination only; all require specific diagnostic tests, as described above and in the topics on each infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=see_link\">",
"     \"Candida vulvovaginitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link\">",
"     \"Bacterial vaginosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=see_link\">",
"     \"Trichomonas vaginalis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following principles reflect the general approach to women in whom Candida vaginitis, bacterial vaginosis, and trichomoniasis have been ruled out:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the patient had minimal symptoms at the time of initial evaluation and the evaluation was nondiagnostic, it should be repeated at a second visit when she is symptomatic.",
"     </li>",
"     <li>",
"      Avoid empiric blind therapy, which often aggravates symptoms",
"     </li>",
"     <li>",
"      Determine vaginal pH, as it guides differential diagnosis: &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If pH is increased, consider non-infectious causes of vaginal symptoms, such as vaginal atrophy, atrophic vaginitis, erosive lichen planus, lichen sclerosus, desquamative inflammatory vaginitis, and pemphigoid syndromes",
"     </li>",
"     <li>",
"      If pH is normal, the vagina is likely to be normal with normal microbiome, so focus on the most common vulvar and external causes of vulvovaginal symptoms, such as contact or irritant dermatitis, seborrheic or eczematoid dermatitis, and psoriasis.",
"     </li>",
"     <li>",
"      Group A streptococcal vaginitis is associated with a normal or mildly increased pH, but this is a rare disease",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obtain information on the duration of symptoms (acute versus chronic disease), site of symptoms (vulva versus vagina), and whether there has been a recent change in sexual partner, as this information is also helpful in forming a differential diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1321296\">",
"    <span class=\"h3\">",
"     Detailed history",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following information from a detailed history may be helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Estrogen status",
"      </strong>",
"      - Is the woman menopausal or otherwise hypoestrogenic? Atrophic vaginitis is a common cause of vaginitis in hypoestrogenic women. In premenopausal women, hypoestrogenic settings include the postpartum period, lactation, and during administration of antiestrogenic drugs (and sometimes with low estrogen levels related to contraceptives). Menopausal women receiving hormone therapy may not have adequate estrogen levels for vaginal health and thus remain prone to atrophic vaginitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link\">",
"       \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Acuity and timing of symptoms",
"      </strong>",
"      - Are the symptoms acute, chronic, or recurrent? An acute process is likely to have an infectious etiology; a chronic process is more likely from inflammation unrelated to infection. If the woman has had recurrent episodes of vaginitis, look up the results of past diagnostic testing, the type of therapy she received, and her response to this therapy.",
"      <br/>",
"     </li>",
"     <li>",
"      <strong>",
"       Associated symptoms",
"      </strong>",
"      - Does the patient have pelvic pain or systemic symptoms (eg, fever, nausea)? Pelvic pain is suggestive of pelvic inflammatory disease (PID) and suprapubic pain is suggestive of cystitis; both are rare with vaginitis. The common causes of vaginitis are not associated with systemic symptoms. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link\">",
"       \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Sexual practices",
"      </strong>",
"      - What are the patient&rsquo;s sexual practices? What is the gender of her sex partner? Women who have sex with women are at increased risk of bacterial vaginosis. Has there been exposure to a new sexual partner? A new sexual partner increases the risk of acquiring sexually transmitted infections such as Trichomonas vaginalis, or cervicitis related to Neisseria gonorrhoeae or Chlamydia trachomatis. Is there a history of sexually transmitted infection? (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"       \"Screening for sexually transmitted infections\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Medication history",
"      </strong>",
"      - What medications (prescription and nonprescription) are being used? Antibiotics predispose to candidal vulvovaginitis; estrogen-progestin contraceptives can increase physiologic discharge; pruritus and burning unresponsive to antifungal agents may be due to vulvovaginal dermatitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/13/5336?source=see_link\">",
"       \"Dermatitis of the vulva\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Hygienic practices",
"      </strong>",
"      - What are the patient's hygienic practices? Mechanical, chemical, or allergic irritation may cause vulvovaginal symptoms (pruritus, burning) mistakenly attributed to an infectious source. Vaginal symptoms can result from irritants (eg, scented panty liners, spermicides, povidone-iodine, soaps and perfumes, and some topical drugs) and allergens (eg, latex condoms, topical antifungal agents, seminal fluid, chemical preservatives) that produce acute and chronic hypersensitivity reactions, including contact dermatitis. For women from the developing world, it is important to ask about vaginal practices using traditional products and medicines, as these can have adverse effects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/10\">",
"       10",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Careful assessment of the woman's personal practices is the best way to detect potential irritants and allergens in her environment and habits unhealthy for the vulvar skin. Patient",
"      <span class=\"nowrap\">",
"       symptom/contact",
"      </span>",
"      diaries may be helpful. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/13/5336?source=see_link\">",
"       \"Dermatitis of the vulva\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Medical history",
"      </strong>",
"      - Does the patient have a history of an oral mucosal, ocular, cutaneous, or systemic disease that could affect the vulvovaginal area? For example, herpes simplex virus and Beh&ccedil;et&rsquo;s disease can cause vulvovaginal ulcers. Women with diabetes are prone to vulvovaginal candidiasis. Women with human immunodeficiency virus (HIV) are prone to vaginal infections (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/35/16954?source=see_link\">",
"       \"HIV and women\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/35/16954?source=see_link&amp;anchor=H12#H12\">",
"       \"HIV and women\", section on 'Clinical manifestations in women'",
"      </a>",
"      ). After transplantation, graft versus host disease can cause vaginal irritation, discharge, ulceration, and stenosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Stevens-Johnson syndrome and toxic epidermal necrolysis have potentially severe vulvovaginal sequelae [",
"      <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Surgical history",
"      </strong>",
"      - Has the patient had recent transvaginal surgery or repair of perineal lacerations from childbirth? Vaginal symptoms may be related to a foreign body, bacterial infection, or granulation tissue.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1860693\">",
"    <span class=\"h2\">",
"     Irritants and allergens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal discharge can result from irritants (eg, scented panty liners, spermicides, povidone-iodine, soaps and perfumes, and some prescription and nonprescription topical medications) and allergens (eg, latex condoms, topical antifungal agents, seminal fluid, chemical preservatives) that produce acute and chronic hypersensitivity reactions, including contact dermatitis. Women from the developing world may have vaginal practices or use traditional products and medicines that have adverse effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnosis and management involve identifying and eliminating the offending agent by taking a thorough history and systematically removing potential irritants and allergens from the urogenital environment. Patient",
"    <span class=\"nowrap\">",
"     symptom/contact",
"    </span>",
"    diaries may be helpful. Corticosteroid therapy is indicated to control inflammation and relieve symptoms. We use a medium potency fluorinated topical steroid two to three times per day, as needed, until symptoms resolve (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"mobipreview.htm?38/56/39809\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of dermatitis\", section on 'Allergic contact dermatitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of dermatitis\", section on 'Irritant contact dermatitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=see_link\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636015\">",
"    <span class=\"h2\">",
"     Menopausal women",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21339655\">",
"    <span class=\"h3\">",
"     Atrophic vaginitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Menopausal women should be evaluated for atrophic vaginitis, which is a common diagnosis in this age group. Nonspecific signs and symptoms include a watery, white or yellow, and malodorous discharge; vaginal burning or irritation; dyspareunia; and urinary symptoms. Physical findings include thinning of the vaginal epithelium, loss of elasticity, loss of rugae, pH &ge;5, vaginal erosions, and cervicovaginal friability. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=see_link\">",
"     \"Clinical manifestations and diagnosis of vaginal atrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The wet mount is nonspecific, as similar findings occur in other inflammatory vaginal conditions. It shows parabasal cells, many polymorphonuclear leukocytes (PMNs), no lactobacilli, with or without background bacteria. Parabasal cells are immature squamous epithelial cells that are rounded and have a large nucleus-to-cytoplasm ratio; in contrast, mature squamous epithelial cells are larger, cuboidal, with a smaller nucleus-to-cytoplasm ratio, and sometimes folded. The presence of epithelial cells rather than parabasal cells and premenopausal status helps to distinguish bacterial vaginosis from atrophic vaginitis.",
"   </p>",
"   <p>",
"    Symptomatic response to topical estrogen therapy, which restores the vaginal epithelium, supports the diagnosis. Antibiotics are not needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/50/6954?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of vaginal atrophy\", section on 'Vaginal estrogen therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21339664\">",
"    <span class=\"h3\">",
"     Intraepithelial neoplasia and cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following disorders are more common in menopausal women:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vaginal intraepithelial neoplasia can present with vaginal discharge",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      postcoital spotting, although patients are usually asymptomatic. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5560?source=see_link\">",
"       \"Vaginal intraepithelial neoplasia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Vulvar intraepithelial neoplasia may cause vulvar pruritus (see",
"      <a class=\"local\" href=\"#H1860803\">",
"       'Vulvar intraepithelial neoplasia'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Fallopian tube cancer may present with a serosanguineous vaginal discharge and pelvic pain (see",
"      <a class=\"local\" href=\"#H23792213\">",
"       'Serosanguinous discharge and pelvic pain'",
"      </a>",
"      below).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636039\">",
"    <span class=\"h2\">",
"     Pruritus, with a negative Candida culture",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2343561\">",
"    <span class=\"h3\">",
"     Cytolytic vaginosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytolytic vaginosis refers to a rare syndrome of vaginal hyperacidity due to overgrowth of lactobacilli, although the existence of this entity is controversial. It is characterized by pruritus, dyspareunia, vulvar dysuria, and",
"    <strong>",
"     cyclical",
"    </strong>",
"    <strong>",
"     increase in symptoms",
"    </strong>",
"    during the luteal phase [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic criteria include presence of white vaginal discharge, pH between 3.5 and 4.5, Gram's stain showing overgrowth of lactobacilli, paucity of white blood cells, evidence of cytolysis (bare nuclei, shreds of cytoplasm), and exclusion of candidal infection by culture.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     Sodium bicarbonate",
"    </a>",
"    douches have been used for treatment. A solution of one rounded teaspoon of sodium bicarbonate in 600 mL of water is used for irrigating the vagina, once per day for 7 to 14 days. There are no data to support longer courses of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1860837\">",
"    <span class=\"h3\">",
"     Vulvar disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1860803\">",
"    <span class=\"h4\">",
"     Vulvar intraepithelial neoplasia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vulvar pruritus is the most common complaint among symptomatic women with vulvar intraepithelial neoplasia. Other presentations include a visible lesion, a palpable abnormality, perineal pain or burning, or dysuria. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32952?source=see_link\">",
"     \"Vulvar intraepithelial neoplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1860763\">",
"    <span class=\"h4\">",
"     Vulvar dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with vulvar dermatitis experience chronic vulvar irritation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pruritus; the vagina is sometimes affected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/13/5336?source=see_link\">",
"     \"Dermatitis of the vulva\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2343469\">",
"    <span class=\"h2\">",
"     Acute onset of purulent discharge and pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group A streptococcus (Streptococcus pyogenes [GAS]) is an uncommon cause of vulvovaginitis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. In one series of almost 7000 pregnant women, only 0.03 percent were colonized with GAS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/16\">",
"     16",
"    </a>",
"    ]. GAS vulvovaginitis typically occurs in prepubertal girls and in mothers whose children suffer from active GAS infection or who serve as GAS carriers. Carriage or exposure to a carrier is an important source of recurrent GAS infection. GAS can colonize and be transmitted from skin (especially in individuals with chronic dermatological conditions), nasopharynx, and the gastrointestinal tract (including the perianal area) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical features include acute onset of frankly purulent discharge accompanied by pruritus, soreness and irritation, erythema, labial edema, and possibly dysuria from burning of the skin with voiding. Microscopy of the discharge reveals a marked increase in PMNs and Gram's stain shows chains of gram-positive cocci.",
"   </p>",
"   <p>",
"    Penicillin treatment after confirmation of the diagnosis by culture rapidly leads to cure. We use Penicillin VK 500 mg four times daily for 10 to 14 days or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    cream 2% vaginally for 7 to 10 days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23792213\">",
"    <span class=\"h2\">",
"     Serosanguinous discharge and pelvic pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with fallopian tube carcinoma often present in the fifth or sixth decades with vague complaints, although the incidence of this cancer is very low. The type and frequency of so-called \"classic\" symptoms and signs associated with this malignancy are: serosanguineous vaginal discharge (50 to 60 percent), pelvic pain (30 to 50 percent), and a pelvic mass (12 to 61 percent); however, the full triad (Latzko's triad) is noted in fewer than 15 percent of patients. Hydrops tubae profluens, which refers to intermittent discharge of clear or blood-tinged fluid spontaneously or on pressure followed by shrinkage of the adnexal mass, has been described as pathognomonic of the disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=see_link&amp;anchor=H9533947#H9533947\">",
"     \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis\", section on 'Subacute presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636101\">",
"    <span class=\"h2\">",
"     Chronic introital pain as a primary symptom",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vestibulodynia refers to pain on penetration of the introitus and tenderness provoked by focal vestibular pressure. These symptoms should be present for at least three to six months and other causes of vestibular pain, such as vaginitis, should be excluded before making the diagnosis. Vaginal discharge and vaginal inflammation are typical features of vaginitis, but are not part of the clinical spectrum of vestibulodynia. Candidal vulvovaginitis may mimic localized, provoked vulvodynia, and may also be an initial trigger for this condition. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=see_link\">",
"     \"Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636141\">",
"    <span class=\"h2\">",
"     Postcoital vulvovaginal pruritus and pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seminal plasma allergy or hypersensitivity is a rare disorder characterized by postcoital vulvovaginal itching, burning, edema, and erythema with or without systemic signs and symptoms. Vaginal discharge is not a typical feature. Complaints occur immediately or within one hour after contact with seminal plasma. Most affected women are under age 40 years and have a family history of atopy.",
"   </p>",
"   <p>",
"    The diagnosis is based on absence of symptoms with condom use and on positive skin testing with a pooled sample of seminal fluid. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2392?source=see_link\">",
"     \"Allergic reactions to seminal plasma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28344329\">",
"    <span class=\"h2\">",
"     Desquamative inflammatory vaginitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Desquamative inflammatory vaginitis is a rare, chronic clinical syndrome of unknown etiology that usually occurs in perimenopausal women. Patients present with purulent vaginal discharge, vulvovaginal burning or irritation, dyspareunia, and vulvar and vaginal erythema. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37876?source=see_link\">",
"     \"Desquamative inflammatory vaginitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis requires all of the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At least one of the following symptoms: vaginal discharge, dyspareunia, pruritus, burning, irritation",
"     </li>",
"     <li>",
"      Vaginal inflammation (spotted ecchymotic rash, erythema, focal or linear erosion)",
"     </li>",
"     <li>",
"      Vaginal pH &gt;4.5",
"     </li>",
"     <li>",
"      Saline microscopy showing increased parabasal and inflammatory cells (ie, leukocyte to epithelial cell ratio greater than 1:1)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3649739\">",
"    <span class=\"h2\">",
"     Persistent genital malodor",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal odor of vaginal secretions cannot be clearly defined, but is probably slightly sour due to lactic acid and volatile sulfur compounds. Persistent genital malodor can seriously impair a woman&rsquo;s quality of life; the cause is difficult to identify after readily diagnosable causes have been excluded. These causes include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Neglected foreign body (including retained tampon)",
"     </li>",
"     <li>",
"      Bacterial vaginosis",
"     </li>",
"     <li>",
"      Trichomoniasis",
"     </li>",
"     <li>",
"      Infectious",
"      <span class=\"nowrap\">",
"       ulcer/pelvic",
"      </span>",
"      inflammatory disease (PID)",
"     </li>",
"     <li>",
"      Pelvic fistula (rectovaginal, vesicovaginal, ureterovaginal)",
"     </li>",
"     <li>",
"      Hidradenitis suppurativa",
"     </li>",
"     <li>",
"      Chronic constipation",
"     </li>",
"     <li>",
"      Urinary incontinence",
"     </li>",
"     <li>",
"      Fecal incontinence",
"     </li>",
"     <li>",
"      Poor hygiene",
"     </li>",
"     <li>",
"      Malignant ulcer",
"     </li>",
"     <li>",
"      Excessive genital perspiration and local bacterial colonization related to obesity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other potential causes of malodor include metabolic disorders (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=see_link&amp;anchor=H2366118#H2366118\">",
"     \"Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features\", section on 'Abnormal odors'",
"    </a>",
"    ), olfactory reference syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/20\">",
"     20",
"    </a>",
"    ], and olfactory hallucinations (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/41/18074?source=see_link&amp;anchor=H29#H29\">",
"     \"Nonepileptic paroxysmal disorders in adolescents and adults\", section on 'Olfactory hallucinations'",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Management depends on determining a cause. In the absence of poor hygiene, frequent washing and vaginal douching are not helpful and can be harmful. Excessive soaping of the genital area can cause a chemical vulvitis and douching (rinsing of the vagina with vinegar or an antiseptic with the aid of a douche bag) can increase the risk of vaginal and pelvic infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For women with an elevated vaginal pH or lack of lactobacilli on Gram stain of vaginal discharge, a trial of antibiotics for anaerobic infection is reasonable (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    500 mg orally twice daily for seven days). For women with no identifiable abnormalities, use of a specific medical grade stainless steel douching device (Water Works Douching Device&reg;) can be helpful. A randomized trial including 140 women with perceived vaginal odor and no vaginal infection reported significant improvement after douching daily for four weeks with tap water using this device [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/22\">",
"     22",
"    </a>",
"    ]. In the Water Works group, odor intensity scores fell from 7.3 to 1.8 (p&lt;.001), which was superior to that among women who used a conventional over-the-counter plastic douche bag, 7.2 to 3.4 (p&lt;.003).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636395\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following diagnoses are listed because clinicians sometimes attempt to diagnose and treat women for these conditions. We do not believe they are causes of vaginitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636460\">",
"    <span class=\"h3\">",
"     Group B streptococcus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Group B streptococcus (GBS) commonly colonizes the vagina: approximately 20 percent of women are colonized with GBS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/16,23\">",
"     16,23",
"    </a>",
"    ]. Whether GBS is a pathogen in vulvovaginitis is controversial. Some clinicians believe it has a pathogenic role in vulvovaginitis and report an ameliorative effect on vulvovaginal symptoms with antibiotic treatment (oral penicillin or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    cream). We and most experts do not believe this organism has a pathogenic role in symptomatic vulvovaginitis and that positive culture results merely reflect colonization, which is facilitated by disruption of the normal vaginal bacterial environment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/23\">",
"     23",
"    </a>",
"    ]. Therefore, in women with vaginitis, both GBS culture and treatment of positive culture results should be avoided.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H636467\">",
"    <span class=\"h3\">",
"     \"Non-specific bacterial vaginitis\"",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concept of non-specific bacterial vaginitis is no longer acceptable. In the past, many women with bacterial vaginosis were given the diagnosis of non-specific vaginitis, but this should no longer occur since clear diagnostic criteria for bacterial vaginosis are now available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H5#H5\">",
"     \"Bacterial vaginosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As discussed above, vaginal bacterial cultures are rarely indicated in women with vaginal discharge and are frequently misleading, leading to unnecessary antibacterial therapy. Apart from Group A streptococcus, a clear causal relationship between any bacteria and vaginitis has not been established.",
"   </p>",
"   <p>",
"    Treatment of infectious causes of vulvovaginitis should be targeted to the causative organism.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/17/39186?source=see_link\">",
"     Sulfanilamide",
"    </a>",
"    cream (eg, triple sulfa or AVC cream) has no role in the treatment of vulvovaginitis, as it is less effective than other therapies (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    for trichomonas vaginalis and bacterial vaginosis,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    for candida vulvovaginitis) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?35/49/36633/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12175163\">",
"    <span class=\"h1\">",
"     POSTDIAGNOSTIC MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a confirmed diagnosis are treated, as appropriate. (See individual topic reviews). Trichomoniasis is a sexually transmitted infection. Infected patients are at increased risk of acquiring other sexually transmitted diseases. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=see_link\">",
"     \"Screening for sexually transmitted infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186474307\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF PHYSIOLOGICAL LEUKORRHEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;After exclusion of pathological causes of vaginal discharge, women with a change in their normal vaginal discharge can be reassured that changes in the volume and character of vaginal discharge are normal and can be due to changes in diet, sexual activity, medication, stress, etc. Although hormonal therapy, such as depot",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    injection every three months or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/52/16199?source=see_link\">",
"     norethindrone acetate",
"    </a>",
"    5 mg orally daily, will decrease estrogen levels and thus may decrease physiological leukorrhea, the use of hormonal therapy for this indication alone is rarely appropriate given the side effects and risks associated with these drugs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/50/33570?source=see_link\">",
"       \"Patient information: Vaginal discharge in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/54/33634?source=see_link\">",
"       \"Patient information: Vulvar itching (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/44/40641?source=see_link\">",
"       \"Patient information: Vaginal discharge in adult women (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/53/2899?source=see_link\">",
"       \"Patient information: Vaginal yeast infection (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/43/36529?source=see_link\">",
"       \"Patient information: Bacterial vaginosis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=see_link\">",
"       \"Patient information: Gonorrhea (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=see_link\">",
"       \"Patient information: Chlamydia (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vaginitis is the general term for disorders of the vagina caused by infection, inflammation, or changes in the normal vaginal flora. Signs and symptoms are similar, irrespective of the underlying etiology. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H635661\">",
"       'Causes of vaginitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with vaginitis typically present with one or more of the following: change in vaginal discharge, pruritus, burning, irritation, erythema, dyspareunia, spotting, and dysuria. (See",
"      <a class=\"local\" href=\"#H635499\">",
"       'Patient presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic evaluation for bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis is important since these disorders account for over 90 percent of vaginitis in premenopausal women. (See",
"      <a class=\"local\" href=\"#H635661\">",
"       'Causes of vaginitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H635637\">",
"       'General principles of evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical findings may suggest a particular diagnosis (",
"      <a class=\"graphic graphic_table graphicRef81449 \" href=\"mobipreview.htm?39/6/40043\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef68759 \" href=\"mobipreview.htm?38/29/39388\">",
"       table 2",
"      </a>",
"      ). Measurement of vaginal pH is the single most important finding that drives the diagnostic process and should always be determined. Laboratory documentation of the etiology of vaginitis is mandatory before initiating therapy, given the nonspecific nature of the symptoms. Empiric therapy should be avoided because of frequent misdiagnosis and inappropriate therapy when assessment is based on history and physical examination alone. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Trichomonas is classically associated with a greenish-yellow purulent discharge; candidiasis with a thick, white, adherent, \"cottage cheese-like\" discharge; and bacterial vaginosis with a thin, homogeneous, \"fishy smelling\" gray discharge. However, the appearance of the discharge is not a reliable basis for diagnosis. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Saline microscopy should be performed to look for candidal buds or hyphae (",
"      <a class=\"graphic graphic_picture graphicRef59030 \" href=\"mobipreview.htm?9/37/9809\">",
"       picture 4",
"      </a>",
"      ), motile trichomonads (",
"      <a class=\"graphic graphic_picture graphicRef71667 \" href=\"mobipreview.htm?41/1/42014\">",
"       picture 5",
"      </a>",
"      ), epithelial cells studded with adherent coccobacilli (clue cells suggesting bacterial vaginosis (",
"      <a class=\"graphic graphic_picture graphicRef73248 \" href=\"mobipreview.htm?36/29/37332\">",
"       picture 7",
"      </a>",
"      )), and polymorphonuclear cells. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Microscopy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial office evaluation (history and physical examination, vaginal pH, wet mount microscopy, whiff test) correctly diagnoses 60 percent of Candida vulvovaginitis, 70 percent of trichomoniasis, and 90 percent of bacterial vaginosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest culture for Candida species or Trichomonas vaginalis (or a rapid antigen and nucleic acid amplification test), as indicated by clinical findings, if microscopy is negative because microscopy is not sufficiently sensitive to exclude these diagnoses in symptomatic patients. Bacterial cultures are rarely indicated in women with vaginal discharge. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Vaginal culture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the woman had minimal symptoms at the time of initial evaluation and the evaluation was nondiagnostic, the evaluation should be repeated at a second visit when she is symptomatic. In other cases, less common and rare infectious and inflammatory disorders need to be considered. (See",
"      <a class=\"local\" href=\"#H12175230\">",
"       'Women without a diagnosis after the initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/1\">",
"      Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/2\">",
"      Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Womens Health 1998; 7:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/3\">",
"      Landers DV, Wiesenfeld HC, Heine RP, et al. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol 2004; 190:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/4\">",
"      Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999; 25:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/5\">",
"      Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. JAMA 2004; 291:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/6\">",
"      Allen-Davis JT, Beck A, Parker R, et al. Assessment of vulvovaginal complaints: accuracy of telephone triage and in-office diagnosis. Obstet Gynecol 2002; 99:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/7\">",
"      Carr PL, Rothberg MB, Friedman RH, et al. \"Shotgun\" versus sequential testing. Cost-effectiveness of diagnostic strategies for vaginitis. J Gen Intern Med 2005; 20:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/8\">",
"      Sobel JD. Erosive Vulvovaginitis. Curr Infect Dis Rep 2003; 5:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/9\">",
"      Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 2011; 118:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/10\">",
"      Hull T, Hilber AM, Chersich MF, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Womens Health (Larchmt) 2011; 20:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/11\">",
"      Zantomio D, Grigg AP, MacGregor L, et al. Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management. Bone Marrow Transplant 2006; 38:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/12\">",
"      Spiryda LB, Laufer MR, Soiffer RJ, Antin JA. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biol Blood Marrow Transplant 2003; 9:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/13\">",
"      Kaser DJ, Reichman DE, Laufer MR. Prevention of vulvovaginal sequelae in stevens-johnson syndrome and toxic epidermal necrolysis. Rev Obstet Gynecol 2011; 4:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/14\">",
"      Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol 1991; 165:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/15\">",
"      Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol 2004; 12:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/16\">",
"      Mead PB, Winn WC. Vaginal-rectal colonization with group A streptococci in late pregnancy. Infect Dis Obstet Gynecol 2000; 8:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/17\">",
"      Bray S, Morgan J. Two cases of group A streptococcal vulvovaginitis in premenopausal adults in a sexual health setting. Sex Health 2006; 3:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/18\">",
"      Sobel JD, Funaro D, Kaplan EL. Recurrent group A streptococcal vulvovaginitis in adult women: family epidemiology. Clin Infect Dis 2007; 44:e43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/19\">",
"      Subramanian C, Nyirjesy P, Sobel JD. Genital malodor in women: a modern reappraisal. J Low Genit Tract Dis 2012; 16:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/20\">",
"      Begum M, McKenna PJ. Olfactory reference syndrome: a systematic review of the world literature. Psychol Med 2011; 41:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/21\">",
"      Grimley DM, Annang L, Foushee HR, et al. Vaginal douches and other feminine hygiene products: women's practices and perceptions of product safety. Matern Child Health J 2006; 10:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/22\">",
"      Hassan S, Chatwani A, Brovender H, et al. Douching for perceived vaginal odor with no infectious cause of vaginitis: a randomized controlled trial. J Low Genit Tract Dis 2011; 15:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/23\">",
"      Leclair CM, Hart AE, Goetsch MF, et al. Group B streptococcus: prevalence in a non-obstetric population. J Low Genit Tract Dis 2010; 14:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/24\">",
"      Rein MF. Current therapy of vulvovaginitis. Sex Transm Dis 1981; 8:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?35/49/36633/abstract/25\">",
"      duBouchet L, Spence MR, Rein MF, et al. Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis. Sex Transm Dis 1997; 24:156.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5477 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-197.136.42.3-0869272E05-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36633=[""].join("\n");
var outline_f35_49_36633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H635661\">",
"      CAUSES OF VAGINITIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1860628\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H635499\">",
"      PATIENT PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H635637\">",
"      GENERAL PRINCIPLES OF EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3894620\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnostic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Vaginal pH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Microscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H87576964\">",
"      Saline wet mount",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H87576971\">",
"      Potassium hydroxide wet mount",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H87577006\">",
"      - Amine test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2343327\">",
"      - Options when microscopy is not available",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Vaginal culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Cervical culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12175230\">",
"      WOMEN WITHOUT A DIAGNOSIS AFTER THE INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3063536\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1321296\">",
"      - Detailed history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1860693\">",
"      Irritants and allergens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H636015\">",
"      Menopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21339655\">",
"      - Atrophic vaginitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21339664\">",
"      - Intraepithelial neoplasia and cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H636039\">",
"      Pruritus, with a negative Candida culture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2343561\">",
"      - Cytolytic vaginosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1860837\">",
"      - Vulvar disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1860803\">",
"      Vulvar intraepithelial neoplasia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H1860763\">",
"      Vulvar dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2343469\">",
"      Acute onset of purulent discharge and pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23792213\">",
"      Serosanguinous discharge and pelvic pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H636101\">",
"      Chronic introital pain as a primary symptom",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H636141\">",
"      Postcoital vulvovaginal pruritus and pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28344329\">",
"      Desquamative inflammatory vaginitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3649739\">",
"      Persistent genital malodor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H636395\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H636460\">",
"      - Group B streptococcus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H636467\">",
"      - \"Non-specific bacterial vaginitis\"",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12175163\">",
"      POSTDIAGNOSTIC MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186474307\">",
"      MANAGEMENT OF PHYSIOLOGICAL LEUKORRHEA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5477\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5477|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/30/19942\" title=\"picture 1\">",
"      Condyloma acuminatum3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?35/17/36114\" title=\"picture 2\">",
"      Chlamydia cervicitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/46/12005\" title=\"picture 3\">",
"      Budding yeast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/37/9809\" title=\"picture 4\">",
"      Candida albicans vaginitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/1/42014\" title=\"picture 5\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/47/21240\" title=\"picture 6\">",
"      Clue cell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/29/37332\" title=\"picture 7\">",
"      Clue cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5477|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/6/40043\" title=\"table 1\">",
"      Likelihood vaginitis by symptom",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/29/39388\" title=\"table 2\">",
"      Clinical features of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/56/39809\" title=\"table 3\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/4/64?source=related_link\">",
"      Acute cervicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/21/2392?source=related_link\">",
"      Allergic reactions to seminal plasma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/1/15386?source=related_link\">",
"      Candida vulvovaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=related_link\">",
"      Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/54/8039?source=related_link\">",
"      Clinical manifestations and diagnosis of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/38/23144?source=related_link\">",
"      Condylomata acuminata (anogenital warts)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=related_link\">",
"      Congenital cervical anomalies and benign cervical lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/13/5336?source=related_link\">",
"      Dermatitis of the vulva",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/63/37876?source=related_link\">",
"      Desquamative inflammatory vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/6/31849?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/35/16954?source=related_link\">",
"      HIV and women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/58/24489?source=related_link\">",
"      Inborn errors of metabolism: Epidemiology, pathogenesis, and clinical features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/41/18074?source=related_link\">",
"      Nonepileptic paroxysmal disorders in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/43/36529?source=related_link\">",
"      Patient information: Bacterial vaginosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/44/40641?source=related_link\">",
"      Patient information: Vaginal discharge in adult women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/50/33570?source=related_link\">",
"      Patient information: Vaginal discharge in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?2/53/2899?source=related_link\">",
"      Patient information: Vaginal yeast infection (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/54/33634?source=related_link\">",
"      Patient information: Vulvar itching (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32951?source=related_link\">",
"      Rectovaginal, anovaginal, and colovesical fistulas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/30/490?source=related_link\">",
"      Screening for sexually transmitted infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/50/6954?source=related_link\">",
"      Treatment of vaginal atrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/34/27178?source=related_link\">",
"      Treatment of vulvar and vaginal warts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1881?source=related_link\">",
"      Trichomonas vaginalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44792?source=related_link\">",
"      Urogenital tract fistulas in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/27/5560?source=related_link\">",
"      Vaginal intraepithelial neoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/11/32952?source=related_link\">",
"      Vulvar intraepithelial neoplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f35_49_36634="Pyogenic granuloma 2";
var content_f35_49_36634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F52128%7EDERM%2F52429%7EDERM%2F60189%7EDERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F52128%7EDERM%2F52429%7EDERM%2F60189%7EDERM%2F67395&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma on the finger",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A rapidly growing, red, dome-shaped, friable papule with a collarette of scale is consistent with a pyogenic granuloma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fleisher, GR, Ludwig, S, Baskin, MN. Atlas of Pediatric Emergency Medicine, Lippincott Williams &amp; Wilkins, Philadelphia 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pyogenic granuloma: the epithelial \"collarette\" can be seen at the base of the lesion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma of the lip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyogenic granuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A red, protruding vascular papule consistent with a pyogenic granuloma is present on the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36634=[""].join("\n");
var outline_f35_49_36634=null;
var title_f35_49_36635="Healthy vulval hygiene practice";
var content_f35_49_36635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F64538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F64538&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Healthy vulval hygiene practices",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Avoid",
"      </td>",
"      <td class=\"subtitle1\">",
"       Substitute",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\" rowspan=\"2\">",
"       Pantyhose",
"      </td>",
"      <td>",
"       Stockings with a garter belt",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Thigh high or knee high stockings",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Synthetic underwear",
"      </td>",
"      <td>",
"       Cotton underwear or no underwear",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Jeans and other tight pants",
"      </td>",
"      <td>",
"       Loose pants, skirts, dresses",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Swimsuits, leotards, thongs, lycra garments",
"      </td>",
"      <td>",
"       Loose-fitting cotton garments",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pantyliners",
"      </td>",
"      <td>",
"       Tampons or cotton pads",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Scented soaps or shampoos",
"      </td>",
"      <td>",
"       Fragrance free pH neutral soap (eg, Basis, Neutrogena, Dove soap)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bubble bath",
"      </td>",
"      <td>",
"       Tub baths in the morning and at night without additives and at a comfortable temperature",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Scented detergents",
"      </td>",
"      <td>",
"       Unscented detergents",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Washcloths",
"      </td>",
"      <td>",
"       Use fingertips for washing; pat dry, don't rub dry",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Feminine sprays, douches, powders",
"      </td>",
"      <td>",
"       These are not necessary products and can be omitted from personal practices",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dyed toilet articles",
"      </td>",
"      <td>",
"       Toilet articles without dyes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hair dryers to dry vulva skin without contact",
"      </td>",
"      <td>",
"       Dry vulva by gentle patting",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36635=[""].join("\n");
var outline_f35_49_36635=null;
var title_f35_49_36636="Example exposure hierarchy for snake phobia";
var content_f35_49_36636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F83263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F83263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Example exposure hierarchy for snake phobia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Step",
"       </td>",
"       <td class=\"subtitle1\">",
"        Situation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Fear rating",
"        <br/>",
"        (0-100)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Avoidance rating",
"        <br/>",
"        (0-100)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td>",
"        Hold a live snake",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"       <td>",
"        Touch a live snake being held by another person",
"       </td>",
"       <td class=\"centered\">",
"        98",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"       <td>",
"        Stand in front of someone holding a live snake",
"       </td>",
"       <td class=\"centered\">",
"        95",
"       </td>",
"       <td class=\"centered\">",
"        98",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        4",
"       </td>",
"       <td>",
"        Stand 3 feet from someone holding a live snake",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"       <td class=\"centered\">",
"        95",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        5",
"       </td>",
"       <td>",
"        Stand 1 foot from an aquarium holding a live snake",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        6",
"       </td>",
"       <td>",
"        Walk on a trail in the woods",
"       </td>",
"       <td class=\"centered\">",
"        85",
"       </td>",
"       <td class=\"centered\">",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        7",
"       </td>",
"       <td>",
"        Stand 3 feet from an aquarium holding a live snake",
"       </td>",
"       <td class=\"centered\">",
"        85",
"       </td>",
"       <td class=\"centered\">",
"        90",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        8",
"       </td>",
"       <td>",
"        Watch a video of live snakes",
"       </td>",
"       <td class=\"centered\">",
"        75",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        9",
"       </td>",
"       <td>",
"        Hold a rubber snake",
"       </td>",
"       <td class=\"centered\">",
"        70",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        10",
"       </td>",
"       <td>",
"        Sit 3 feet away from a rubber snake",
"       </td>",
"       <td class=\"centered\">",
"        65",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        11",
"       </td>",
"       <td>",
"        Touch a picture of a snake",
"       </td>",
"       <td class=\"centered\">",
"        60",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td>",
"        Look at a picture of a snake",
"       </td>",
"       <td class=\"centered\">",
"        55",
"       </td>",
"       <td class=\"centered\">",
"        75",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        13",
"       </td>",
"       <td>",
"        Say the word snake",
"       </td>",
"       <td class=\"centered\">",
"        45",
"       </td>",
"       <td class=\"centered\">",
"        75",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36636=[""].join("\n");
var outline_f35_49_36636=null;
var title_f35_49_36637="Clopidogrel in CREDO one year";
var content_f35_49_36637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F80138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F80138&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 511px\">",
"   <div class=\"ttl\">",
"    Clopidogrel after PCI",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 491px; height: 363px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Data from the CREDO trial of more than 2100 patients undergoing elective percutaneous coronary intervention (PCI), almost all with stenting, who were treated with a loading dose of clopidogrel or placebo before the procedure and then clopidogrel for 28 days; clopidogrel or placebo, according to original randomization, was then given for the remainder of one year. The combined end point of death, myocardial infarction, or stroke at one year occurred significantly less often in those treated with clopidogrel (relative risk reduction 26.9 percent, 95 percent CI 3.9 to 44.4 percent).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Steinhubl SR, Berger PB, Mann JT 3rd, et al. JAMA 2002; 288:2411.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36637=[""].join("\n");
var outline_f35_49_36637=null;
var title_f35_49_36638="Traumatic knee effusion";
var content_f35_49_36638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F52601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F52601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Posttraumatic knee effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 266px; height: 394px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The lateral view of the knee demonstrates suprapatellar soft tissue density (arrow) consistent with joint effusion in a patient with patellar fracture.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36638=[""].join("\n");
var outline_f35_49_36638=null;
var title_f35_49_36639="Grade I nipple inversion";
var content_f35_49_36639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F51390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F51390&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Grade I nipple inversion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In Grade I nipple inversion, the nipple is easily pulled out with gentle retraction or squeezing of the areolar skin. Nipple projection is well maintained for several minutes but then the nipple reverts to an inverted state.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f35_49_36639=[""].join("\n");
var outline_f35_49_36639=null;
